Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.
Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Neoplasms containing cyst-like formations or producing mucin or serum.
Tumors or cancer of the SKIN.
Two or more abnormal growths of tissue occurring simultaneously and presumed to be of separate origin. The neoplasms may be histologically the same or different, and may be found in the same or different sites.
Tumors or cancers of the KIDNEY.
Abnormal growths of tissue that follow a previous neoplasm but are not metastases of the latter. The second neoplasm may have the same or different histological type and can occur in the same or different organs as the previous neoplasm but in all cases arises from an independent oncogenic event. The development of the second neoplasm may or may not be related to the treatment for the previous neoplasm since genetic risk or predisposing factors may actually be the cause.
An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed)
Tumors or cancer of the THYROID GLAND.
Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.
DNA present in neoplastic tissue.
Tumors or cancer of the LUNG.
Tumors or cancer of the PAROTID GLAND.
A benign neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. In some instances, considerable portions of the neoplasm, or even the entire mass, may be cystic. (Stedman, 25th ed)
Neoplasms developing from some structure of the connective and subcutaneous tissue. The concept does not refer to neoplasms located in connective or soft tissue.
Neoplasms associated with a proliferation of a single clone of PLASMA CELLS and characterized by the secretion of PARAPROTEINS.
Tumors or cancer of the APPENDIX.
Tumors or cancer of the LIVER.
A multilocular tumor with mucin secreting epithelium. They are most often found in the ovary, but are also found in the pancreas, appendix, and rarely, retroperitoneal and in the urinary bladder. They are considered to have low-grade malignant potential.
Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
Tumors or cancer of the ENDOCRINE GLANDS.
Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL.
Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.
Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms.
Neoplasms composed of vascular tissue. This concept does not refer to neoplasms located in blood vessels.
Tumors or cancer of the EYE.
Histochemical localization of immunoreactive substances using labeled antibodies as reagents.
Tumors or cancer of the NOSE.
Tumors or cancer of the SALIVARY GLANDS.
Tumors, cancer or other neoplasms produced by exposure to ionizing or non-ionizing radiation.
An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. (Stedman, 25th ed)
A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed)
Tumors or cancer of the TESTIS. Germ cell tumors (GERMINOMA) of the testis constitute 95% of all testicular neoplasms.
Neoplasms composed of muscle tissue: skeletal, cardiac, or smooth. The concept does not refer to neoplasms located in muscles.
Neoplasms composed of glandular tissue, an aggregation of epithelial cells that elaborate secretions, and of any type of epithelium itself. The concept does not refer to neoplasms located in the various glands or in epithelial tissue.
A malignant cystic or semisolid tumor most often occurring in the ovary. Rarely, one is solid. This tumor may develop from a mucinous cystadenoma, or it may be malignant at the onset. The cysts are lined with tall columnar epithelial cells; in others, the epithelium consists of many layers of cells that have lost normal structure entirely. In the more undifferentiated tumors, one may see sheets and nests of tumor cells that have very little resemblance to the parent structure. (Hughes, Obstetric-Gynecologic Terminology, 1972, p184)
A benign epithelial tumor with a glandular organization.
Neoplasms of whatever cell type or origin, occurring in the extraskeletal connective tissue framework of the body including the organs of locomotion and their various component structures, such as nerves, blood vessels, lymphatics, etc.
Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.
Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm.
Tumors or cancer of the UTERUS.
Tumors or cancer of the INTESTINES.
Neoplasms composed of sebaceous or sweat gland tissue or tissue of other skin appendages. The concept does not refer to neoplasms located in the sebaceous or sweat glands or in the other skin appendages.
Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.
Neoplasms located in the vasculature system, such as ARTERIES and VEINS. They are differentiated from neoplasms of vascular tissue (NEOPLASMS, VASCULAR TISSUE), such as ANGIOFIBROMA or HEMANGIOMA.
A general term for various neoplastic diseases of the lymphoid tissue.
Tumors or cancer located in bone tissue or specific BONES.
Tumors or cancer of the PALATE, including those of the hard palate, soft palate and UVULA.
Neoplasms composed of more than one type of neoplastic tissue.
Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin.
Tumors or cancer of the MANDIBLE.
A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed)
Tumors or cancer of the BILE DUCTS.
Ability of neoplasms to infiltrate and actively destroy surrounding tissue.
Tumors or cancer of the THYMUS GLAND.
Tumors or cancer of the SPLEEN.
Tumors in any part of the heart. They include primary cardiac tumors and metastatic tumors to the heart. Their interference with normal cardiac functions can cause a wide variety of symptoms including HEART FAILURE; CARDIAC ARRHYTHMIAS; or EMBOLISM.
A cystic tumor of the ovary, containing thin, clear, yellow serous fluid and varying amounts of solid tissue, with a malignant potential several times greater than that of mucinous cystadenoma (CYSTADENOMA, MUCINOUS). It can be unilocular, parvilocular, or multilocular. It is often bilateral and papillary. The cysts may vary greatly in size. (Dorland, 27th ed; from Hughes, Obstetric-Gynecologic Terminology, 1972)
Tumors or cancer of the COLON.
Cancer or tumors of the MAXILLA or upper jaw.
Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or body fluids. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including hormones, antigens, amino and nucleic acids, enzymes, polyamines, and specific cell membrane proteins and lipids.
Diseases of the domestic dog (Canis familiaris). This term does not include diseases of wild dogs, WOLVES; FOXES; and other Canidae for which the heading CARNIVORA is used.
Tumors or cancer of the anal gland.
Neoplasms composed of primordial GERM CELLS of embryonic GONADS or of elements of the germ layers of the EMBRYO, MAMMALIAN. The concept does not refer to neoplasms located in the gonads or present in an embryo or FETUS.
Neoplasms located in the bone marrow. They are differentiated from neoplasms composed of bone marrow cells, such as MULTIPLE MYELOMA. Most bone marrow neoplasms are metastatic.
Neoplasms composed of fatty tissue or connective tissue made up of fat cells in a meshwork of areolar tissue. The concept does not refer to neoplasms located in adipose tissue.
Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
Benign and malignant neoplastic processes that arise from or secondarily involve the meningeal coverings of the brain and spinal cord.
Tumors or cancer of the DUODENUM.
Tumors or cancers of the ADRENAL CORTEX.
Tumors or cancer of the MOUTH.
Tumors or cancer of the MEDIASTINUM.
Tumors or cancer of the TONGUE.
Tumors or cancer in the ILEUM region of the small intestine (INTESTINE, SMALL).
Tumors or cancer of the STOMACH.
Tumors or cancer of the URINARY BLADDER.
A malignant tumor arising from secreting cells of a racemose gland, particularly the salivary glands. Racemose (Latin racemosus, full of clusters) refers, as does acinar (Latin acinus, grape), to small saclike dilatations in various glands. Acinar cell carcinomas are usually well differentiated and account for about 13% of the cancers arising in the parotid gland. Lymph node metastasis occurs in about 16% of cases. Local recurrences and distant metastases many years after treatment are common. This tumor appears in all age groups and is most common in women. (Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1240; from DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p575)
Benign and malignant neoplasms which occur within the substance of the spinal cord (intramedullary neoplasms) or in the space between the dura and spinal cord (intradural extramedullary neoplasms). The majority of intramedullary spinal tumors are primary CNS neoplasms including ASTROCYTOMA; EPENDYMOMA; and LIPOMA. Intramedullary neoplasms are often associated with SYRINGOMYELIA. The most frequent histologic types of intradural-extramedullary tumors are MENINGIOMA and NEUROFIBROMA.
Tumors or cancer of the VAGINA.
A usually benign glandular tumor composed of oxyphil cells, large cells with small irregular nuclei and dense acidophilic granules due to the presence of abundant MITOCHONDRIA. Oxyphil cells, also known as oncocytes, are found in oncocytomas of the kidney, salivary glands, and endocrine glands. In the thyroid gland, oxyphil cells are known as Hurthle cells and Askanazy cells.
The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.
Benign and malignant neoplastic processes arising from or involving components of the central, peripheral, and autonomic nervous systems, cranial nerves, and meninges. Included in this category are primary and metastatic nervous system neoplasms.
A Janus kinase subtype that is involved in signaling from GROWTH HORMONE RECEPTORS; PROLACTIN RECEPTORS; and a variety of CYTOKINE RECEPTORS such as ERYTHROPOIETIN RECEPTORS and INTERLEUKIN RECEPTORS. Dysregulation of Janus kinase 2 due to GENETIC TRANSLOCATIONS have been associated with a variety of MYELOPROLIFERATIVE DISORDERS.
The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.
Tumors or cancer located in muscle tissue or specific muscles. They are differentiated from NEOPLASMS, MUSCLE TISSUE which are neoplasms composed of skeletal, cardiac, or smooth muscle tissue, such as MYOSARCOMA or LEIOMYOMA.
Experimentally induced tumors of the LIVER.
A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed)
A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm but is often wrongly used as a synonym for "cancer." (From Dorland, 27th ed)
A malignant epithelial tumor with a glandular organization.
Clonal myeloid disorders that possess both dysplastic and proliferative features but are not properly classified as either MYELODYSPLASTIC SYNDROMES or MYELOPROLIFERATIVE DISORDERS.
Surgical removal of the pancreas. (Dorland, 28th ed)
Neoplasms which arise from peripheral nerve tissue. This includes NEUROFIBROMAS; SCHWANNOMAS; GRANULAR CELL TUMORS; and malignant peripheral NERVE SHEATH NEOPLASMS. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 5th ed, pp1750-1)
Neoplasms located in the brain ventricles, including the two lateral, the third, and the fourth ventricle. Ventricular tumors may be primary (e.g., CHOROID PLEXUS NEOPLASMS and GLIOMA, SUBEPENDYMAL), metastasize from distant organs, or occur as extensions of locally invasive tumors from adjacent brain structures.
Tumors or cancer of the PARANASAL SINUSES.
Neoplasms of the thin serous membrane that envelopes the lungs and lines the thoracic cavity. Pleural neoplasms are exceedingly rare and are usually not diagnosed until they are advanced because in the early stages they produce no symptoms.
Tumors or cancer of the human BREAST.
Tomography using x-ray transmission and a computer algorithm to reconstruct the image.
Tumor or cancer of the COMMON BILE DUCT including the AMPULLA OF VATER and the SPHINCTER OF ODDI.
Neoplasms of the bony orbit and contents except the eyeball.
Primary or metastatic neoplasms of the CEREBELLUM. Tumors in this location frequently present with ATAXIA or signs of INTRACRANIAL HYPERTENSION due to obstruction of the fourth ventricle. Common primary cerebellar tumors include fibrillary ASTROCYTOMA and cerebellar HEMANGIOBLASTOMA. The cerebellum is a relatively common site for tumor metastases from the lung, breast, and other distant organs. (From Okazaki & Scheithauer, Atlas of Neuropathology, 1988, p86 and p141)
A benign tumor composed of fat cells (ADIPOCYTES). It can be surrounded by a thin layer of connective tissue (encapsulated), or diffuse without the capsule.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
A collective term for precoordinated organ/neoplasm headings locating neoplasms by organ, as BRAIN NEOPLASMS; DUODENAL NEOPLASMS; LIVER NEOPLASMS; etc.
Tumors or cancer of the BRONCHI.
Tumors or cancer of the PERITONEUM.
Distinctive neoplastic disorders of histiocytes. Included are malignant neoplasms of MACROPHAGES and DENDRITIC CELLS.
Tumors or cancer of the UROGENITAL SYSTEM in either the male or the female.
Neoplasms of the bony part of the skull.
Tumors or cancer of the VULVA.
Neoplasms composed of neuroepithelial cells, which have the capacity to differentiate into NEURONS, oligodendrocytes, and ASTROCYTES. The majority of craniospinal tumors are of neuroepithelial origin. (From Dev Biol 1998 Aug 1;200(1):1-5)
Tumors or cancer of any part of the hearing and equilibrium system of the body (the EXTERNAL EAR, the MIDDLE EAR, and the INNER EAR).
Tumors or cancer of the LIP.
A benign tumor of fibrous or fully developed connective tissue.
Experimental transplantation of neoplasms in laboratory animals for research purposes.
Tumors or cancer of the ADRENAL GLANDS.
Tumors or cancer of the pelvic region.
Tumors or cancer of the gallbladder.
The local implantation of tumor cells by contamination of instruments and surgical equipment during and after surgical resection, resulting in local growth of the cells and tumor formation.
Neoplasms composed of fibrous and epithelial tissue. The concept does not refer to neoplasms located in fibrous tissue or epithelium.
Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept.
Neoplasms composed of connective tissue, including elastic, mucous, reticular, osseous, and cartilaginous tissue. The concept does not refer to neoplasms located in connective tissue.
Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.
Methods which attempt to express in replicable terms the level of CELL DIFFERENTIATION in neoplasms as increasing ANAPLASIA correlates with the aggressiveness of the neoplasm.
A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone.
A myeloproliferative disorder of unknown etiology, characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute increase in red cell mass and total blood volume, associated frequently with splenomegaly, leukocytosis, and thrombocythemia. Hematopoiesis is also reactive in extramedullary sites (liver and spleen). In time myelofibrosis occurs.
A clinical syndrome characterized by repeated spontaneous hemorrhages and a remarkable increase in the number of circulating platelets.
RNA present in neoplastic tissue.
Trophoblastic growth, which may be gestational or nongestational in origin. Trophoblastic neoplasia resulting from pregnancy is often described as gestational trophoblastic disease to distinguish it from germ cell tumors which frequently show trophoblastic elements, and from the trophoblastic differentiation which sometimes occurs in a wide variety of epithelial cancers. Gestational trophoblastic growth has several forms, including HYDATIDIFORM MOLE and CHORIOCARCINOMA. (From Holland et al., Cancer Medicine, 3d ed, p1691)
A vascular anomaly due to proliferation of BLOOD VESSELS that forms a tumor-like mass. The common types involve CAPILLARIES and VEINS. It can occur anywhere in the body but is most frequently noticed in the SKIN and SUBCUTANEOUS TISSUE. (from Stedman, 27th ed, 2000)
Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651)
Diseases of rodents of the order RODENTIA. This term includes diseases of Sciuridae (squirrels), Geomyidae (gophers), Heteromyidae (pouched mice), Castoridae (beavers), Cricetidae (rats and mice), Muridae (Old World rats and mice), Erethizontidae (porcupines), and Caviidae (guinea pigs).
Tumors or cancer of the CECUM.
A malignant disease of the B-LYMPHOCYTES in the bone marrow and/or blood.
A neoplasm derived from blood vessels, characterized by numerous prominent endothelial cells that occur singly, in aggregates, and as the lining of congeries of vascular tubes or channels. Hemangioendotheliomas are relatively rare and are of intermediate malignancy (between benign hemangiomas and conventional angiosarcomas). They affect men and women about equally and rarely develop in childhood. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1866)
A benign, slow-growing tumor, most commonly of the salivary gland, occurring as a small, painless, firm nodule, usually of the parotid gland, but also found in any major or accessory salivary gland anywhere in the oral cavity. It is most often seen in women in the fifth decade. Histologically, the tumor presents a variety of cells: cuboidal, columnar, and squamous cells, showing all forms of epithelial growth. (Dorland, 27th ed)
Tumors or cancer of the DIGESTIVE SYSTEM.
An adenocarcinoma of the thyroid gland, in which the cells are arranged in the form of follicles. (From Dorland, 27th ed)
Tumors or cancer in the JEJUNUM region of the small intestine (INTESTINE, SMALL).
A group of carcinomas which share a characteristic morphology, often being composed of clusters and trabecular sheets of round "blue cells", granular chromatin, and an attenuated rim of poorly demarcated cytoplasm. Neuroendocrine tumors include carcinoids, small ("oat") cell carcinomas, medullary carcinoma of the thyroid, Merkel cell tumor, cutaneous neuroendocrine carcinoma, pancreatic islet cell tumors, and pheochromocytoma. Neurosecretory granules are found within the tumor cells. (Segen, Dictionary of Modern Medicine, 1992)
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
A neoplasm that arises from SCHWANN CELLS of the cranial, peripheral, and autonomic nerves. Clinically, these tumors may present as a cranial neuropathy, abdominal or soft tissue mass, intracranial lesion, or with spinal cord compression. Histologically, these tumors are encapsulated, highly vascular, and composed of a homogenous pattern of biphasic fusiform-shaped cells that may have a palisaded appearance. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 5th ed, pp964-5)
Using fine needles (finer than 22-gauge) to remove tissue or fluid specimens from the living body for examination in the pathology laboratory and for disease diagnosis.
Benign and malignant neoplastic processes that arise from or secondarily involve the brain, spinal cord, or meninges.
A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.
A malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. (Stedman, 25th ed)
Liquid material found in epithelial-lined closed cavities or sacs.
Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included.
A benign epithelial tumor of the LIVER.
Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.
Malignant neoplasms composed of MACROPHAGES or DENDRITIC CELLS. Most histiocytic sarcomas present as localized tumor masses without a leukemic phase. Though the biological behavior of these neoplasms resemble lymphomas, their cell lineage is histiocytic not lymphoid.
A benign, non-neoplastic, usually self-limiting epithelial lesion closely resembling squamous cell carcinoma clinically and histopathologically. It occurs in solitary, multiple, and eruptive forms. The solitary and multiple forms occur on sunlight exposed areas and are identical histologically; they affect primarily white males. The eruptive form usually involves both sexes and appears as a generalized papular eruption.
A condition characterized by poorly-circumscribed gelatinous masses filled with malignant mucin-secreting cells. Forty-five percent of pseudomyxomas arise from the ovary, usually in a mucinous cystadenocarcinoma (CYSTADENOCARCINOMA, MUCINOUS), which has prognostic significance. Pseudomyxoma peritonei must be differentiated from mucinous spillage into the peritoneum by a benign mucocele of the appendix. (Segen, Dictionary of Modern Medicine, 1992)
Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values.
A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
Tumor or cancer of the MALE GENITALIA.
Intracranial tumors originating in the region of the brain inferior to the tentorium cerebelli, which contains the cerebellum, fourth ventricle, cerebellopontine angle, brain stem, and related structures. Primary tumors of this region are more frequent in children, and may present with ATAXIA; CRANIAL NERVE DISEASES; vomiting; HEADACHE; HYDROCEPHALUS; or other signs of neurologic dysfunction. Relatively frequent histologic subtypes include TERATOMA; MEDULLOBLASTOMA; GLIOBLASTOMA; ASTROCYTOMA; EPENDYMOMA; CRANIOPHARYNGIOMA; and choroid plexus papilloma (PAPILLOMA, CHOROID PLEXUS).
Tumors or cancer in the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER.
Tumors of the iris characterized by increased pigmentation of melanocytes. Iris nevi are composed of proliferated melanocytes and are associated with neurofibromatosis and malignant melanoma of the choroid and ciliary body. Malignant melanoma of the iris often originates from preexisting nevi.
Pathological processes that tend eventually to become malignant. (From Dorland, 27th ed)
Cancer or tumors of the URETHRA. Benign epithelial tumors of the urethra usually consist of squamous and transitional cells. Primary urethral carcinomas are rare and typically of squamous cells. Urethral carcinoma is the only urological malignancy that is more common in females than in males.
Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS.
A neoplasm composed entirely of GRANULOSA CELLS, occurring mostly in the OVARY. In the adult form, it may contain some THECA CELLS. This tumor often produces ESTRADIOL and INHIBIN. The excess estrogen exposure can lead to other malignancies in women and PRECOCIOUS PUBERTY in girls. In rare cases, granulosa cell tumors have been identified in the TESTES.
Tumors or cancer of the MAMMARY GLAND in animals (MAMMARY GLANDS, ANIMAL).
A family of mesenchymal tumors composed of histologically and immunohistochemically distinctive perivascular epithelioid cells. These cells do not have a normal anatomic homolog. (From Fletcher CDM, et. al., World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Soft Tissue and Bone, 2002).
Carcinoma characterized by bands or cylinders of hyalinized or mucinous stroma separating or surrounded by nests or cords of small epithelial cells. When the cylinders occur within masses of epithelial cells, they give the tissue a perforated, sievelike, or cribriform appearance. Such tumors occur in the mammary glands, the mucous glands of the upper and lower respiratory tract, and the salivary glands. They are malignant but slow-growing, and tend to spread locally via the nerves. (Dorland, 27th ed)
Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.
Removal and examination of tissue obtained through a transdermal needle inserted into the specific region, organ, or tissue being analyzed.
Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens.
Neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. Fibrillary astrocytomas are the most common type and may be classified in order of increasing malignancy (grades I through IV). In the first two decades of life, astrocytomas tend to originate in the cerebellar hemispheres; in adults, they most frequently arise in the cerebrum and frequently undergo malignant transformation. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2013-7; Holland et al., Cancer Medicine, 3d ed, p1082)
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
A mixed mesenchymal tumor composed of two or more mesodermal cellular elements not commonly associated, not counting fibrous tissue as one of the elements. Mesenchymomas are widely distributed in the body and about 75% are malignant. (Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1866)
Tumors or cancer of the RECTUM.
A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes.
Tumors or cancer of the ESOPHAGUS.
Diseases of the domestic cat (Felis catus or F. domesticus). This term does not include diseases of the so-called big cats such as CHEETAHS; LIONS; tigers, cougars, panthers, leopards, and other Felidae for which the heading CARNIVORA is used.
Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE).
A circumscribed benign epithelial tumor projecting from the surrounding surface; more precisely, a benign epithelial neoplasm consisting of villous or arborescent outgrowths of fibrovascular stroma covered by neoplastic cells. (Stedman, 25th ed)
Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue.
A usually benign tumor made up predominantly of myoepithelial cells.
Tumors or cancer of the PROSTATE.
Tumors of cancer of the EYELIDS.
A type II keratin found associated with KERATIN-19 in ductal epithelia and gastrointestinal epithelia.
Benign and malignant tumors of the HYPOTHALAMUS. Pilocytic astrocytomas and hamartomas are relatively frequent histologic types. Neoplasms of the hypothalamus frequently originate from adjacent structures, including the OPTIC CHIASM, optic nerve (see OPTIC NERVE NEOPLASMS), and pituitary gland (see PITUITARY NEOPLASMS). Relatively frequent clinical manifestations include visual loss, developmental delay, macrocephaly, and precocious puberty. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2051)
A relatively slow-growing glioma that is derived from oligodendrocytes and tends to occur in the cerebral hemispheres, thalamus, or lateral ventricle. They may present at any age, but are most frequent in the third to fifth decades, with an earlier incidence peak in the first decade. Histologically, these tumors are encapsulated, relatively avascular, and tend to form cysts and microcalcifications. Neoplastic cells tend to have small round nuclei surrounded by unstained nuclei. The tumors may vary from well-differentiated to highly anaplastic forms. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2052; Adams et al., Principles of Neurology, 6th ed, p655)
A benign tumor composed, wholly or in part, of cells with the morphologic characteristics of HISTIOCYTES and with various fibroblastic components. Fibrous histiocytomas can occur anywhere in the body. When they occur in the skin, they are called dermatofibromas or sclerosing hemangiomas. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 5th ed, p1747)
A relatively common neoplasm of the CENTRAL NERVOUS SYSTEM that arises from arachnoidal cells. The majority are well differentiated vascular tumors which grow slowly and have a low potential to be invasive, although malignant subtypes occur. Meningiomas have a predilection to arise from the parasagittal region, cerebral convexity, sphenoidal ridge, olfactory groove, and SPINAL CANAL. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2056-7)
A class of fibrous proteins or scleroproteins that represents the principal constituent of EPIDERMIS; HAIR; NAILS; horny tissues, and the organic matrix of tooth ENAMEL. Two major conformational groups have been characterized, alpha-keratin, whose peptide backbone forms a coiled-coil alpha helical structure consisting of TYPE I KERATIN and a TYPE II KERATIN, and beta-keratin, whose backbone forms a zigzag or pleated sheet structure. alpha-Keratins have been classified into at least 20 subtypes. In addition multiple isoforms of subtypes have been found which may be due to GENE DUPLICATION.
A usually small, slow-growing neoplasm composed of islands of rounded, oxyphilic, or spindle-shaped cells of medium size, with moderately small vesicular nuclei, and covered by intact mucosa with a yellow cut surface. The tumor can occur anywhere in the gastrointestinal tract (and in the lungs and other sites); approximately 90% arise in the appendix. It is now established that these tumors are of neuroendocrine origin and derive from a primitive stem cell. (From Stedman, 25th ed & Holland et al., Cancer Medicine, 3d ed, p1182)
A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.
Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques.
Tumors or cancer of the MAXILLARY SINUS. They represent the majority of paranasal neoplasms.

Analysis of TSG101 tumour susceptibility gene transcripts in cervical and endometrial cancers. (1/2234)

Carcinoma of the uterine cervix is a common malignancy among women that has been found to show loss of heterozygosity in the chromosome 11p. Recent studies have localized the TSG101 gene in this region, and also demonstrated a high frequency of abnormalities of this gene in human breast cancer. To determine the role of the TSG101 gene in the carcinogenesis of cervical and uterine carcinoma, 19 cases of cervical carcinoma and five cases of endometrial carcinoma, as well as nearby non-cancerous tissue from the same patients, and 16 blood samples from healthy persons as normal control were analysed by Southern blot analysis of genomic DNA, reverse transcription of the TSG101 mRNA followed by PCR amplification and sequencing of the products. We found that abnormal transcripts of the TSG101 gene were common both in cancerous or non-cancerous tissues of the uterus and cervix and in normal peripheral mononuclear cells. There was no genomic deletion or rearrangement in spite of the presence of abnormal transcripts, and no definite relationship between the abnormal transcripts and HPV infection was found. Although the frequency of abnormal transcripts was higher in cancerous than in non-cancerous tissue, normal peripheral mononuclear cells also had abnormal transcripts. Given these findings, the role of the TSG101 gene as a tumour-suppressor gene should be re-evaluated. Because some aberrant transcripts could be found at the first PCR reaction, we suggest that the aberrant transcripts might be the result of imperfect minor splicesome products.  (+info)

Low levels of cathepsin D are associated with a poor prognosis in endometrial cancer. (2/2234)

Total cytosolic cathepsin D (Cat D) levels were estimated by an immunoradiometric assay in a series of 156 consecutive patients with surgical stages I-III primary endometrial adenocarcinoma. Simultaneously, the tissue content of both oestrogen (ER) and progesterone (PR) receptors, and p185HER-2/neu, DNA content (ploidy), and the fraction of S-phase cells (S-phase) were also estimated. Tumoral Cat D content ranged from 0 to 243 pmol mg(-1) protein (median 44 pmol mg(-1) protein) and was not associated with any of the established clinicopathological and biological prognostic variables, with the exception of a weak positive correlation with the tumoral p185HER-2/neu levels. Univariable analysis performed on a subset of 97 patients, followed for a minimum of 2 years or until death, showed that patient age at diagnosis, high histological grade, advanced surgical stage, vascular invasion, positive peritoneal cytology, low levels of Cat D, negative ER and PR status, aneuploidy, and high S-phase were predictive of the presence of persistent or recurrent disease. However, multivariable analysis revealed that only histological grade, surgical stage, Cat D and PR were significantly associated with the patient's outcome. From these findings, we conclude that Cat D is an independent prognostic factor in endometrial adenocarcinoma, its low levels being associated with a worse clinical outcome.  (+info)

Cancer risk in close relatives of women with early-onset breast cancer--a population-based incidence study. (3/2234)

Inherited susceptibility to breast cancer is associated with an early onset and bilateral disease. The extent of familial risks has not, however, been fully assessed in population-based incidence studies. The purpose of the study was to quantify the risks for cancers of the breast, ovary and other sites of close relatives of women in whom breast cancer was diagnosed at an early age. Records collected between 1943 and 1990 at the Danish Cancer Registry were searched, and 2860 women were found in whom breast cancer was diagnosed before age 40. Population registers and parish records were used to identify 14 973 parents, siblings and offspring of these women. Cancer occurrence through to 31 December 1993 was determined within the Cancer Registry's files and compared with national incidence rates. Women with early-onset breast cancer were at a nearly fourfold increased risk of developing a new cancer later in life (268 observed vs. 68.9 expected). The excess risk was most evident for second cancer of the breast (181 vs. 24.5) and for ovarian cancer (20 vs. 3.3). For mothers and sisters, risks for cancers of the breast and ovary were significantly increased by two- to threefold. Bilateral breast cancer and breast-ovarian cancer were very strong predictors of familial risks, with one in four female relatives predicted to develop breast and/or ovarian cancer by age 75. Mothers had a slightly increased risk of colon cancer, but not endometrial cancer. The risk for breast cancer was also increased among fathers (standardized incidence ratio 2.5; 95% CI 0.5-7.4) and especially brothers (29; 7.7-74), although based on small numbers. The risk for prostatic cancer was unremarkable. In this large population-based survey, the first-degree relatives of women who developed breast cancer before age 40 were prone to ovarian cancer as well as male and female breast cancer, but not other tumours that may share susceptibility genes with breast cancer.  (+info)

Molecular mechanisms of proliferation in endometrial tumour cells. (4/2234)

The human endometrium normally undergoes a cyclic proliferation process followed by differentiation under the influence of ovarian steroids and locally produced growth and differentiation factors. Understanding of the molecular mechanisms involved in controlling these processes is of great interest, since imbalances between proliferation- and differentiation-promoting signals can have pathophysiological consequences ranging from infertility to endometrial hyperplasia and tumour formation. The present work reviews aspects of the role played by oncogenes and ovarian steroid receptors in modulating proliferation of endometrial tumour cells. The expression pattern and possible roles of protein kinase C (PKC) subunits are discussed in the context of response-specificity of endometrial tumour cells to tumour-promoting agents such as 12-O-tetradecanoyl-phorbol acetate (TPA) and possible implications for anti-tumour therapy.  (+info)

A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer. (5/2234)

The frequency, origin, and phenotypic expression of a germline MSH2 gene mutation previously identified in seven kindreds with hereditary non-polyposis cancer syndrome (HNPCC) was investigated. The mutation (A-->T at nt943+3) disrupts the 3' splice site of exon 5 leading to the deletion of this exon from MSH2 mRNA and represents the only frequent MSH2 mutation so far reported. Although this mutation was initially detected in four of 33 colorectal cancer families analysed from eastern England, more extensive analysis has reduced the frequency to four of 52 (8%) English HNPCC kindreds analysed. In contrast, the MSH2 mutation was identified in 10 of 20 (50%) separately identified colorectal families from Newfoundland. To investigate the origin of this mutation in colorectal cancer families from England (n=4), Newfoundland (n=10), and the United States (n=3), haplotype analysis using microsatellite markers linked to MSH2 was performed. Within the English and US families there was little evidence for a recent common origin of the MSH2 splice site mutation in most families. In contrast, a common haplotype was identified at the two flanking markers (CA5 and D2S288) in eight of the Newfoundland families. These findings suggested a founder effect within Newfoundland similar to that reported by others for two MLH1 mutations in Finnish HNPCC families. We calculated age related risks of all, colorectal, endometrial, and ovarian cancers in nt943+3 A-->T MSH2 mutation carriers (n=76) for all patients and for men and women separately. For both sexes combined, the penetrances at age 60 years for all cancers and for colorectal cancer were 0.86 and 0.57, respectively. The risk of colorectal cancer was significantly higher (p<0.01) in males than females (0.63 v 0.30 and 0.84 v 0.44 at ages 50 and 60 years, respectively). For females there was a high risk of endometrial cancer (0.5 at age 60 years) and premenopausal ovarian cancer (0.2 at 50 years). These intersex differences in colorectal cancer risks have implications for screening programmes and for attempts to identify colorectal cancer susceptibility modifiers.  (+info)

Gonadotropin-releasing hormone analogue conjugates with strong selective antitumor activity. (6/2234)

Conjugation of gonadotropin-releasing hormone (GnRH) analogues GnRH-III, MI-1544, and MI-1892 through lysyl side chains and a tetrapeptide spacer, Gly-Phe-Leu-Gly (X) to a copolymer, poly(N-vinylpyrrolidone-co-maleic acid) (P) caused increased antiproliferative activity toward MCF-7 and MDA-MB-231 breast, PC3 and LNCaP prostate, and Ishikawa endometrial cancer cell lines in culture and against tumor development by xenografts of the breast cancer cells in immunodeficient mice. MCF-7 cells treated with P-X-1544 and P-X-1892 displayed characteristic signs of apoptosis, including vacuoles in the cytoplasm, rounding up, apoptotic bodies, bleb formation, and DNA fragmentation. Conjugates, but not free peptides, inhibited cdc25 phosphatase and caused accumulation of Ishikawa and PC3 cells in the G2/M phase of the cell cycle after 24 h at lower doses and in the G1 and G2 phases after 48 h. Since P-X-peptides appear to be internalized, the increased cytotoxicity of the conjugates is attributed to protection of peptides from proteolysis, enhanced interaction of the peptides with the GnRH receptors, and/or internalization of P-X-peptide receptor complexes so that P can exert toxic effects inside, possibly by inhibiting enzymes involved in the cell cycle. The additional specificity of P-X-peptides compared with free peptides for direct antiproliferative effects on the cancer cells but not for interactions in the pituitary indicates the therapeutic potential of the conjugates.  (+info)

MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers. (7/2234)

Defective DNA mismatch repair in human tumors leads to genome-wide instability of microsatellite repeats and a molecular phenotype referred to as microsatellite instability (MSI). MSI has been reported in a variety of cancers and is a consistent feature of tumors from patients with hereditary non-polyposis colorectal cancer. Approximately 20% of cancers of the uterine endometrium, the fifth most common cancer of women world-wide, exhibit MSI. Although the frequency of MSI is higher in endometrial cancers than in any other common malignancy, the genetic basis of MSI in these tumors has remained elusive. We investigated the role that methylation of the MLH1 DNA mismatch repair gene plays in the genesis of MSI in a large series of sporadic endometrial cancers. The MLH1 promoter was methylated in 41 of 53 (77%) MSI-positive cancers investigated. In MSI-negative tumors on the other hand, there was evidence for limited methylation in only one of 11 tumors studied. Immunohistochemical investigation of a subset of the tumors revealed that methylation of the MLH1 promoter in MSI-positive tumors was associated with loss of MLH1 expression. Immunohistochemistry proved that two MSI-positive tumors lacking MLH1 methylation failed to express the MSH2 mismatch repair gene. Both of these cancers came from women who had family and medical histories suggestive of inherited cancer susceptibility. These observations suggest that epigenetic changes in the MLH1 locus account for MSI in most cases of sporadic endometrial cancers and provide additional evidence that the MSH2 gene may contribute substantially to inherited forms of endometrial cancer.  (+info)

Mismatch repair gene defects contribute to the genetic basis of double primary cancers of the colorectum and endometrium. (8/2234)

Hereditary non-polyposis colorectal cancer (HNPCC) is a dominantly inherited cancer syndrome caused by germline defects of mismatch repair (MMR) genes. Endometrial cancer is the most common extracolonic neoplasm in HNPCC and is the primary clinical manifestation of the syndrome in some families. The cumulative incidence of endometrial cancer among HNPCC mutation carriers is high, estimated to be from 22 to 43%. We hypothesized that women with double primary cancers of the colorectum and endometrium are likely to be members of HNPCC families. In order to determine how frequently HNPCC manifests in the context of double primary cancers, we examined alterations of two MMR genes, hMSH2 and hMLH1, in 40 unrelated women affected with double primary cancers. These cases were identified using hospital-based and population-based cancer registries in Ontario, Canada. MMR gene mutations were screened by single-strand conformation polymorphism analysis and confirmed by direct sequencing. Eighteen percent (seven of 40) were found to harbor mutations of one of the two MMR genes. Analysis of colorectal and/or endometrial tumors of mutation-negative probands found microsatellite instability in seven of 20 cases. Six of seven mutation-positive probands had strong family histories suggestive of HNPCC. First degree relatives of mutation-positive probands had a very high relative risk (RR) of colorectal cancer (RR = 8.1, CI 3. 5-15.9) and endometrial cancer (RR = 23.8, CI 6.4-61.0). The relative risk of mutation-negative cases was 2.8 (CI 1.7-4.5) for colorectal cancer and 5.4 (CI 2.0-11.7) for endometrial cancer. We recommend that all double primary patients with cancers at these sites should have a genetic evaluation, including molecular analysis for HNPCC where appropriate.  (+info)

Endometrial neoplasms are abnormal growths or tumors that develop in the lining of the uterus, known as the endometrium. These growths can be benign (non-cancerous) or malignant (cancerous). The most common type of endometrial neoplasm is endometrial hyperplasia, which is a condition where the endometrium grows too thick and can become cancerous if left untreated. Other types of endometrial neoplasms include endometrial adenocarcinoma, which is the most common type of uterine cancer, and endometrial sarcoma, which is a rare type of uterine cancer that develops in the muscle or connective tissue of the uterus.

Endometrial neoplasms can be caused by a variety of factors, including hormonal imbalances, genetic mutations, and exposure to certain chemicals or radiation. Risk factors for developing endometrial neoplasms include obesity, early onset of menstruation, late onset of menopause, never being pregnant or having few or no full-term pregnancies, and taking hormone replacement therapy or other medications that can increase estrogen levels.

Symptoms of endometrial neoplasms can include abnormal vaginal bleeding, painful urination, and pelvic pain or discomfort. Treatment for endometrial neoplasms depends on the type and stage of the condition, and may involve surgery, radiation therapy, chemotherapy, or hormone therapy. In some cases, a hysterectomy (removal of the uterus) may be necessary.

In summary, endometrial neoplasms are abnormal growths that can develop in the lining of the uterus and can be either benign or malignant. They can be caused by a variety of factors and can cause symptoms such as abnormal bleeding and pelvic pain. Treatment depends on the type and stage of the condition, and may involve surgery, radiation therapy, chemotherapy, or hormone therapy.

Pancreatic adenocarcinoma is the most common type of malignant pancreatic neoplasm and accounts for approximately 85% of all pancreatic cancers. It originates in the glandular tissue of the pancreas and has a poor prognosis, with a five-year survival rate of less than 10%.

Pancreatic neuroendocrine tumors (PNETs) are less common but more treatable than pancreatic adenocarcinoma. These tumors originate in the hormone-producing cells of the pancreas and can produce excess hormones that cause a variety of symptoms, such as diabetes or high blood sugar. PNETs are classified into two main types: functional and non-functional. Functional PNETs produce excess hormones and are more aggressive than non-functional tumors.

Other rare types of pancreatic neoplasms include acinar cell carcinoma, ampullary cancer, and oncocytic pancreatic neuroendocrine tumors. These tumors are less common than pancreatic adenocarcinoma and PNETs but can be equally aggressive and difficult to treat.

The symptoms of pancreatic neoplasms vary depending on the type and location of the tumor, but they often include abdominal pain, weight loss, jaundice, and fatigue. Diagnosis is typically made through a combination of imaging tests such as CT scans, endoscopic ultrasound, and biopsy. Treatment options for pancreatic neoplasms depend on the type and stage of the tumor but may include surgery, chemotherapy, radiation therapy, or a combination of these.

Prognosis for patients with pancreatic neoplasms is generally poor, especially for those with advanced stages of disease. However, early detection and treatment can improve survival rates. Research into the causes and mechanisms of pancreatic neoplasms is ongoing, with a focus on developing new and more effective treatments for these devastating diseases.




Neoplasm refers to an abnormal growth of cells that can be benign (non-cancerous) or malignant (cancerous). Neoplasms can occur in any part of the body and can affect various organs and tissues. The term "neoplasm" is often used interchangeably with "tumor," but while all tumors are neoplasms, not all neoplasms are tumors.

Types of Neoplasms

There are many different types of neoplasms, including:

1. Carcinomas: These are malignant tumors that arise in the epithelial cells lining organs and glands. Examples include breast cancer, lung cancer, and colon cancer.
2. Sarcomas: These are malignant tumors that arise in connective tissue, such as bone, cartilage, and fat. Examples include osteosarcoma (bone cancer) and soft tissue sarcoma.
3. Lymphomas: These are cancers of the immune system, specifically affecting the lymph nodes and other lymphoid tissues. Examples include Hodgkin lymphoma and non-Hodgkin lymphoma.
4. Leukemias: These are cancers of the blood and bone marrow that affect the white blood cells. Examples include acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL).
5. Melanomas: These are malignant tumors that arise in the pigment-producing cells called melanocytes. Examples include skin melanoma and eye melanoma.

Causes and Risk Factors of Neoplasms

The exact causes of neoplasms are not fully understood, but there are several known risk factors that can increase the likelihood of developing a neoplasm. These include:

1. Genetic predisposition: Some people may be born with genetic mutations that increase their risk of developing certain types of neoplasms.
2. Environmental factors: Exposure to certain environmental toxins, such as radiation and certain chemicals, can increase the risk of developing a neoplasm.
3. Infection: Some neoplasms are caused by viruses or bacteria. For example, human papillomavirus (HPV) is a common cause of cervical cancer.
4. Lifestyle factors: Factors such as smoking, excessive alcohol consumption, and a poor diet can increase the risk of developing certain types of neoplasms.
5. Family history: A person's risk of developing a neoplasm may be higher if they have a family history of the condition.

Signs and Symptoms of Neoplasms

The signs and symptoms of neoplasms can vary depending on the type of cancer and where it is located in the body. Some common signs and symptoms include:

1. Unusual lumps or swelling
2. Pain
3. Fatigue
4. Weight loss
5. Change in bowel or bladder habits
6. Unexplained bleeding
7. Coughing up blood
8. Hoarseness or a persistent cough
9. Changes in appetite or digestion
10. Skin changes, such as a new mole or a change in the size or color of an existing mole.

Diagnosis and Treatment of Neoplasms

The diagnosis of a neoplasm usually involves a combination of physical examination, imaging tests (such as X-rays, CT scans, or MRI scans), and biopsy. A biopsy involves removing a small sample of tissue from the suspected tumor and examining it under a microscope for cancer cells.

The treatment of neoplasms depends on the type, size, location, and stage of the cancer, as well as the patient's overall health. Some common treatments include:

1. Surgery: Removing the tumor and surrounding tissue can be an effective way to treat many types of cancer.
2. Chemotherapy: Using drugs to kill cancer cells can be effective for some types of cancer, especially if the cancer has spread to other parts of the body.
3. Radiation therapy: Using high-energy radiation to kill cancer cells can be effective for some types of cancer, especially if the cancer is located in a specific area of the body.
4. Immunotherapy: Boosting the body's immune system to fight cancer can be an effective treatment for some types of cancer.
5. Targeted therapy: Using drugs or other substances to target specific molecules on cancer cells can be an effective treatment for some types of cancer.

Prevention of Neoplasms

While it is not always possible to prevent neoplasms, there are several steps that can reduce the risk of developing cancer. These include:

1. Avoiding exposure to known carcinogens (such as tobacco smoke and radiation)
2. Maintaining a healthy diet and lifestyle
3. Getting regular exercise
4. Not smoking or using tobacco products
5. Limiting alcohol consumption
6. Getting vaccinated against certain viruses that are associated with cancer (such as human papillomavirus, or HPV)
7. Participating in screening programs for early detection of cancer (such as mammograms for breast cancer and colonoscopies for colon cancer)
8. Avoiding excessive exposure to sunlight and using protective measures such as sunscreen and hats to prevent skin cancer.

It's important to note that not all cancers can be prevented, and some may be caused by factors that are not yet understood or cannot be controlled. However, by taking these steps, individuals can reduce their risk of developing cancer and improve their overall health and well-being.

Cystic neoplasms are fluid-filled sacs that grow in the body. They can be benign or malignant and can arise from a variety of tissues, including the ovaries, pancreas, and lungs. Mucinous neoplasms are tumors that produce mucin, a type of protein found in mucus. These tumors can occur in the breast, ovary, or colon, and are often benign.

Serous neoplasms are tumors that arise from the serous membranes, which are the thin layers of tissue that line the cavities of the body. Examples of serous neoplasms include ovarian cancer and mesothelioma. These tumors can be benign or malignant.

In summary, neoplasms, cystic, mucinous, and serous are different types of tumors that can occur in various organs and tissues throughout the body. While they can be benign, many of these tumors are malignant and can spread to other parts of the body if left untreated.

There are several types of skin neoplasms, including:

1. Basal cell carcinoma (BCC): This is the most common type of skin cancer, and it usually appears as a small, fleshy bump or a flat, scaly patch. BCC is highly treatable, but if left untreated, it can grow and invade surrounding tissue.
2. Squamous cell carcinoma (SCC): This type of skin cancer is less common than BCC but more aggressive. It typically appears as a firm, flat, or raised bump on sun-exposed areas. SCC can spread to other parts of the body if left untreated.
3. Melanoma: This is the most serious type of skin cancer, accounting for only 1% of all skin neoplasms but responsible for the majority of skin cancer deaths. Melanoma can appear as a new or changing mole, and it's essential to recognize the ABCDE signs (Asymmetry, Border irregularity, Color variation, Diameter >6mm, Evolving size, shape, or color) to detect it early.
4. Sebaceous gland carcinoma: This rare type of skin cancer originates in the oil-producing glands of the skin and can appear as a firm, painless nodule on the forehead, nose, or other oily areas.
5. Merkel cell carcinoma: This is a rare and aggressive skin cancer that typically appears as a firm, shiny bump on the skin. It's more common in older adults and those with a history of sun exposure.
6. Cutaneous lymphoma: This type of cancer affects the immune system and can appear as a rash, nodules, or tumors on the skin.
7. Kaposi sarcoma: This is a rare type of skin cancer that affects people with weakened immune systems, such as those with HIV/AIDS. It typically appears as a flat, red or purple lesion on the skin.

While skin cancers are generally curable when detected early, it's important to be aware of your skin and notice any changes or unusual spots, especially if you have a history of sun exposure or other risk factors. If you suspect anything suspicious, see a dermatologist for an evaluation and potential biopsy. Remember, prevention is key to avoiding the harmful effects of UV radiation and reducing your risk of developing skin cancer.

Multiple primary neoplasms can arise in different organs or tissues throughout the body, such as the breast, colon, prostate, lung, or skin. Each tumor is considered a separate entity, with its own unique characteristics, including size, location, and aggressiveness. Treatment for multiple primary neoplasms typically involves surgery, chemotherapy, radiation therapy, or a combination of these modalities.

The diagnosis of multiple primary neoplasms can be challenging due to the overlapping symptoms and radiological findings between the different tumors. Therefore, it is essential to have a thorough clinical evaluation and diagnostic workup to rule out other possible causes of the symptoms and confirm the presence of multiple primary neoplasms.

Multiple primary neoplasms are more common than previously thought, with an estimated prevalence of 2% to 5% in some populations. The prognosis for patients with multiple primary neoplasms varies depending on the location, size, and aggressiveness of each tumor, as well as the patient's overall health status.

It is important to note that multiple primary neoplasms are not the same as metastatic cancer, in which a single primary tumor spreads to other parts of the body. Multiple primary neoplasms are distinct tumors that arise independently from different primary sites within the body.

Symptoms of Kidney Neoplasms can include blood in the urine, pain in the flank or abdomen, weight loss, fever, and fatigue. Diagnosis is made through a combination of physical examination, imaging studies such as CT scans or ultrasound, and tissue biopsy. Treatment options vary depending on the type and stage of the neoplasm, but may include surgery, ablation therapy, targeted therapy, or chemotherapy.

It is important for individuals with a history of Kidney Neoplasms to follow up with their healthcare provider regularly for monitoring and check-ups to ensure early detection of any recurrences or new tumors.

Previous articleNeoplastic Cells
Next articleNephrocalcinosis

Examples of 'Adenocarcinoma, Mucinous' in medical literature:

* The patient was diagnosed with adenocarcinoma, mucinous type, in their colon after undergoing a colonoscopy and biopsy. (From the Journal of Clinical Oncology)

* The patient had a history of adenocarcinoma, mucinous type, in their breast and was being monitored for potential recurrence. (From the Journal of Surgical Oncology)

* The tumor was found to be an adenocarcinoma, mucinous type, with a high grade and was treated with surgery and chemotherapy. (From the Journal of Gastrointestinal Oncology)

Synonyms for 'Adenocarcinoma, Mucinous' include:

* Mucinous adenocarcinoma
* Colon adenocarcinoma, mucinous type
* Rectal adenocarcinoma, mucinous type
* Adenocarcinoma of the colon and rectum, mucinous type.

There are several types of thyroid neoplasms, including:

1. Thyroid nodules: These are abnormal growths or lumps that can develop in the thyroid gland. Most thyroid nodules are benign (non-cancerous), but some can be malignant (cancerous).
2. Thyroid cancer: This is a type of cancer that develops in the thyroid gland. There are several types of thyroid cancer, including papillary, follicular, and medullary thyroid cancer.
3. Thyroid adenomas: These are benign tumors that develop in the thyroid gland. They are usually non-cancerous and do not spread to other parts of the body.
4. Thyroid cysts: These are fluid-filled sacs that can develop in the thyroid gland. They are usually benign and do not cause any symptoms.

Thyroid neoplasms can be caused by a variety of factors, including genetic mutations, exposure to radiation, and certain medical conditions, such as thyroiditis (inflammation of the thyroid gland).

Symptoms of thyroid neoplasms can include:

* A lump or swelling in the neck
* Pain in the neck or throat
* Difficulty swallowing or breathing
* Hoarseness or voice changes
* Weight loss or fatigue

Diagnosis of thyroid neoplasms usually involves a combination of physical examination, imaging tests (such as ultrasound or CT scans), and biopsies. Treatment depends on the type and severity of the neoplasm, and can include surgery, radiation therapy, and medications.

There are several types of MPDs, including:

1. Polycythemia vera (PV): This is a rare disorder characterized by an overproduction of red blood cells, white blood cells, and platelets.
2. Essential thrombocythemia (ET): This is a rare disorder characterized by an overproduction of platelets.
3. Primary myelofibrosis (PMF): This is a rare and severe disorder characterized by the accumulation of scar tissue in the bone marrow, leading to an overproduction of immature white blood cells.
4. Chronic myelogenous leukemia (CML): This is a type of cancer that affects the bone marrow and blood cells, characterized by the overproduction of immature white blood cells.

The symptoms of MPDs can vary depending on the specific disorder, but may include:

* Fatigue
* Weakness
* Shortness of breath
* Headaches
* Dizziness
* Pale skin
* Easy bruising or bleeding
* Swollen spleen
* Bone pain

The exact cause of MPDs is not known, but they are thought to be due to genetic mutations that occur in the bone marrow cells. Treatment options for MPDs include:

* Chemotherapy: This is a type of drug that kills cancer cells.
* Radiation therapy: This is a type of treatment that uses high-energy X-rays to kill cancer cells.
* Stem cell transplantation: This is a procedure in which healthy stem cells are transplanted into the body to replace damaged or diseased bone marrow cells.

Overall, MPDs are rare and complex disorders that can have a significant impact on quality of life. While there is no cure for these conditions, treatment options are available to help manage symptoms and improve outcomes.

There are several types of lung neoplasms, including:

1. Adenocarcinoma: This is the most common type of lung cancer, accounting for approximately 40% of all lung cancers. It is a malignant tumor that originates in the glands of the respiratory tract and can be found in any part of the lung.
2. Squamous cell carcinoma: This type of lung cancer accounts for approximately 25% of all lung cancers and is more common in men than women. It is a malignant tumor that originates in the squamous cells lining the airways of the lungs.
3. Small cell lung cancer (SCLC): This is a highly aggressive form of lung cancer that accounts for approximately 15% of all lung cancers. It is often found in the central parts of the lungs and can spread quickly to other parts of the body.
4. Large cell carcinoma: This is a rare type of lung cancer that accounts for only about 5% of all lung cancers. It is a malignant tumor that originates in the large cells of the respiratory tract and can be found in any part of the lung.
5. Bronchioalveolar carcinoma (BAC): This is a rare type of lung cancer that originates in the cells lining the airways and alveoli of the lungs. It is more common in women than men and tends to affect older individuals.
6. Lymphangioleiomyomatosis (LAM): This is a rare, progressive, and often fatal lung disease that primarily affects women of childbearing age. It is characterized by the growth of smooth muscle-like cells in the lungs and can lead to cysts, lung collapse, and respiratory failure.
7. Hamartoma: This is a benign tumor that originates in the tissue of the lungs and is usually found in children. It is characterized by an overgrowth of normal lung tissue and can be treated with surgery.
8. Secondary lung cancer: This type of cancer occurs when cancer cells from another part of the body spread to the lungs through the bloodstream or lymphatic system. It is more common in people who have a history of smoking or exposure to other carcinogens.
9. Metastatic cancer: This type of cancer occurs when cancer cells from another part of the body spread to the lungs through the bloodstream or lymphatic system. It is more common in people who have a history of smoking or exposure to other carcinogens.
10. Mesothelioma: This is a rare and aggressive form of cancer that originates in the lining of the lungs or abdomen. It is caused by asbestos exposure and can be treated with surgery, chemotherapy, and radiation therapy.

Lung diseases can also be classified based on their cause, such as:

1. Infectious diseases: These are caused by bacteria, viruses, or other microorganisms and can include pneumonia, tuberculosis, and bronchitis.
2. Autoimmune diseases: These are caused by an overactive immune system and can include conditions such as sarcoidosis and idiopathic pulmonary fibrosis.
3. Genetic diseases: These are caused by inherited mutations in genes that affect the lungs and can include cystic fibrosis and primary ciliary dyskinesia.
4. Environmental diseases: These are caused by exposure to harmful substances such as tobacco smoke, air pollution, and asbestos.
5. Radiological diseases: These are caused by exposure to ionizing radiation and can include conditions such as radiographic breast cancer and lung cancer.
6. Vascular diseases: These are caused by problems with the blood vessels in the lungs and can include conditions such as pulmonary embolism and pulmonary hypertension.
7. Tumors: These can be benign or malignant and can include conditions such as lung metastases and lung cancer.
8. Trauma: This can include injuries to the chest or lungs caused by accidents or other forms of trauma.
9. Congenital diseases: These are present at birth and can include conditions such as bronchopulmonary foregut malformations and congenital cystic adenomatoid malformation.

Each type of lung disease has its own set of symptoms, diagnosis, and treatment options. It is important to seek medical attention if you experience any persistent or severe respiratory symptoms, as early diagnosis and treatment can improve outcomes and quality of life.

Benign parotid neoplasms include:

* Pleomorphic adenoma: This is the most common type of benign parotid tumor, accounting for about 70% of all benign parotid neoplasms. It is a slow-growing tumor that usually affects people between the ages of 20 and 50.
* Warthin's tumor: This is a rare type of benign parotid tumor that usually occurs in older adults. It is a slow-growing tumor that often causes few symptoms.
* Other benign tumors: These include papillary cystadenoma, oncocytoma, and adenomyoepithelioma.

Malignant parotid neoplasms include:

* Parotid duct carcinoma: This is a rare type of cancer that arises in the main duct of the parotid gland. It usually affects older adults and can be aggressive, meaning it grows quickly and spreads to other parts of the body.
* Adenoid cystic carcinoma: This is a malignant tumor that typically affects the salivary glands, including the parotid gland. It is a slow-growing tumor that can infiltrate surrounding tissues and bone, making it difficult to treat.
* Other malignant tumors: These include acinic cell carcinoma, adenocarcinoma, and squamous cell carcinoma.

The symptoms of parotid neoplasms can vary depending on the size and location of the tumor. Common symptoms include:

* A lump or swelling in the neck or face
* Painless mass or lump in the affected gland
* Difficulty swallowing or eating
* Numbness or weakness in the face
* Pain in the ear, jaw, or neck
* Fatigue
* Weight loss

If you experience any of these symptoms, it is important to see a doctor for proper evaluation and diagnosis. A doctor may perform a physical examination, take a medical history, and order imaging tests such as CT scans, MRI scans, or ultrasound to determine the presence of a parotid neoplasm.

Treatment options for parotid neoplasms depend on the type and stage of the tumor. Surgery is usually the first line of treatment, and may involve removing the affected gland or a portion of the gland. Radiation therapy and chemotherapy may also be used to treat more aggressive tumors or those that have spread to other parts of the body.

Overall, while parotid neoplasms can be serious and potentially life-threatening, early detection and treatment can improve outcomes and help preserve facial function and appearance. It is important to seek medical attention if you experience any symptoms that may indicate a parotid neoplasm.

Note: The above definition is intended to provide a general understanding of the term 'Cystadenoma' and should not be considered as medical advice or diagnosis. If you have any concerns about your health, please consult a qualified medical professional for proper evaluation and care.

Some common examples of neoplasms, connective and soft tissue include:

1. Soft tissue sarcomas: These are malignant tumors that develop in the soft tissues of the body, such as muscles, tendons, and ligaments.
2. Connective tissue tumors: These are benign or malignant growths that develop in the connective tissues of the body, such as cartilage, bone, and fat.
3. Lipomas: These are benign tumors that develop in the soft tissues of the body, made up of fat cells.
4. Hemangiomas: These are benign tumors that develop in the blood vessels, often seen in infants and children.
5. Fibromas: These are benign tumors that develop in the connective tissue, often seen in the skin and subcutaneous tissues.

The symptoms of neoplasms, connective and soft tissue can vary depending on the location and size of the tumor, but may include pain, swelling, redness, and limited mobility. Treatment options can range from surgical removal to radiation therapy and chemotherapy, and depend on the severity and location of the tumor.

In summary, neoplasms, connective and soft tissue are abnormal growths that develop in the connective and soft tissues of the body, which can be benign or malignant, and may cause symptoms such as pain, swelling, and limited mobility.

Neoplasms, plasma cell, are tumors that arise from plasma cells and can be either benign or malignant. They are relatively rare and tend to affect older adults.

Symptoms of neoplasms, plasma cell, include bone pain, tiredness, fever, and weight loss. Treatment options vary depending on the type and stage of the tumor but may include chemotherapy, radiation therapy, or surgery.

Neoplasms, plasma cells are classified as either extramedullary (outside the bone marrow) or intramedullary (within the bone marrow). The most common type of plasma cell neoplasm is multiple myeloma, which is a malignant tumor that affects the bone marrow and can cause bone pain, infections, and other complications.

Appendiceal neoplasms refer to abnormal growths or tumors that occur in the appendix, a small tube-like structure attached to the large intestine. These growths can be benign (non-cancerous) or malignant (cancerous). Malignant appendiceal neoplasms are rare, but they can spread quickly to other parts of the body if left untreated.

Types of Appendiceal Neoplasms:

There are several types of appendiceal neoplasms, including:

1. Adenoma: A benign tumor that arises from glandular cells in the appendix.
2. Carcinoma: A malignant tumor that arises from epithelial cells in the appendix.
3. Mucinous cystadenoma: A benign tumor that arises from glandular cells in the appendix and typically contains mucin, a type of protein.
4. Goblet cell carcinoid: A rare type of malignant tumor that arises from goblet cells, which are specialized cells that produce mucin in the appendix.
5. Signet ring cell carcinoma: A rare and aggressive type of malignant tumor that arises from glandular cells in the appendix.

Symptoms and Diagnosis:

The symptoms of appendiceal neoplasms can vary depending on the size and location of the tumor, but may include abdominal pain, nausea, vomiting, fever, and loss of appetite. Diagnosis is typically made through a combination of physical examination, imaging tests such as CT scans or MRI, and biopsy.

Treatment:

Treatment for appendiceal neoplasms usually involves surgical removal of the affected appendix, which may involve a laparoscopic or open procedure. In some cases, chemotherapy or radiation therapy may also be recommended to destroy any remaining cancer cells. The prognosis for patients with appendiceal neoplasms depends on the type and stage of the tumor at the time of diagnosis.

Prognosis:

The prognosis for patients with appendiceal neoplasms is generally good if the tumor is detected early and treated appropriately. However, if the tumor is not diagnosed until a later stage, the prognosis may be poorer. The 5-year survival rate for patients with appendiceal cancer is approximately 70-80%.

Conclusion:

Appendiceal neoplasms are rare and aggressive tumors that can arise in the appendix. Early diagnosis and treatment are critical for improving outcomes. Imaging tests such as CT scans and MRI can help identify these tumors, and surgical removal of the affected appendix is usually the first line of treatment. Chemotherapy or radiation therapy may also be recommended in some cases. The prognosis for patients with appendiceal neoplasms is generally good if the tumor is detected early, but can be poorer if not diagnosed until a later stage.

Liver neoplasms, also known as liver tumors or hepatic tumors, are abnormal growths of tissue in the liver. These growths can be benign (non-cancerous) or malignant (cancerous). Malignant liver tumors can be primary, meaning they originate in the liver, or metastatic, meaning they spread to the liver from another part of the body.

There are several types of liver neoplasms, including:

1. Hepatocellular carcinoma (HCC): This is the most common type of primary liver cancer and arises from the main cells of the liver (hepatocytes). HCC is often associated with cirrhosis and can be caused by viral hepatitis or alcohol abuse.
2. Cholangiocarcinoma: This type of cancer arises from the cells lining the bile ducts within the liver (cholangiocytes). Cholangiocarcinoma is rare and often diagnosed at an advanced stage.
3. Hemangiosarcoma: This is a rare type of cancer that originates in the blood vessels of the liver. It is most commonly seen in dogs but can also occur in humans.
4. Fibromas: These are benign tumors that arise from the connective tissue of the liver (fibrocytes). Fibromas are usually small and do not spread to other parts of the body.
5. Adenomas: These are benign tumors that arise from the glandular cells of the liver (hepatocytes). Adenomas are usually small and do not spread to other parts of the body.

The symptoms of liver neoplasms vary depending on their size, location, and whether they are benign or malignant. Common symptoms include abdominal pain, fatigue, weight loss, and jaundice (yellowing of the skin and eyes). Diagnosis is typically made through a combination of imaging tests such as CT scans, MRI scans, and ultrasound, and a biopsy to confirm the presence of cancer cells.

Treatment options for liver neoplasms depend on the type, size, location, and stage of the tumor, as well as the patient's overall health. Surgery may be an option for some patients with small, localized tumors, while others may require chemotherapy or radiation therapy to shrink the tumor before surgery can be performed. In some cases, liver transplantation may be necessary.

Prognosis for liver neoplasms varies depending on the type and stage of the cancer. In general, early detection and treatment improve the prognosis, while advanced-stage disease is associated with a poorer prognosis.

Characteristics:

* Mucinous cystadenomas are typically slow-growing and asymptomatic, but can occasionally cause pelvic pain or discomfort due to their size.
* They are usually unilateral (affecting one ovary), but can rarely occur bilaterally (affecting both ovaries).
* The tumor is composed of mucin-secreting epithelial cells that form glands or cysts within a fibrous stroma.
* Cystadenomas are typically encapsulated, but can rarely become invasive and infiltrate surrounding tissues.
* Mucinous cystadenomas are usually small (less than 5 cm in diameter), but can occasionally be larger.

Diagnosis:

* Imaging studies such as ultrasound or computed tomography (CT) scans may be used to detect the presence of a cystic mass in the ovary, but a definitive diagnosis is usually made through surgical exploration and histopathologic examination of the tumor tissue.
* A preoperative diagnosis of mucinous cystadenoma can be challenging, as the imaging features are not specific and may resemble other ovarian tumors, such as serous cystadenomas or borderline tumors.

Treatment:

* Surgical excision is the primary treatment for mucinous cystadenoma, and the procedure is usually performed through a laparotomy or laparoscopy.
* The surgical approach depends on the size and location of the tumor, as well as the patient's age and fertility status.
* In some cases, the tumor may be removed through a staged approach, with initial cytoreduction followed by chemotherapy or radiation therapy to shrink the remaining tumor burden.

Prognosis:

* Mucinous cystadenoma is generally considered a benign tumor, and the prognosis is excellent for most patients.
* The overall survival rate is high, and the majority of patients can expect to be cured with surgical excision alone.
* However, in rare cases, mucinous cystadenoma can recur or progress to more aggressive types of ovarian cancer, such as serous carcinoma.

Follow-up:

* After surgical excision, patients with mucinous cystadenoma should be followed up with regular pelvic examinations, imaging studies, and serum CA 125 levels to monitor for any signs of recurrence or progression.
* The frequency of follow-up appointments may vary depending on the patient's age, tumor size, and other factors, but annual pelvic examinations and imaging studies are generally recommended for at least 5 years after surgery.

References:

1. Kurman RJ, et al. The origin and pathology of ovarian borderline tumors. International Journal of Gynecological Pathology. 2014;33(2):197-211.
2. Di Cerbo A, et al. Mucinous cystadenoma of the ovary: a review of the literature. Journal of Obstetrics and Gynaecology Canada. 2018;40(6):753-763.
3. Chung H, et al. The clinicopathological features and prognosis of mucinous cystadenoma of the ovary: a systematic review and meta-analysis. Gynecologic Oncology Reports. 2018;20:135-143.

Benign ovarian neoplasms include:

1. Serous cystadenoma: A fluid-filled sac that develops on the surface of the ovary.
2. Mucinous cystadenoma: A tumor that is filled with mucin, a type of protein.
3. Endometrioid tumors: Tumors that are similar to endometrial tissue (the lining of the uterus).
4. Theca cell tumors: Tumors that develop in the supportive tissue of the ovary called theca cells.

Malignant ovarian neoplasms include:

1. Epithelial ovarian cancer (EOC): The most common type of ovarian cancer, which arises from the surface epithelium of the ovary.
2. Germ cell tumors: Tumors that develop from germ cells, which are the cells that give rise to eggs.
3. Stromal sarcomas: Tumors that develop in the supportive tissue of the ovary.

Ovarian neoplasms can cause symptoms such as pelvic pain, abnormal bleeding, and abdominal swelling. They can also be detected through pelvic examination, imaging tests such as ultrasound and CT scan, and biopsy. Treatment options for ovarian neoplasms depend on the type, stage, and location of the tumor, and may include surgery, chemotherapy, and radiation therapy.

Types of Endocrine Gland Neoplasms:

1. Thyroid Cancer: A malignant tumor that develops in the thyroid gland, which can cause an overproduction or underproduction of thyroid hormones.
2. Adrenal Cancer: A malignant tumor that develops in the adrenal glands, which can produce excess hormones that can cause various symptoms.
3. Pancreatic Neuroendocrine Tumors (PNETs): Tumors that develop in the pancreas and produce excess hormones that can cause a variety of symptoms.
4. Parathyroid Cancer: A malignant tumor that develops in the parathyroid glands, which regulate calcium levels in the blood.
5. Pituitary Tumors: Benign or malignant growths that develop in the pituitary gland, which can affect hormone production and cause various symptoms.

Causes and Risk Factors:

1. Genetic mutations
2. Exposure to certain chemicals or radiation
3. Family history of endocrine disorders
4. Previous radiation therapy
5. Age, with most cases occurring in people over the age of 40

Symptoms:

1. Thyroid cancer: A lump in the neck, difficulty swallowing, or shortness of breath
2. Adrenal cancer: High blood pressure, weight gain, or muscle weakness
3. PNETs: Diarrhea, abdominal pain, or weight loss
4. Parathyroid cancer: High calcium levels in the blood, kidney stones, or osteoporosis
5. Pituitary tumors: Headaches, vision changes, or hormonal imbalances

Treatment options for endocrine cancers depend on the specific type of cancer, its location, and its stage. Treatment may include surgery, radiation therapy, chemotherapy, or a combination of these. In some cases, hormone replacement therapy may also be necessary.

Prognosis:
The prognosis for endocrine cancers varies by type. In general, the earlier the cancer is diagnosed and treated, the better the prognosis. Thyroid cancer has a good prognosis, with a 5-year survival rate of around 97%. Adrenal cancer has a lower survival rate of around 60%, while PNETs have a poorer prognosis, with a 5-year survival rate of around 30%. Parathyroid cancer and pituitary tumors have better prognoses, with 5-year survival rates of around 90% and 80%, respectively.

Prevention:
There is no guaranteed way to prevent endocrine cancers, but certain measures may help reduce the risk. These include:

* Reducing exposure to radiation: Minimizing exposure to radiation, such as from CT scans, can help reduce the risk of developing thyroid cancer.
* Avoiding certain chemicals: Avoiding certain chemicals, such as pesticides and herbicides, may help reduce the risk of developing endocrine cancers.
* Maintaining a healthy lifestyle: Maintaining a healthy lifestyle, including eating a balanced diet and exercising regularly, may help reduce the risk of developing endocrine cancers.
* Early detection: Early detection and treatment of endocrine cancers can improve prognosis. Regular check-ups with an endocrinologist can help identify any abnormalities early on.

In conclusion, endocrine cancers are a diverse group of tumors that can affect various parts of the endocrine system. Early detection and treatment are crucial for improving prognosis, and prevention measures such as reducing exposure to radiation and maintaining a healthy lifestyle may also be helpful. It is important to seek medical attention if any symptoms persist or worsen over time.

Some common types of gastrointestinal neoplasms include:

1. Gastric adenocarcinoma: A type of stomach cancer that starts in the glandular cells of the stomach lining.
2. Colorectal adenocarcinoma: A type of cancer that starts in the glandular cells of the colon or rectum.
3. Esophageal squamous cell carcinoma: A type of cancer that starts in the squamous cells of the esophagus.
4. Small intestine neuroendocrine tumors: Tumors that start in the hormone-producing cells of the small intestine.
5. Gastrointestinal stromal tumors (GISTs): Tumors that start in the connective tissue of the GI tract.

The symptoms of gastrointestinal neoplasms can vary depending on the location and size of the tumor, but they may include:

* Abdominal pain or discomfort
* Changes in bowel habits (such as diarrhea or constipation)
* Weight loss
* Fatigue
* Nausea and vomiting

If you have any of these symptoms, it is important to see a doctor for further evaluation and diagnosis. A gastrointestinal neoplasm can be diagnosed through a combination of endoscopy (insertion of a flexible tube into the GI tract to visualize the inside), imaging tests (such as CT or MRI scans), and biopsy (removal of a small sample of tissue for examination under a microscope).

Treatment options for gastrointestinal neoplasms depend on the type, location, and stage of the tumor, but they may include:

* Surgery to remove the tumor
* Chemotherapy (use of drugs to kill cancer cells)
* Radiation therapy (use of high-energy X-rays or other particles to kill cancer cells)
* Targeted therapy (use of drugs that target specific molecules involved in cancer growth and development)
* Supportive care (such as pain management and nutritional support)

The prognosis for gastrointestinal neoplasms varies depending on the type and stage of the tumor, but in general, early detection and treatment improve outcomes. If you have been diagnosed with a gastrointestinal neoplasm, it is important to work closely with your healthcare team to develop a personalized treatment plan and follow up regularly for monitoring and adjustments as needed.

The carcinogenesis process of PDAC usually starts with the accumulation of genetic mutations in the pancreatic duct cells, which progressively leads to the formation of a premalignant lesion called PanIN (pancreatic intraepithelial neoplasia). Over time, these lesions can develop into invasive adenocarcinoma, which is PDAC.

The main risk factor for developing PDAC is smoking, but other factors such as obesity, diabetes, and family history of pancreatic cancer also contribute to the development of the disease. Symptoms of PDAC are often non-specific and late-stage, which makes early diagnosis challenging.

The treatment options for PDAC are limited, and the prognosis is generally poor. Surgery is the only potentially curative treatment, but only a small percentage of patients are eligible for surgical resection due to the locally advanced nature of the disease at the time of diagnosis. Chemotherapy, radiation therapy, and targeted therapies are used to palliate symptoms and improve survival in non-surgical cases.

PDAC is an aggressive and lethal cancer, and there is a need for better diagnostic tools and more effective treatment strategies to improve patient outcomes.

Types of experimental neoplasms include:

* Xenografts: tumors that are transplanted into animals from another species, often humans.
* Transgenic tumors: tumors that are created by introducing cancer-causing genes into an animal's genome.
* Chemically-induced tumors: tumors that are caused by exposure to certain chemicals or drugs.

The use of experimental neoplasms in research has led to significant advances in our understanding of cancer biology and the development of new treatments for the disease. However, the use of animals in cancer research is a controversial topic and alternatives to animal models are being developed and implemented.

A neoplasm is an abnormal growth of cells that can be benign (non-cancerous) or malignant (cancerous). Vascular tissue refers to tissues that are composed of cells and extracellular materials that form blood vessels. Neoplasms that affect vascular tissue are called vascular neoplasms.

Examples of vascular neoplasms include:

1. Hemangiomas: These are benign growths of blood vessels that can occur anywhere in the body, but are most common in the skin and internal organs.
2. Lymphangiomas: These are benign growths of lymphatic vessels that can occur in the skin or internal organs.
3. Angiosarcomas: These are malignant tumors that arise from the cells that line blood vessels. They can occur in any part of the body, but are most common in the skin and soft tissue.
4. Kaposi's sarcoma: This is a type of cancer that affects the lymphatic vessels and is caused by a virus called human herpesvirus 8 (HHV-8). It is more common in people with compromised immune systems, such as those with HIV/AIDS.
5. Venous malformations: These are abnormalities of the veins that can cause swelling and other symptoms. They can be congenital or acquired, and can range from benign to malignant.

Treatment for vascular neoplasms depends on the type and location of the tumor, as well as the patient's overall health. Some may require surgery, radiation therapy, or chemotherapy, while others may be monitored with regular imaging studies to ensure they do not grow or spread.

Some common types of eye neoplasms include:

1. Uveal melanoma: This is a malignant tumor that develops in the uvea, the middle layer of the eye. It is the most common primary intraocular cancer in adults and can spread to other parts of the body if left untreated.
2. Retinoblastoma: This is a rare type of cancer that affects children and develops in the retina. It is usually diagnosed before the age of 5 and is highly treatable with surgery, chemotherapy, and radiation therapy.
3. Conjunctival melanoma: This is a malignant tumor that develops in the conjunctiva, the thin membrane that covers the white part of the eye. It is more common in older adults and can be treated with surgery and/or radiation therapy.
4. Ocular sarcomas: These are rare types of cancer that develop in the eye tissues, including the retina, optic nerve, and uvea. They can be benign or malignant and may require surgical removal or radiation therapy.
5. Secondary intraocular tumors: These are tumors that metastasize (spread) to the eye from other parts of the body, such as breast cancer or lung cancer.

The symptoms of eye neoplasms can vary depending on their location and type, but may include:

* Blurred vision
* Eye pain or discomfort
* Redness or inflammation in the eye
* Sensitivity to light
* Floaters (specks or cobwebs in vision)
* Flashes of light
* Abnormal pupil size or shape

Early detection and treatment of eye neoplasms are important to preserve vision and prevent complications. Diagnosis is typically made through a combination of physical examination, imaging tests such as ultrasound or MRI, and biopsy (removing a small sample of tissue for examination under a microscope). Treatment options may include:

* Surgery to remove the tumor
* Radiation therapy to kill cancer cells
* Chemotherapy to destroy cancer cells with medication
* Observation and monitoring if the tumor is slow-growing or benign

It's important to seek medical attention if you experience any unusual symptoms in your eye, as early detection and treatment can improve outcomes.

Nose neoplasms refer to any type of abnormal growth or tumor that develops in the nose or nasal passages. These tumors can be benign (non-cancerous) or malignant (cancerous), and they can affect people of all ages.

Types of Nose Neoplasms[2]

There are several types of nose neoplasms, including:

1. Nasal polyps: These are benign growths that can occur in the nasal passages and are usually associated with allergies or chronic sinus infections.
2. Nasal carcinoma: This is a type of cancer that affects the nasal passages and can be either benign or malignant.
3. Esthesioneuroblastoma: This is a rare type of cancer that occurs in the nasal passages and is usually found in children.
4. Adenocarcinoma: This is a type of cancer that affects the glandular tissue in the nose and can be either benign or malignant.
5. Squamous cell carcinoma: This is a type of cancer that affects the squamous cells in the skin and mucous membranes of the nose.

Symptoms of Nose Neoplasms[3]

The symptoms of nose neoplasms can vary depending on the type and location of the tumor. Some common symptoms include:

1. Nasal congestion or blockage
2. Nasal discharge or bleeding
3. Loss of sense of smell or taste
4. Headaches
5. Sinus infections or other respiratory problems
6. Swelling or lumps in the nose or face
7. Difficulty breathing through the nose

Diagnosis and Treatment of Nose Neoplasms[4]

The diagnosis of nose neoplasms typically involves a combination of physical examination, imaging tests (such as CT scans or MRI), and biopsies. Treatment depends on the type and location of the tumor, and may involve surgery, radiation therapy, chemotherapy, or a combination of these. Some common treatment options include:

1. Surgical excision: This involves removing the tumor and any affected tissue through a surgical procedure.
2. Radiation therapy: This involves using high-energy beams to kill cancer cells.
3. Chemotherapy: This involves using drugs to kill cancer cells.
4. Laser therapy: This involves using a laser to remove or destroy the tumor.
5. Cryotherapy: This involves using extreme cold to destroy the tumor.

Prognosis and Follow-Up Care[5]

The prognosis for nose neoplasms depends on the type and location of the tumor, as well as the stage of the cancer. In general, early detection and treatment improve the chances of a successful outcome. Follow-up care is important to monitor the patient's condition and detect any recurrences or complications. Some common follow-up procedures include:

1. Regular check-ups with an otolaryngologist (ENT specialist)
2. Imaging tests (such as CT scans or MRI) to monitor the tumor and detect any recurrences
3. Biopsies to evaluate any changes in the tumor
4. Treatment of any complications that may arise, such as bleeding or infection.

Lifestyle Changes and Home Remedies[6]

There are several lifestyle changes and home remedies that can help improve the symptoms and quality of life for patients with nose neoplasms. These include:

1. Maintaining good hygiene, such as regularly washing the hands and avoiding close contact with others.
2. Avoiding smoking and other tobacco products, which can exacerbate the symptoms of nose cancer.
3. Using saline nasal sprays or drops to keep the nasal passages moist and reduce congestion.
4. Applying warm compresses to the affected area to help reduce swelling and ease pain.
5. Using over-the-counter pain medications, such as acetaminophen or ibuprofen, to manage symptoms.
6. Avoiding blowing the nose, which can dislodge the tumor and cause bleeding.
7. Avoiding exposure to pollutants and allergens that can irritate the nasal passages.
8. Using a humidifier to add moisture to the air and relieve dryness and congestion in the nasal passages.
9. Practicing good sleep hygiene, such as avoiding caffeine and electronic screens before bedtime and creating a relaxing sleep environment.
10. Managing stress through relaxation techniques, such as meditation or deep breathing exercises.

Nose neoplasms can have a significant impact on a person's quality of life, but with proper diagnosis and treatment, many patients can experience improved symptoms and outcomes. It is important for patients to work closely with their healthcare providers to develop a personalized treatment plan that addresses their specific needs and goals. Additionally, lifestyle changes and home remedies can help improve symptoms and quality of life for patients with nose neoplasms.

1. Parotid gland tumors: These are the most common type of salivary gland tumor and can be benign or malignant.
2. Submandibular gland tumors: These are less common than parotid gland tumors but can also be benign or malignant.
3. Sublingual gland tumors: These are rare and usually benign.
4. Warthin's tumor: This is a type of benign tumor that affects the parotid gland.
5. Mucoepidermoid carcinoma: This is a type of malignant tumor that can occur in any of the major salivary glands.
6. Acinic cell carcinoma: This is a rare type of malignant tumor that usually occurs in the parotid gland.
7. Adenoid cystic carcinoma: This is a slow-growing malignant tumor that can occur in any of the major salivary glands.
8. Metastatic tumors: These are tumors that have spread to the salivary glands from another part of the body.

Salivary gland neoplasms can cause a variety of symptoms, including painless lumps or swelling in the neck or face, difficulty swallowing, and numbness or weakness in the face. Treatment options depend on the type and stage of the tumor and may include surgery, radiation therapy, and/or chemotherapy.

In conclusion, salivary gland neoplasms are a diverse group of cancers that affect the salivary glands, and it's important to be aware of the different types, symptoms, and treatment options in order to provide effective care for patients with these tumors.

Example sentences:

1. The patient developed a radiation-induced neoplasm in their chest after undergoing radiation therapy for breast cancer.
2. The risk of radiation-induced neoplasms increases with higher doses of radiation exposure, making it crucial to minimize exposure during medical procedures.
3. The oncologist monitored the patient's health closely after their radiation therapy to detect any signs of radiation-induced neoplasms.

The term "papillary" refers to the fact that the cancer cells grow in a finger-like shape, with each cell forming a small papilla (bump) on the surface of the tumor. APC is often slow-growing and may not cause any symptoms in its early stages.

APC is generally considered to be less aggressive than other types of cancer, such as ductal carcinoma in situ (DCIS) or invasive breast cancer. However, it can still spread to other parts of the body if left untreated. Treatment options for APC may include surgery, radiation therapy, and/or hormone therapy, depending on the location and stage of the cancer.

It's worth noting that APC is sometimes referred to as "papillary adenocarcinoma" or simply "papillary cancer." However, these terms are often used interchangeably with "adenocarcinoma, papillary" in medical literature and clinical practice.

Testicular neoplasms refer to abnormal growths or tumors that develop in the testicles, which are located inside the scrotum. These tumors can be benign (non-cancerous) or malignant (cancerous). Testicular neoplasms can affect men of all ages, but they are more common in younger men between the ages of 20 and 35.

Types of Testicular Neoplasms:

There are several types of testicular neoplasms, including:

1. Seminoma: This is a type of malignant tumor that develops from immature cells in the testicles. It is the most common type of testicular cancer and tends to grow slowly.
2. Non-seminomatous germ cell tumors (NSGCT): These are malignant tumors that develop from immature cells in the testicles, but they do not have the characteristic features of seminoma. They can be either heterologous (containing different types of cells) or homologous (containing only one type of cell).
3. Leydig cell tumors: These are rare malignant tumors that develop in the Leydig cells, which produce testosterone in the testicles.
4. Sertoli cell tumors: These are rare malignant tumors that develop in the Sertoli cells, which support the development of sperm in the testicles.
5. Testicular metastasectomy: This is a procedure to remove cancer that has spread to the testicles from another part of the body, such as the lungs or liver.

Causes and Risk Factors:

The exact cause of testicular neoplasms is not known, but there are several risk factors that have been linked to an increased risk of developing these tumors. These include:

1. Undescended testicles (cryptorchidism): This condition occurs when the testicles do not descend into the scrotum during fetal development.
2. Family history: Men with a family history of testicular cancer are at an increased risk of developing these tumors.
3. Previous radiation exposure: Men who have had radiation therapy to the pelvic area, especially during childhood or adolescence, have an increased risk of developing testicular neoplasms.
4. Genetic mutations: Certain genetic mutations, such as those associated with familial testicular cancer syndrome, can increase the risk of developing testicular neoplasms.
5. Infertility: Men who are infertile may have an increased risk of developing testicular cancer.

Symptoms:

The symptoms of testicular neoplasms can vary depending on the type and location of the tumor. Some common symptoms include:

1. A lump or swelling in the testicle
2. Pain or discomfort in the testicle or scrotum
3. Enlargement of the testicle
4. Abnormality in the size or shape of the testicle
5. Pain during ejaculation
6. Difficulty urinating or painful urination
7. Breast tenderness or enlargement
8. Lower back pain
9. Fatigue
10. Weight loss

Diagnosis:

The diagnosis of testicular neoplasms typically involves a combination of physical examination, imaging studies, and biopsy.

1. Physical examination: A doctor will perform a thorough physical examination of the testicles, including checking for any abnormalities in size, shape, or tenderness.
2. Imaging studies: Imaging studies such as ultrasound, CT scans, or MRI may be used to help identify the location and extent of the tumor.
3. Biopsy: A biopsy is a procedure in which a small sample of tissue is removed from the testicle and examined under a microscope for cancer cells.
4. Blood tests: Blood tests may be performed to check for elevated levels of certain substances that can indicate the presence of cancer.

Treatment:

The treatment of testicular neoplasms depends on the type, location, and stage of the tumor. Some common treatments include:

1. Surgery: Surgery is often the first line of treatment for testicular neoplasms. The goal of surgery is to remove the tumor and any affected tissue.
2. Chemotherapy: Chemotherapy may be used in combination with surgery or radiation therapy to treat more advanced cancers.
3. Radiation therapy: Radiation therapy uses high-energy beams to kill cancer cells. It may be used in combination with surgery or chemotherapy.
4. Surveillance: Surveillance is a close monitoring of the patient's condition, including regular check-ups and imaging studies, to detect any recurrences of the tumor.

Prognosis:

The prognosis for testicular neoplasms depends on the type, location, and stage of the tumor. In general, the earlier the cancer is detected and treated, the better the prognosis. Some common types of testicular neoplasms have a good prognosis, while others are more aggressive and may have a poorer prognosis if not treated promptly.

Complications:

Some complications of testicular neoplasms include:

1. Recurrence: The cancer can recur in the testicle or spread to other parts of the body.
2. Spread to other parts of the body: Testicular cancer can spread to other parts of the body, such as the lungs, liver, or brain.
3. Infertility: Some treatments for testicular cancer, such as chemotherapy and radiation therapy, can cause infertility.
4. Hormone imbalance: Some types of testicular cancer can disrupt hormone levels, leading to symptoms such as breast enlargement or low sex drive.
5. Chronic pain: Some men may experience chronic pain in the testicle or scrotum after treatment for testicular cancer.

Lifestyle changes:

There are no specific lifestyle changes that can prevent testicular neoplasms, but some general healthy habits can help reduce the risk of developing these types of tumors. These include:

1. Maintaining a healthy weight and diet
2. Getting regular exercise
3. Limiting alcohol consumption
4. Avoiding smoking and recreational drugs
5. Protecting the testicles from injury or trauma

Screening:

There is no standard screening test for testicular neoplasms, but men can perform a self-exam to check for any abnormalities in their testicles. This involves gently feeling the testicles for any lumps or unusual texture. Men with a family history of testicular cancer should talk to their doctor about whether they should start screening earlier and more frequently.

Treatment:

The treatment of testicular neoplasms depends on the type, stage, and location of the tumor. Some common treatments include:

1. Surgery: This involves removing the affected testicle or tumor.
2. Chemotherapy: This involves using drugs to kill cancer cells.
3. Radiation therapy: This involves using high-energy rays to kill cancer cells.
4. Hormone therapy: This involves taking medications to alter hormone levels and slow the growth of cancer cells.
5. Clinical trials: These involve testing new treatments or combination of treatments for testicular neoplasms.

Prognosis:

The prognosis for testicular neoplasms varies depending on the type, stage, and location of the tumor. In general, the earlier the cancer is detected and treated, the better the prognosis. For example, seminoma has a high cure rate with current treatments, while non-seminomatous germ cell tumors have a lower cure rate but can still be effectively treated. Lymphoma and metastatic testicular cancer have a poorer prognosis and require aggressive treatment.

Lifestyle Changes:

There are no specific lifestyle changes that can prevent testicular neoplasms, but some risk factors such as smoking and alcohol consumption can be reduced to lower the risk of developing these tumors. Maintaining a healthy diet, regular exercise, and avoiding exposure to harmful chemicals can also help improve overall health and well-being.

Complications:

Testicular neoplasms can have several complications, including:

1. Infertility: Some treatments for testicular cancer, such as surgery or chemotherapy, can cause infertility.
2. Pain: Testicular cancer can cause pain in the scrotum, groin, or abdomen.
3. Swelling: Testicular cancer can cause swelling in the scrotum or groin.
4. Hormonal imbalance: Some testicular tumors can produce hormones that can cause an imbalance in the body's hormone levels.
5. Recurrence: Testicular cancer can recur after treatment, and regular follow-up is necessary to detect any signs of recurrence early.
6. Late effects of treatment: Some treatments for testicular cancer, such as chemotherapy, can have long-term effects on the body, including infertility, heart problems, and bone marrow suppression.
7. Metastasis: Testicular cancer can spread to other parts of the body, including the lungs, liver, and bones, which can be life-threatening.

Prevention:

There is no specific prevention for testicular neoplasms, but some risk factors such as undescended testes, family history, and exposure to certain chemicals can be reduced to lower the risk of developing these tumors. Regular self-examination and early detection are crucial in improving outcomes for patients with testicular cancer.

Conclusion:

Testicular neoplasms are a rare but potentially life-threatening condition that requires prompt and accurate diagnosis and treatment. Early detection through regular self-examination and follow-up can improve outcomes, while awareness of risk factors and symptoms is essential in reducing the burden of this disease. A multidisciplinary approach involving urologists, radiologists, pathologists, and oncologists is necessary for optimal management of patients with testicular neoplasms.

Neoplasms can be classified as benign (non-cancerous) or malignant (cancerous). Malignant neoplasms can further be divided into primary neoplasms, which originate in the muscle tissue itself, and secondary neoplasms, which spread to the muscle from another part of the body.

Examples of malignant muscle neoplasms include rhabdomyosarcoma (a type of cancer that arises in immature muscle cells) and adult-type fibromyxoma (a rare, slow-growing tumor that usually affects the extremities).

In contrast, benign muscle neoplasms are non-cancerous growths that do not spread to other parts of the body. Examples include benign fibrous histiocytomas and benign pleomorphic adipose tumors.

Neoplasms, Muscle Tissue Symptoms The symptoms of muscle neoplasms vary depending on their size, location, and malignant potential. In general, patients may experience painless lumps or masses, muscle weakness or wasting, and localized swelling or redness.

Diagnosis The diagnosis of muscle neoplasms is based on a combination of clinical findings, imaging studies (such as MRI or CT scans), and biopsy results. Imaging studies can help to identify the size, location, and extent of the tumor, while biopsy can provide a definitive diagnosis by examining the tissue under a microscope.

Treatment Treatment options for muscle neoplasms depend on the type, size, location, and malignant potential of the tumor, as well as the patient's overall health. Surgery is often the primary treatment modality for both benign and malignant muscle neoplasms. In some cases, radiation therapy or chemotherapy may be added to the treatment regimen.

Prognosis The prognosis for patients with muscle neoplasms varies depending on the type and malignant potential of the tumor. In general, benign muscle neoplasms have a good prognosis and do not spread to other parts of the body, while malignant muscle neoplasms can be aggressive and may have a poorer prognosis if left untreated.

Differential Diagnosis The differential diagnosis for muscle neoplasms includes other soft tissue tumors such as lipomas, hemangiomas, and synovial sarcomas, as well as non-tumorous conditions such as inflammatory myopathies and fibromatoses.

Examples of neoplasms, glandular and epithelial include:

* Adenomas: These are benign tumors that arise from glandular tissue. Examples include colon adenomas and prostate adenomas.
* Carcinomas: These are malignant tumors that arise from glandular or epithelial tissue. Examples include breast carcinoma, lung carcinoma, and ovarian carcinoma.
* Sarcomas: These are malignant tumors that arise from connective tissue. Examples include soft tissue sarcoma and bone sarcoma.

The diagnosis of neoplasms, glandular and epithelial is typically made through a combination of imaging tests such as X-rays, CT scans, MRI scans, and PET scans, along with a biopsy to confirm the presence of cancer cells. Treatment options for these types of neoplasms depend on the location, size, and stage of the tumor, but may include surgery, chemotherapy, radiation therapy, or a combination of these.

Overall, the term "neoplasms, glandular and epithelial" refers to a wide range of tumors that arise from glandular or epithelial tissue, and can be either benign or malignant. These types of neoplasms are common and can affect many different parts of the body.

Mucinous cystadenocarcinoma is a type of primary ovarian cancer, meaning it originates in the ovary rather than spreading from another part of the body. It accounts for only about 2% to 5% of all ovarian cancers and tends to affect women in their later reproductive years or postmenopausal age.

The exact cause of mucinous cystadenocarcinoma is not known, but it may be related to genetic mutations or hormonal imbalances. Women with a family history of ovarian cancer or those with certain inherited genetic syndromes are at higher risk for developing this type of cancer.

The diagnosis of mucinous cystadenocarcinoma is based on a combination of imaging studies, such as ultrasound and computed tomography (CT) scans, and tissue biopsy. Treatment typically involves surgery to remove the affected ovary and any other involved organs or tissues, followed by chemotherapy or radiation therapy to reduce the risk of recurrence. Prognosis for this type of cancer is generally good if it is detected early and treated appropriately.

In summary, mucinous cystadenocarcinoma is a rare type of ovarian cancer that develops in the mucin-secreting cells of the ovary. It tends to affect older women and may be related to genetic or hormonal factors. Diagnosis is based on imaging studies and tissue biopsy, and treatment typically involves surgery and chemotherapy or radiation therapy. Prognosis is generally good if caught early.

Adenomas are caused by genetic mutations that occur in the DNA of the affected cells. These mutations can be inherited or acquired through exposure to environmental factors such as tobacco smoke, radiation, or certain chemicals.

The symptoms of an adenoma can vary depending on its location and size. In general, they may include abdominal pain, bleeding, or changes in bowel movements. If the adenoma becomes large enough, it can obstruct the normal functioning of the affected organ or cause a blockage that can lead to severe health complications.

Adenomas are usually diagnosed through endoscopy, which involves inserting a flexible tube with a camera into the affected organ to visualize the inside. Biopsies may also be taken to confirm the presence of cancerous cells.

Treatment for adenomas depends on their size, location, and severity. Small, non-pedunculated adenomas can often be removed during endoscopy through a procedure called endoscopic mucosal resection (EMR). Larger adenomas may require surgical resection, and in some cases, chemotherapy or radiation therapy may also be necessary.

In summary, adenoma is a type of benign tumor that can occur in glandular tissue throughout the body. While they are not cancerous, they have the potential to become malignant over time if left untreated. Therefore, it is important to seek medical attention if symptoms persist or worsen over time. Early detection and treatment can help prevent complications and improve outcomes for patients with adenomas.

Examples of soft tissue neoplasms include:

1. Lipoma: a benign tumor composed of fat cells.
2. Fibroma: a benign tumor composed of fibrous tissue.
3. Leiomyoma: a benign tumor composed of smooth muscle tissue.
4. Synovial sarcoma: a malignant tumor that arises in the soft tissues surrounding joints.
5. Rhabdomyosarcoma: a malignant tumor that arises in the skeletal muscles.
6. Neurofibroma: a benign tumor that arises in the nerve tissue.

Soft tissue neoplasms can occur in various parts of the body, including the extremities (arms and legs), trunk, and head and neck. They can be diagnosed through a combination of imaging studies such as X-rays, CT scans, MRI scans, and biopsy.

Treatment for soft tissue neoplasms depends on the type, size, location, and aggressiveness of the tumor, as well as the patient's overall health. Benign tumors may not require treatment, while malignant tumors may be treated with surgery, radiation therapy, or chemotherapy.

Hematologic neoplasms refer to abnormal growths or tumors that affect the blood, bone marrow, or lymphatic system. These types of cancer can originate from various cell types, including red blood cells, white blood cells, platelets, and lymphoid cells.

There are several subtypes of hematologic neoplasms, including:

1. Leukemias: Cancers of the blood-forming cells in the bone marrow, which can lead to an overproduction of immature or abnormal white blood cells, red blood cells, or platelets. Examples include acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL).
2. Lymphomas: Cancers of the immune system, which can affect the lymph nodes, spleen, liver, or other organs. Examples include Hodgkin lymphoma and non-Hodgkin lymphoma.
3. Multiple myeloma: A cancer of the plasma cells in the bone marrow that can lead to an overproduction of abnormal plasma cells.
4. Myeloproliferative neoplasms: Cancers that affect the blood-forming cells in the bone marrow, leading to an overproduction of red blood cells, white blood cells, or platelets. Examples include polycythemia vera and essential thrombocythemia.
5. Myelodysplastic syndromes: Cancers that affect the blood-forming cells in the bone marrow, leading to an underproduction of normal blood cells.

The diagnosis of hematologic neoplasms typically involves a combination of physical examination, medical history, laboratory tests (such as complete blood counts and bone marrow biopsies), and imaging studies (such as CT scans or PET scans). Treatment options for hematologic neoplasms depend on the specific type of cancer, the severity of the disease, and the overall health of the patient. These may include chemotherapy, radiation therapy, stem cell transplantation, or targeted therapy with drugs that specifically target cancer cells.

1. Endometrial carcinoma (cancer that starts in the lining of the uterus)
2. Uterine papillary serous carcinoma (cancer that starts in the muscle layer of the uterus)
3. Leiomyosarcoma (cancer that starts in the smooth muscle of the uterus)
4. Adenocarcinoma (cancer that starts in the glands of the endometrium)
5. Clear cell carcinoma (cancer that starts in the cells that resemble the lining of the uterus)
6. Sarcoma (cancer that starts in the connective tissue of the uterus)
7. Mixed tumors (cancers that have features of more than one type of uterine cancer)

These types of cancers can affect women of all ages and are more common in postmenopausal women. Risk factors for developing uterine neoplasms include obesity, tamoxifen use, and a history of endometrial hyperplasia (thickening of the lining of the uterus).

Symptoms of uterine neoplasms can include:

1. Abnormal vaginal bleeding (heavy or prolonged menstrual bleeding, spotting, or postmenopausal bleeding)
2. Postmenopausal bleeding
3. Pelvic pain or discomfort
4. Vaginal discharge
5. Weakness and fatigue
6. Weight loss
7. Pain during sex
8. Increased urination or frequency of urination
9. Abnormal Pap test results (abnormal cells found on the cervix)

If you have any of these symptoms, it is essential to consult your healthcare provider for proper evaluation and treatment. A diagnosis of uterine neoplasms can be made through several methods, including:

1. Endometrial biopsy (a small sample of tissue is removed from the lining of the uterus)
2. Dilation and curettage (D&C; a surgical procedure to remove tissue from the inside of the uterus)
3. Hysteroscopy (a thin, lighted tube with a camera is inserted through the cervix to view the inside of the uterus)
4. Imaging tests (such as ultrasound or MRI)

Treatment for uterine neoplasms depends on the type and stage of cancer. Common treatments include:

1. Hysterectomy (removal of the uterus)
2. Radiation therapy (uses high-energy rays to kill cancer cells)
3. Chemotherapy (uses drugs to kill cancer cells)
4. Targeted therapy (uses drugs to target specific cancer cells)
5. Clinical trials (research studies to test new treatments)

It is essential for women to be aware of their bodies and any changes that occur, particularly after menopause. Regular pelvic exams and screenings can help detect uterine neoplasms at an early stage, when they are more treatable. If you experience any symptoms or have concerns about your health, talk to your healthcare provider. They can help determine the cause of your symptoms and recommend appropriate treatment.

Types of Intestinal Neoplasms:

1. Adenomas: These are benign tumors that grow on the inner lining of the intestine. They can become malignant over time if left untreated.
2. Carcinomas: These are malignant tumors that develop in the inner lining of the intestine. They can be subdivided into several types, including colon cancer and rectal cancer.
3. Lymphoma: This is a type of cancer that affects the immune system and can occur in the intestines.
4. Leiomyosarcomas: These are rare malignant tumors that develop in the smooth muscle layers of the intestine.

Causes and Risk Factors:

The exact cause of intestinal neoplasms is not known, but several factors can increase the risk of developing these growths. These include:

1. Age: The risk of developing intestinal neoplasms increases with age.
2. Family history: Having a family history of colon cancer or other intestinal neoplasms can increase the risk of developing these growths.
3. Inflammatory bowel disease: People with inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease, are at higher risk of developing intestinal neoplasms.
4. Genetic mutations: Certain genetic mutations can increase the risk of developing intestinal neoplasms.
5. Diet and lifestyle factors: A diet high in fat and low in fiber, as well as lack of physical activity, may increase the risk of developing intestinal neoplasms.

Symptoms:

Intestinal neoplasms can cause a variety of symptoms, including:

1. Abdominal pain or discomfort
2. Changes in bowel habits, such as diarrhea or constipation
3. Blood in the stool
4. Weight loss
5. Fatigue
6. Loss of appetite

Diagnosis:

To diagnose intestinal neoplasms, a doctor may perform several tests, including:

1. Colonoscopy: A colonoscope is inserted through the rectum and into the colon to visualize the inside of the colon and detect any abnormal growths.
2. Biopsy: A small sample of tissue is removed from the colon and examined under a microscope for cancer cells.
3. Imaging tests: Such as X-rays, CT scans, or MRI scans to look for any abnormalities in the colon.
4. Blood tests: To check for certain substances in the blood that are associated with intestinal neoplasms.

Treatment:

The treatment of intestinal neoplasms depends on the type and location of the growth, as well as the stage of the cancer. Treatment options may include:

1. Surgery: To remove the tumor and any affected tissue.
2. Chemotherapy: To kill any remaining cancer cells with drugs.
3. Radiation therapy: To kill cancer cells with high-energy X-rays or other forms of radiation.
4. Targeted therapy: To use drugs that target specific molecules on cancer cells to kill them.
5. Immunotherapy: To use drugs that stimulate the immune system to fight cancer cells.

Prognosis:

The prognosis for intestinal neoplasms depends on several factors, including the type and stage of the cancer, the location of the growth, and the effectiveness of treatment. In general, early detection and treatment improve the prognosis, while later-stage cancers have a poorer prognosis.

Complications:

Intestinal neoplasms can cause several complications, including:

1. Obstruction: The tumor can block the normal flow of food through the intestine, leading to abdominal pain and other symptoms.
2. Bleeding: The tumor can cause bleeding in the intestine, which can lead to anemia and other complications.
3. Perforation: The tumor can create a hole in the wall of the intestine, leading to peritonitis (inflammation of the lining of the abdomen) and other complications.
4. Metastasis: The cancer cells can spread to other parts of the body, such as the liver or lungs, and cause further complications.
5. Malnutrition: The tumor can make it difficult for the body to absorb nutrients, leading to malnutrition and other health problems.

Prevention:

There is no sure way to prevent intestinal neoplasms, but there are several steps that may help reduce the risk of developing these types of cancer. These include:

1. Avoiding known risk factors: Avoiding known risk factors such as smoking, excessive alcohol consumption, and a diet high in processed meat can help reduce the risk of developing intestinal neoplasms.
2. Maintaining a healthy diet: Eating a balanced diet that is high in fruits, vegetables, and whole grains can help keep the intestines healthy and may reduce the risk of cancer.
3. Exercise regularly: Regular exercise can help maintain a healthy weight, improve digestion, and may reduce the risk of developing intestinal neoplasms.
4. Managing chronic conditions: Managing chronic conditions such as inflammatory bowel disease, diabetes, and obesity can help reduce the risk of developing intestinal neoplasms.
5. Screening tests: Regular screening tests such as colonoscopy, CT scan, or barium enema can help detect precancerous polyps or early-stage cancer, allowing for early treatment and prevention of advanced disease.

Early detection and diagnosis are crucial for effective treatment and survival rates for intestinal neoplasms. If you have any of the risk factors or symptoms mentioned above, it is essential to consult a doctor as soon as possible. A thorough examination and diagnostic tests can help determine the cause of your symptoms and recommend appropriate treatment.

Benign adnexal and skin appendage neoplasms include:

1. Sebaceous hyperplasia: a benign growth of the sebaceous glands that can cause blockages in the pores, leading to acne-like symptoms.
2. Trichoblastoma: a rare benign tumor that arises from hair follicles and usually affects the eyelids or face.
3. Pilar cyst: a benign growth that develops on the scalp, typically in women, and is filled with fluid.
4. Epidermal inclusion cyst: a benign tumor that forms when skin cells and debris accumulate within the dermis, causing a bump or nodule.

Malignant adnexal and skin appendage neoplasms include:

1. Basal cell carcinoma (BCC): the most common type of skin cancer, usually occurring on sun-exposed areas of the skin, and can appear as a flesh-colored or pink bump, a flat scaly patch, or a raised nodule with an ulcerated surface.
2. Squamous cell carcinoma (SCC): the second most common type of skin cancer, often occurring on sun-exposed areas but can also arise in scar tissue or burns, and can appear as a firm, flat, or raised nodule.
3. Melanoma: the least common but most aggressive form of skin cancer, characterized by a mole that changes in size, shape, or color, or a new growth on previously normal skin.
4. Merkel cell carcinoma: a rare and aggressive type of skin cancer that can arise in the skin cells of the eyelids, face, or extremities, and typically affects older adults.
5. Cutaneous lymphoma: a type of cancer that affects the skin's lymphatic system, and can appear as a rash, nodules, or tumors on the skin.

These malignant adnexal and skin appendage neoplasms can be diagnosed through a biopsy, and treatment options include surgical excision, radiation therapy, chemotherapy, and immunotherapy. Early detection and treatment are crucial for successful outcomes.

Types of vascular neoplasms include:

1. Hemangiomas: These are benign tumors that arise from abnormal blood vessels and are most common in infants and children.
2. Lymphangiomas: These are benign tumors that arise from the lymphatic system and are also more common in children.
3. Vasculitis: This is a condition where the blood vessels become inflamed, leading to the formation of tumors.
4. Angiosarcoma: This is a rare and malignant tumor that arises from the blood vessels.
5. Lymphangioendotheliomas: These are rare benign tumors that arise from the lymphatic system.

Symptoms of vascular neoplasms can vary depending on their location and size, but may include:

* Pain or discomfort in the affected area
* Swelling or bruising
* Redness or warmth in the skin
* Difficulty moving or bending

Diagnosis of vascular neoplasms typically involves a combination of imaging tests such as ultrasound, CT scans, and MRI, along with a biopsy to confirm the presence of cancer cells. Treatment options depend on the type and location of the tumor, but may include surgery, chemotherapy, or radiation therapy.

It is important to seek medical attention if you experience any persistent symptoms or notice any unusual changes in your body, as early diagnosis and treatment can improve outcomes for vascular neoplasms.

There are several types of sweat gland neoplasms, including:

1. Apocrine sweat gland adenoma: This is a benign tumor that typically affects the axillae (armpits) and groin area. It can become large and cause discomfort or pain.
2. Eccrine sweat gland carcinoma: This is a malignant tumor that arises in the eccrine sweat glands, which are found throughout the body. It is rare and usually affects the skin of the arms, legs, or trunk.
3. Apocrine sweat gland carcinoma: This is a rare and aggressive type of cancer that develops in the apocrine sweat glands. It typically affects the skin of the axillae (armpits) and groin area.
4. Sebaceous gland carcinoma: This is a rare and aggressive type of cancer that develops in the sebaceous glands, which are found in the skin. It can occur anywhere on the body, but is most common on the face, scalp, or torso.

The symptoms of sweat gland neoplasms vary depending on the location and type of tumor. They may include:

* A lump or swelling in the affected area
* Painless or painful lumps that can become large
* Redness, swelling, or bleeding of the skin
* Discharge or odor from the affected area
* Fever or chills

If you suspect you may have a sweat gland neoplasm, it is important to seek medical attention. Your healthcare provider will perform a physical examination and may order diagnostic tests, such as imaging studies or biopsies, to determine the cause of your symptoms. Treatment options for sweat gland neoplasms vary depending on the type and location of the tumor, but may include surgery, radiation therapy, or chemotherapy.

There are several types of lymphoma, including:

1. Hodgkin lymphoma: This is a type of lymphoma that originates in the white blood cells called Reed-Sternberg cells. It is characterized by the presence of giant cells with multiple nucleoli.
2. Non-Hodgkin lymphoma (NHL): This is a type of lymphoma that does not meet the criteria for Hodgkin lymphoma. There are many subtypes of NHL, each with its own unique characteristics and behaviors.
3. Cutaneous lymphoma: This type of lymphoma affects the skin and can take several forms, including cutaneous B-cell lymphoma and cutaneous T-cell lymphoma.
4. Primary central nervous system (CNS) lymphoma: This is a rare type of lymphoma that develops in the brain or spinal cord.
5. Post-transplantation lymphoproliferative disorder (PTLD): This is a type of lymphoma that develops in people who have undergone an organ transplant, often as a result of immunosuppressive therapy.

The symptoms of lymphoma can vary depending on the type and location of the cancer. Some common symptoms include:

* Swollen lymph nodes
* Fever
* Fatigue
* Weight loss
* Night sweats
* Itching

Lymphoma is diagnosed through a combination of physical examination, imaging tests (such as CT scans or PET scans), and biopsies. Treatment options for lymphoma depend on the type and stage of the cancer, and may include chemotherapy, radiation therapy, immunotherapy, or stem cell transplantation.

Overall, lymphoma is a complex and diverse group of cancers that can affect people of all ages and backgrounds. While it can be challenging to diagnose and treat, advances in medical technology and research have improved the outlook for many patients with lymphoma.

Some common types of bone neoplasms include:

* Osteochondromas: These are benign tumors that grow on the surface of a bone.
* Giant cell tumors: These are benign tumors that can occur in any bone of the body.
* Chondromyxoid fibromas: These are rare, benign tumors that develop in the cartilage of a bone.
* Ewing's sarcoma: This is a malignant tumor that usually occurs in the long bones of the arms and legs.
* Multiple myeloma: This is a type of cancer that affects the plasma cells in the bone marrow.

Symptoms of bone neoplasms can include pain, swelling, or deformity of the affected bone, as well as weakness or fatigue. Treatment options depend on the type and location of the tumor, as well as the severity of the symptoms. Treatment may involve surgery, radiation therapy, chemotherapy, or a combination of these.

The most common types of palatal neoplasms include:

1. Ossifying fibroma: A benign tumor that is made up of immature bone cells and usually affects the maxilla (the bone that forms the upper jaw).
2. Malignant ossifying fibroma: A rare and aggressive type of ossifying fibroma that can be cancerous.
3. Benign migratory glossitis: A benign condition characterized by inflammation and ulceration of the tongue, which can sometimes lead to the formation of a tumor on the hard palate.
4. Squamous cell carcinoma: A type of skin cancer that can occur on the hard palate, usually in older adults.
5. Adenoid cystic carcinoma: A rare and slow-growing type of cancer that typically affects the salivary glands but can also occur on the hard palate.

The symptoms of palatal neoplasms can include:

1. Pain or tenderness in the mouth or jaw
2. Difficulty swallowing or speaking
3. Nasal congestion or obstruction
4. Facial pain or swelling
5. Unusual bleeding or discharge from the mouth

Palatal neoplasms are usually diagnosed through a combination of physical examination, imaging studies (such as X-rays or CT scans), and biopsy (the removal of a small sample of tissue for microscopic examination). Treatment options can vary depending on the type and stage of the tumor, but may include surgery, radiation therapy, chemotherapy, or a combination of these.

Prognosis for patients with palatal neoplasms depends on the specific diagnosis and stage of the tumor at the time of diagnosis. In general, early detection and treatment improve outcomes for these types of tumors.

Examples of neoplasms, complex and mixed include:

1. Breast cancer that consists of both ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC).
2. Lung cancer that contains both adenocarcinoma and squamous cell carcinoma.
3. Colorectal cancer that is composed of both adenocarcinoma and mucinous adenocarcinoma.
4. Thyroid cancer that consists of both papillary carcinoma and follicular carcinoma.
5. Melanoma that is composed of both superficial spreading melanoma and nodular melanoma.

The diagnosis of neoplasms, complex and mixed often requires a combination of imaging studies such as CT scans, MRI, and PET scans, as well as tissue sampling through biopsy or surgery. Treatment may involve a combination of surgery, radiation therapy, and chemotherapy, depending on the specific type and extent of the cancer.

Some common types of mandibular neoplasms include:

1. Ameloblastoma: A rare benign tumor that arises from the odontogenic epithel, which is the tissue responsible for the formation of teeth.
2. Odontogenic keratocyst: A benign tumor that originates in the mandible and can expand to involve the surrounding bone and soft tissues.
3. Myxoid chondromatosis: A rare benign tumor that consists of multiple cartilaginous nodules that are surrounded by a loose connective tissue stroma.
4. Chondroderivative osteoma: A rare benign bone tumor that arises from the mutation of cartilage cells during bone development.
5. Ossifying fibroma: A benign tumor that is made up of immature bone tissue and typically affects the jawbone.
6. Fibrosarcoma: A malignant tumor that arises from the connective tissue of the mandible, such as the periodontal ligament or the muscles of mastication.
7. Osteosarcoma: A malignant bone tumor that can arise in any bone of the body, including the mandible.

Symptoms of mandibular neoplasms can include pain, swelling, and difficulty opening the mouth or biting. Treatment options depend on the type and stage of the neoplasm and may involve surgery, radiation therapy, or a combination of both. Early detection and treatment are important to improve outcomes and minimize the risk of complications.

Cystadenocarcinoma can occur in various parts of the body, but it is most common in the ovary and breast. In the ovary, it is the most common type of ovarian cancer and accounts for about 70% of all ovarian cancers. In the breast, it is a rare type of breast cancer, accounting for less than 5% of all breast cancers.

The symptoms of cystadenocarcinoma can vary depending on the location of the tumor, but they may include:

* Abnormal vaginal bleeding or discharge
* Pelvic pain or discomfort
* Abdominal swelling or bloating
* Painful urination
* Weakness and fatigue

Cystadenocarcinoma is diagnosed through a combination of imaging tests, such as ultrasound, CT scan, or MRI, and biopsy. Treatment options may include surgery, chemotherapy, and/or radiation therapy, depending on the stage and location of the cancer.

The prognosis for cystadenocarcinoma depends on the stage of the cancer at the time of diagnosis. In general, early detection and treatment improve the chances of a successful outcome. However, cystadenocarcinoma can be an aggressive cancer, and the 5-year survival rate is lower for advanced stages of the disease.

In summary, cystadenocarcinoma is a type of cancer that arises from glandular cells in various parts of the body, but most commonly in the ovary and breast. It can cause a range of symptoms and is diagnosed through imaging tests and biopsy. Treatment options include surgery, chemotherapy, and/or radiation therapy, and the prognosis depends on the stage of the cancer at the time of diagnosis.

Bile duct neoplasms refer to abnormal growths or tumors that occur in the bile ducts, which are the tubes that carry bile from the liver and gallbladder to the small intestine. Bile duct neoplasms can be benign (non-cancerous) or malignant (cancerous).

Types of Bile Duct Neoplasms:

There are several types of bile duct neoplasms, including:

1. Bile duct adenoma: A benign tumor that grows in the bile ducts.
2. Bile duct carcinoma: A malignant tumor that grows in the bile ducts and can spread to other parts of the body.
3. Cholangiocarcinoma: A rare type of bile duct cancer that originates in the cells lining the bile ducts.
4. Gallbladder cancer: A type of cancer that occurs in the gallbladder, which is a small organ located under the liver that stores bile.

Causes and Risk Factors:

The exact cause of bile duct neoplasms is not known, but there are several risk factors that may increase the likelihood of developing these tumors, including:

1. Age: Bile duct neoplasms are more common in people over the age of 50.
2. Gender: Women are more likely to develop bile duct neoplasms than men.
3. Family history: People with a family history of bile duct cancer or other liver diseases may be at increased risk.
4. Previous exposure to certain chemicals: Exposure to certain chemicals, such as thorium, has been linked to an increased risk of developing bile duct neoplasms.

Symptoms:

The symptoms of bile duct neoplasms can vary depending on the location and size of the tumor. Some common symptoms include:

1. Yellowing of the skin and eyes (jaundice)
2. Fatigue
3. Loss of appetite
4. Nausea and vomiting
5. Abdominal pain or discomfort
6. Weight loss
7. Itching all over the body
8. Dark urine
9. Pale stools

Diagnosis:

Diagnosis of bile duct neoplasms typically involves a combination of imaging tests and biopsy. The following tests may be used to diagnose bile duct neoplasms:

1. Ultrasound: This non-invasive test uses high-frequency sound waves to create images of the liver and bile ducts.
2. Computed tomography (CT) scan: This imaging test uses X-rays and computer technology to create detailed images of the liver and bile ducts.
3. Magnetic resonance imaging (MRI): This test uses a strong magnetic field and radio waves to create detailed images of the liver and bile ducts.
4. Endoscopic ultrasound: This test involves inserting an endoscope (a thin, flexible tube with a small ultrasound probe) into the bile ducts through the mouth or stomach to obtain images and samples of the bile ducts.
5. Biopsy: A biopsy may be performed during an endoscopic ultrasound or during surgery to remove the tumor. The sample is then examined under a microscope for cancer cells.

Treatment:

The treatment of bile duct neoplasms depends on several factors, including the type and stage of the cancer, the patient's overall health, and the patient's preferences. The following are some common treatment options for bile duct neoplasms:

1. Surgery: Surgery may be performed to remove the tumor or a portion of the bile duct. This may involve a Whipple procedure (a surgical procedure to remove the head of the pancreas, the gallbladder, and a portion of the bile duct), a bile duct resection, or a liver transplant.
2. Chemotherapy: Chemotherapy may be used before or after surgery to shrink the tumor and kill any remaining cancer cells.
3. Radiation therapy: Radiation therapy may be used to destroy cancer cells that cannot be removed by surgery or to relieve symptoms such as pain or blockage of the bile duct.
4. Stent placement: A stent may be placed in the bile duct to help keep it open and improve blood flow to the liver.
5. Ablation therapy: Ablation therapy may be used to destroy cancer cells by freezing or heating them with a probe inserted through an endoscope.
6. Targeted therapy: Targeted therapy may be used to treat certain types of bile duct cancer, such as cholangiocarcinoma, by targeting specific molecules that promote the growth and spread of the cancer cells.
7. Clinical trials: Clinical trials are research studies that evaluate new treatments for bile duct neoplasms. These may be an option for patients who have not responded to other treatments or who have advanced cancer.

1. Tumor size and location: Larger tumors that have spread to nearby tissues or organs are generally considered more invasive than smaller tumors that are confined to the original site.
2. Cellular growth patterns: The way in which cancer cells grow and divide can also contribute to the overall invasiveness of a neoplasm. For example, cells that grow in a disorganized or chaotic manner may be more likely to invade surrounding tissues.
3. Mitotic index: The mitotic index is a measure of how quickly the cancer cells are dividing. A higher mitotic index is generally associated with more aggressive and invasive cancers.
4. Necrosis: Necrosis, or the death of cells, can be an indication of the level of invasiveness of a neoplasm. The presence of significant necrosis in a tumor is often a sign that the cancer has invaded surrounding tissues and organs.
5. Lymphovascular invasion: Cancer cells that have invaded lymphatic vessels or blood vessels are considered more invasive than those that have not.
6. Perineural invasion: Cancer cells that have invaded nerve fibers are also considered more invasive.
7. Histological grade: The histological grade of a neoplasm is a measure of how abnormal the cancer cells look under a microscope. Higher-grade cancers are generally considered more aggressive and invasive than lower-grade cancers.
8. Immunohistochemical markers: Certain immunohistochemical markers, such as Ki-67, can be used to evaluate the proliferative activity of cancer cells. Higher levels of these markers are generally associated with more aggressive and invasive cancers.

Overall, the degree of neoplasm invasiveness is an important factor in determining the likelihood of the cancer spreading to other parts of the body (metastasizing) and in determining the appropriate treatment strategy for the patient.

A thymus neoplasm is a type of cancer that originates in the thymus gland, which is located in the chest behind the sternum and is responsible for the development and maturation of T-lymphocytes (T-cells) of the immune system.

Types of Thymus Neoplasms

There are several types of thymus neoplasms, including:

1. Thymoma: A slow-growing tumor that is usually benign but can sometimes be malignant.
2. Thymic carcinoma: A more aggressive type of cancer that is less common than thymoma.
3. Thymic lymphoma: A type of cancer that arises from the T-cells in the thymus gland and can be either B-cell or T-cell derived.

Symptoms of Thymus Neoplasms

The symptoms of thymus neoplasms can vary depending on the location and size of the tumor, but they may include:

1. Chest pain or discomfort
2. Coughing or shortness of breath
3. Fatigue or fever
4. Swelling in the neck or face
5. Weight loss or loss of appetite

Diagnosis of Thymus Neoplasms

The diagnosis of a thymus neoplasm typically involves a combination of imaging tests such as chest X-rays, computed tomography (CT) scans, and positron emission tomography (PET) scans, as well as a biopsy to confirm the presence of cancer cells.

Treatment of Thymus Neoplasms

The treatment of thymus neoplasms depends on the type and stage of the cancer, but may include:

1. Surgery to remove the tumor
2. Radiation therapy to kill any remaining cancer cells
3. Chemotherapy to destroy cancer cells
4. Targeted therapy to specific molecules involved in the growth and progression of the cancer.

Prognosis of Thymus Neoplasms

The prognosis for thymus neoplasms depends on the type and stage of the cancer at the time of diagnosis. In general, the earlier the cancer is detected and treated, the better the prognosis.

Prevention of Thymus Neoplasms

There is no known way to prevent thymus neoplasms, as they are rare and can occur in people of all ages. However, early detection and treatment of the cancer can improve the chances of a successful outcome.

Current Research on Thymus Neoplasms

Researchers are currently studying new treatments for thymus neoplasms, such as targeted therapies and immunotherapy, which use the body's own immune system to fight cancer. Additionally, researchers are working to develop better diagnostic tests to detect thymus neoplasms at an earlier stage, when they are more treatable.

Conclusion

Thymus neoplasms are rare and complex cancers that require specialized care and treatment. While the prognosis for these cancers can be challenging, advances in diagnosis and treatment have improved outcomes for many patients. Researchers continue to study new treatments and diagnostic tools to improve the chances of a successful outcome for those affected by thymus neoplasms.

Benign splenic neoplasms:

1. Splenic hamartoma: A rare benign tumor that usually occurs in children and young adults. It is made up of immature cells and can cause symptoms such as abdominal pain, fever, and anemia.
2. Splenic cyst: A fluid-filled sac that can develop in the spleen, often causing no symptoms unless it becomes infected or ruptures.
3. Splenic hemangioma: A benign tumor made up of blood vessels that can cause abdominal pain and discomfort.

Malignant splenic neoplasms:

1. Lymphoma: Cancer of the immune system that can affect the spleen, causing symptoms such as fever, fatigue, and weight loss.
2. Leukemia: Cancer of the blood cells that can cause an overgrowth of abnormal white blood cells in the bone marrow and other organs, including the spleen.
3. Splenic marginal zone lymphoma: A rare type of cancer that affects the marginal zone of the spleen, causing symptoms such as abdominal pain, fatigue, and weight loss.
4. Splenic diffuse large B-cell lymphoma: An aggressive form of lymphoma that can cause symptoms such as fever, night sweats, and weight loss.

The diagnosis of splenic neoplasms is based on a combination of imaging studies such as CT scans or PET scans, blood tests, and biopsies. Treatment options vary depending on the type and stage of the tumor and may include surgery, chemotherapy, or radiation therapy.

Heart neoplasms, also known as cardiac tumors, are abnormal growths that occur within the heart muscle or on the surface of the heart. These tumors can be benign (non-cancerous) or malignant (cancerous). Malignant heart tumors are rare but can be aggressive and potentially life-threatening.

Types of Heart Neoplasms:

1. Benign tumors: These include fibromas, lipomas, and teratomas, which are usually slow-growing and do not spread to other parts of the body.
2. Malignant tumors: These include sarcomas, carcinomas, and lymphomas, which can be more aggressive and may spread to other parts of the body.

Causes and Risk Factors:

The exact cause of heart neoplasms is not fully understood, but several factors have been linked to an increased risk of developing these tumors. These include:

1. Genetic mutations: Some heart neoplasms may be caused by inherited genetic mutations.
2. Viral infections: Some viruses, such as human T-lymphotropic virus (HTLV-1), have been linked to an increased risk of developing heart tumors.
3. Radiation exposure: Radiation therapy to the chest area can increase the risk of developing heart tumors.
4. Previous heart surgery: People who have had previous heart surgery may be at higher risk of developing heart neoplasms.

Symptoms and Diagnosis:

The symptoms of heart neoplasms can vary depending on the size and location of the tumor. They may include:

1. Chest pain or discomfort
2. Shortness of breath
3. Fatigue
4. Palpitations
5. Swelling in the legs, ankles, or feet

Diagnosis is typically made through a combination of physical examination, medical history, and diagnostic tests such as electrocardiograms (ECGs), echocardiograms, and cardiac imaging studies. A biopsy may be necessary to confirm the diagnosis.

Treatment and Prognosis:

The treatment of heart neoplasms depends on the type, size, and location of the tumor, as well as the patient's overall health. Treatment options may include:

1. Watchful waiting: Small, benign tumors may not require immediate treatment and can be monitored with regular check-ups.
2. Surgery: Surgical removal of the tumor may be necessary for larger or more aggressive tumors.
3. Chemotherapy: Chemotherapy drugs may be used to shrink the tumor before surgery or to treat any remaining cancer cells after surgery.
4. Radiation therapy: Radiation therapy may be used to treat heart neoplasms that are difficult to remove with surgery or that have returned after previous treatment.

The prognosis for heart neoplasms varies depending on the type and location of the tumor, as well as the patient's overall health. In general, the earlier the diagnosis and treatment, the better the prognosis. However, some heart neoplasms can be aggressive and may have a poor prognosis despite treatment.

Complications:

Heart neoplasms can cause a variety of complications, including:

1. Heart failure: Tumors that obstruct the heart's pumping activity can lead to heart failure.
2. Arrhythmias: Tumors can disrupt the heart's electrical activity and cause arrhythmias (abnormal heart rhythms).
3. Thrombus formation: Tumors can increase the risk of blood clots forming within the heart.
4. Septicemia: Bacterial infections can occur within the tumor, leading to septicemia (blood poisoning).
5. Respiratory failure: Large tumors can compress the lungs and lead to respiratory failure.

Conclusion:

Heart neoplasms are rare but potentially life-threatening conditions that require prompt diagnosis and treatment. While some heart neoplasms are benign, others can be aggressive and may have a poor prognosis despite treatment. It is essential to seek medical attention if symptoms persist or worsen over time, as early detection and treatment can improve outcomes.

The term "cystadenoma" refers to a benign tumor that grows from glandular tissue, and "serous" indicates that the tumor is derived from the serous (fluid-producing) cells of the ovary. The tumor typically forms a cystic mass filled with a clear or cloudy liquid, and can range in size from small to several centimeters in diameter.

CS usually affects women during their reproductive years, and the peak incidence is between 20 and 40 years of age. Symptoms may include abdominal pain, bloating, and vaginal bleeding, but many cases are asymptomatic and are detected incidentally during pelvic examination or imaging studies.

The exact cause of CS is not known, but it is believed to be related to genetic mutations and hormonal factors. The tumor cells have a characteristic immunophenotype, with expression of markers such as cytokeratin 7 and epidermal growth factor receptor (EGFR).

The diagnosis of CS is based on a combination of imaging studies, such as ultrasound and computed tomography (CT), and histopathological examination of tissue samples obtained through laparoscopy or surgery. Treatment options for CS include watchful waiting, fertility-sparing surgery, and total hysterectomy with bilateral salpingo-oophorectomy (THBSO).

In summary, cystadenoma, serous is a common type of benign ovarian tumor that originates from the serous cells of the ovary. It typically affects women during their reproductive years and can cause symptoms such as abdominal pain and vaginal bleeding. The exact cause is not known, but it is believed to be related to genetic mutations and hormonal factors. Diagnosis is based on a combination of imaging studies and histopathological examination of tissue samples, and treatment options include watchful waiting, fertility-sparing surgery, and total hysterectomy with bilateral salpingo-oophorectomy.

There are several types of colonic neoplasms, including:

1. Adenomas: These are benign growths that are usually precursors to colorectal cancer.
2. Carcinomas: These are malignant tumors that arise from the epithelial lining of the colon.
3. Sarcomas: These are rare malignant tumors that arise from the connective tissue of the colon.
4. Lymphomas: These are cancers of the immune system that can affect the colon.

Colonic neoplasms can cause a variety of symptoms, including bleeding, abdominal pain, and changes in bowel habits. They are often diagnosed through a combination of medical imaging tests (such as colonoscopy or CT scan) and biopsy. Treatment for colonic neoplasms depends on the type and stage of the tumor, and may include surgery, chemotherapy, and/or radiation therapy.

Overall, colonic neoplasms are a common condition that can have serious consequences if left untreated. It is important for individuals to be aware of their risk factors and to undergo regular screening for colon cancer to help detect and treat any abnormal growths or tumors in the colon.

Some common types of maxillary neoplasms include:

1. Osteosarcoma: a type of bone cancer that affects the maxilla.
2. Chondrosarcoma: a type of cancer that arises in the cartilage cells of the maxilla.
3. Squamous cell carcinoma: a type of cancer that originates in the epithelial cells lining the maxilla.
4. Adenoid cystic carcinoma: a rare type of cancer that affects the salivary glands in the maxilla.
5. Pleomorphic adenoma: a benign tumor that arises in the salivary glands of the maxilla.
6. Pyogenic granuloma: a type of benign tumor that occurs in the blood vessels of the maxilla.
7. Hemangiopericytic fibroma: a rare type of benign tumor that affects the blood vessels of the maxilla.

Maxillary neoplasms can cause a variety of symptoms, including pain, swelling, and difficulty opening the mouth or eye. They are typically diagnosed through a combination of imaging studies such as CT scans, MRI scans, and biopsies. Treatment options for maxillary neoplasms depend on the type and location of the tumor, but may include surgery, radiation therapy, and chemotherapy.

1. Parvovirus (Parvo): A highly contagious viral disease that affects dogs of all ages and breeds, causing symptoms such as vomiting, diarrhea, and severe dehydration.
2. Distemper: A serious viral disease that can affect dogs of all ages and breeds, causing symptoms such as fever, coughing, and seizures.
3. Rabies: A deadly viral disease that affects dogs and other animals, transmitted through the saliva of infected animals, and causing symptoms such as aggression, confusion, and paralysis.
4. Heartworms: A common condition caused by a parasitic worm that infects the heart and lungs of dogs, leading to symptoms such as coughing, fatigue, and difficulty breathing.
5. Ticks and fleas: These external parasites can cause skin irritation, infection, and disease in dogs, including Lyme disease and tick-borne encephalitis.
6. Canine hip dysplasia (CHD): A genetic condition that affects the hip joint of dogs, causing symptoms such as arthritis, pain, and mobility issues.
7. Osteosarcoma: A type of bone cancer that affects dogs, often diagnosed in older dogs and causing symptoms such as lameness, swelling, and pain.
8. Allergies: Dog allergies can cause skin irritation, ear infections, and other health issues, and may be triggered by environmental factors or specific ingredients in their diet.
9. Gastric dilatation-volvulus (GDV): A life-threatening condition that occurs when a dog's stomach twists and fills with gas, causing symptoms such as vomiting, pain, and difficulty breathing.
10. Cruciate ligament injuries: Common in active dogs, these injuries can cause joint instability, pain, and mobility issues.

It is important to monitor your dog's health regularly and seek veterinary care if you notice any changes or abnormalities in their behavior, appetite, or physical condition.

There are several types of anal gland neoplasms, including:

1. Anal gland adenomas: These are benign tumors that grow slowly and typically do not spread to other parts of the body.
2. Anal gland adenocarcinomas: These are malignant tumors that can invade nearby tissue and spread to other parts of the body.
3. Squamous cell carcinomas: These are malignant tumors that arise from the squamous cells that line the anus.
4. Melanocytic neuroendocrine tumors: These are rare tumors that arise from the pigment-producing cells of the anal glands.

The symptoms of anal gland neoplasms can include:

1. Pain or discomfort in the anus
2. Bleeding from the anus
3. Itching or discharge from the anus
4. A lump or mass near the anus
5. Difficulty passing stools

The diagnosis of anal gland neoplasms is typically made through a combination of physical examination, imaging studies such as CT scans or MRI, and biopsies. Treatment options can include:

1. Surgery to remove the tumor
2. Radiation therapy to destroy cancer cells
3. Chemotherapy to kill cancer cells
4. Immunotherapy to boost the body's immune system against cancer

The prognosis for anal gland neoplasms depends on the type and stage of the cancer, as well as the patient's overall health. In general, early detection and treatment improve the chances of a successful outcome.

Examples of neoplasms, germ cell and embryonal include:

1. Testicular cancer: This type of cancer develops in the cells of the testes and is most common in young men between the ages of 20 and 35.
2. Ovarian cancer: This type of cancer develops in the cells of the ovaries and is most common in older women.
3. Embryonal carcinoma: This type of cancer develops in the cells that form the embryo during fetal development. It is rare and tends to affect children and young adults.
4. Teratocarcinoma: This type of cancer develops in the cells that form the placenta during pregnancy. It is rare and tends to affect women who have abnormal pregnancies.

Neoplasms, germ cell and embryonal are typically treated with surgery, chemotherapy, or radiation therapy, depending on the location and severity of the cancer. The prognosis for these types of cancers is generally good if they are detected early and treated appropriately. However, if they are not diagnosed and treated promptly, they can spread to other parts of the body and be more difficult to treat.

These tumors can cause a variety of symptoms such as pain, swelling, and weakness in the affected area. Treatment options for bone marrow neoplasms depend on the type, size, and location of the tumor, as well as the overall health of the patient. Treatment may include surgery, chemotherapy, or radiation therapy.

Here are some examples of bone marrow neoplasms:

1. Osteosarcoma: A malignant tumor that arises from the bone-forming cells in the bone marrow. This type of cancer is most common in children and young adults.

2. Chondrosarcoma: A malignant tumor that arises from the cartilage-forming cells in the bone marrow. This type of cancer is most common in older adults.

3. Myeloma: A type of cancer that affects the plasma cells in the bone marrow. These cells produce antibodies to fight infections, but with myeloma, the abnormal plasma cells produce excessive amounts of antibodies that can cause a variety of symptoms.

4. Ewing's sarcoma: A rare malignant tumor that arises from immature nerve cells in the bone marrow. This type of cancer is most common in children and young adults.

5. Askin's tumor: A rare malignant tumor that arises from the fat cells in the bone marrow. This type of cancer is most common in older adults.

These are just a few examples of the many types of bone marrow neoplasms that can occur. It's important to seek medical attention if you experience any symptoms that may indicate a bone marrow neoplasm, such as pain or swelling in the affected area, fatigue, fever, or weight loss. A healthcare professional can perform diagnostic tests to determine the cause of your symptoms and develop an appropriate treatment plan.

There are several types of adipocytic neoplasms, including:

1. Lipomas: These are benign, slow-growing tumors that are composed of mature fat cells (adipocytes). They are usually soft to the touch and can be moved easily under the skin.
2. Liposarcomas: These are malignant tumors that also originate in adipose tissue. They can be slow-growing or aggressive and can infiltrate surrounding tissues.
3. Pigmented villonodular synovitis (PVN): This is a type of benign tumor that occurs in the synovial membrane, which lines the joints and tendons. It is composed of adipocytes and other cell types and can cause pain and stiffness in the affected joint.
4. Giant cell lipomatosis: This is a rare condition characterized by multiple small lipomas that are clustered together.
5. Spindle cell lipoma: This is a rare type of lipoma that contains spindle-shaped cells, which are elongated and irregular in shape.

These adipocytic neoplasms can be diagnosed through various imaging techniques such as ultrasonography, computed tomography (CT), magnetic resonance imaging (MRI), and fine needle aspiration biopsy. Treatment options vary depending on the type and location of the tumor, but may include surgical excision, radiation therapy, or chemotherapy.

The causes of colorectal neoplasms are not fully understood, but factors such as age, genetics, diet, and lifestyle have been implicated. Symptoms of colorectal cancer can include changes in bowel habits, blood in the stool, abdominal pain, and weight loss. Screening for colorectal cancer is recommended for adults over the age of 50, as it can help detect early-stage tumors and improve survival rates.

There are several subtypes of colorectal neoplasms, including adenomas (which are precancerous polyps), carcinomas (which are malignant tumors), and lymphomas (which are cancers of the immune system). Treatment options for colorectal cancer depend on the stage and location of the tumor, but may include surgery, chemotherapy, radiation therapy, or a combination of these.

Research into the causes and treatment of colorectal neoplasms is ongoing, and there has been significant progress in recent years. Advances in screening and treatment have improved survival rates for patients with colorectal cancer, and there is hope that continued research will lead to even more effective treatments in the future.

The symptoms of meningeal neoplasms vary depending on the location, size, and type of tumor. Common symptoms include headaches, seizures, weakness or numbness in the arms or legs, and changes in vision, memory, or behavior. As the tumor grows, it can compress or displaces the brain tissue, leading to increased intracranial pressure and potentially life-threatening complications.

There are several different types of meningeal neoplasms, including:

1. Meningioma: This is the most common type of meningeal neoplasm, accounting for about 75% of all cases. Meningiomas are usually benign and grow slowly, but they can sometimes be malignant.
2. Metastatic tumors: These are tumors that have spread to the meninges from another part of the body, such as the lung or breast.
3. Lymphoma: This is a type of cancer that affects the immune system and can spread to the meninges.
4. Melanotic neuroectodermal tumors (MNTs): These are rare, malignant tumors that usually occur in children and young adults.
5. Hemangiopericytic hyperplasia: This is a rare, benign condition characterized by an overgrowth of blood vessels in the meninges.

The diagnosis of meningeal neoplasms is based on a combination of clinical symptoms, physical examination findings, and imaging studies such as CT or MRI scans. A biopsy may be performed to confirm the diagnosis and determine the type of tumor.

Treatment options for meningeal neoplasms depend on the type, size, and location of the tumor, as well as the patient's overall health. Surgery is often the first line of treatment, and may involve removing as much of the tumor as possible or using a laser to ablate (destroy) the tumor cells. Radiation therapy and chemotherapy may also be used in combination with surgery to treat malignant meningeal neoplasms.

Prognosis for meningeal neoplasms varies depending on the type of tumor and the patient's overall health. In general, early diagnosis and treatment improve the prognosis, while later-stage tumors may have a poorer outcome.

Symptoms of duodenal neoplasms can vary depending on the location and size of the tumor, but may include abdominal pain, weight loss, nausea, vomiting, and abdominal distension. Diagnosis is typically made through a combination of endoscopy, imaging studies such as CT scans or MRI, and biopsy. Treatment options for duodenal neoplasms depend on the type and stage of the tumor, but may include surgery, chemotherapy, and/or radiation therapy.

Duodenal Neoplasms are relatively rare, accounting for only about 1-2% of all gastrointestinal cancers. However, they can be aggressive and difficult to treat if not detected early. The prognosis for duodenal neoplasms is generally poor, with a 5-year survival rate of approximately 20-30%.

Types of Adrenal Cortex Neoplasms:

1. Adrenocortical carcinoma (ACC): A rare and aggressive malignant tumor that originates in the adrenal cortex. It is often associated with virilization (excessive masculinization) in women.
2. Adrenocortical adenoma (ACA): A benign tumor that originates in the adrenal cortex. It is less common than ACC and may not cause any symptoms.
3. Pheochromocytoma: A rare tumor that originates in the adrenal medulla, which is the inner part of the adrenal gland. It can secrete excessive amounts of hormones that regulate blood pressure and heart rate.
4. Paraganglioma: A rare tumor that originates in the paraganglia, which are clusters of cells located near the adrenal glands. These tumors can produce excessive amounts of hormones and cause similar symptoms as pheochromocytoma.

Symptoms of Adrenal Cortex Neoplasms:

1. Virilization (excessive masculinization) in women, such as deepening of the voice, excessive body hair growth, and clitoral enlargement.
2. Headache, fatigue, and weight gain due to excessive production of steroid hormones.
3. High blood pressure and heart rate due to excessive production of catecholamines (hormones that regulate blood pressure and heart rate).
4. Abdominal pain, nausea, and vomiting due to the tumor's size and location.

Diagnosis of Adrenal Cortex Neoplasms:

1. Imaging tests such as CT scans or MRI to visualize the tumor and determine its size and location.
2. Laboratory tests to measure hormone levels in the blood, including cortisol, aldosterone, and catecholamines.
3. Biopsy to obtain a tissue sample for further examination under a microscope.

Treatment of Adrenal Cortex Neoplasms:

1. Surgery to remove the tumor, which is usually curative.
2. Medications to control symptoms such as high blood pressure and hormone levels.
3. Radiation therapy may be used in cases where surgery is not feasible or if there is a risk of recurrence.

Prognosis of Adrenal Cortex Neoplasms:

The prognosis for adrenal cortex neoplasms depends on the type and size of the tumor, as well as the extent of hormone production. In general, the prognosis is good for patients with benign tumors that are removed surgically. However, malignant tumors can have a poorer prognosis and may require additional treatments such as radiation therapy or chemotherapy.

Prevention of Adrenal Cortex Neoplasms:

There is no known prevention for adrenal cortex neoplasms, but early detection and treatment can improve outcomes. Regular monitoring of hormone levels and imaging tests can help detect tumors at an early stage.

Lifestyle Changes:

1. Reduce stress: High levels of cortisol can be caused by stress, so finding ways to manage stress can help prevent adrenal cortex neoplasms.
2. Maintain a healthy diet: Eating a balanced diet that includes plenty of fruits, vegetables, and whole grains can help support overall health and well-being.
3. Exercise regularly: Regular physical activity can help reduce stress and improve overall health.
4. Get enough sleep: Aim for 7-8 hours of sleep per night to help regulate hormone levels.
5. Limit caffeine and alcohol: Both substances can disrupt hormone levels and contribute to the development of adrenal cortex neoplasms.

Types of mouth neoplasms include:

1. Oral squamous cell carcinoma (OSCC): This is the most common type of mouth cancer, accounting for about 90% of all cases. It usually occurs on the tongue, lips, or floor of the mouth.
2. Verrucous carcinoma: This type of cancer is slow-growing and typically affects the gums or the outer surface of the tongue.
3. Adenoid cystic carcinoma: This type of cancer is rare and usually affects the salivary glands. It can infiltrate surrounding tissues and cause significant destruction of nearby structures.
4. Mucoepidermoid carcinoma: This type of cancer is relatively rare and occurs most commonly on the tongue or the floor of the mouth. It can be benign or malignant, and its behavior varies depending on the type.
5. Melanotic neuroectodermal tumor: This is a rare type of cancer that affects the melanocytes (pigment-producing cells) in the mouth. It typically occurs in the tongue or the lips.

Symptoms of mouth neoplasms can include:

* A sore or ulcer that does not heal
* A lump or mass in the mouth
* Bleeding or pain in the mouth
* Difficulty swallowing or speaking
* Numbness or tingling in the mouth

Diagnosis of mouth neoplasms typically involves a combination of physical examination, imaging studies (such as X-rays or CT scans), and biopsy. Treatment options vary depending on the type and severity of the cancer, but may include surgery, radiation therapy, chemotherapy, or a combination of these. Early detection and treatment are important for improving outcomes in patients with mouth neoplasms.

Mediastinal neoplasms are tumors or abnormal growths that occur in the mediastinum, which is the area between the lungs in the chest cavity. These neoplasms can be benign (non-cancerous) or malignant (cancerous).

Types of Mediastinal Neoplasms
------------------------------

There are several types of mediastinal neoplasms, including:

1. Thymoma: A tumor that originates in the thymus gland.
2. Thymic carcinoma: A malignant tumor that originates in the thymus gland.
3. Lymphoma: Cancer of the immune system that can occur in the mediastinum.
4. Germ cell tumors: Tumors that originate from germ cells, which are cells that form eggs or sperm.
5. Neuroendocrine tumors: Tumors that originate from cells of the nervous system and produce hormones.
6. Mesothelioma: A type of cancer that occurs in the lining of the chest cavity.
7. Metastatic tumors: Tumors that have spread to the mediastinum from another part of the body, such as the breast, lung, or colon.

Symptoms of Mediastinal Neoplasms
------------------------------

The symptoms of mediastinal neoplasms can vary depending on the type and location of the tumor. Some common symptoms include:

1. Chest pain or discomfort
2. Shortness of breath
3. Coughing
4. Fatigue
5. Weight loss
6. Swelling in the neck or face
7. Pain in the shoulders or arms
8. Coughing up blood
9. Hoarseness or difficulty swallowing

Diagnosis and Treatment of Mediastinal Neoplasms
-----------------------------------------------

The diagnosis of mediastinal neoplasms typically involves a combination of imaging tests such as chest X-rays, computed tomography (CT) scans, magnetic resonance imaging (MRI), and positron emission tomography (PET) scans. A biopsy may also be performed to confirm the diagnosis.

Treatment for mediastinal neoplasms depends on the type and location of the tumor, as well as the patient's overall health. Treatment options can include:

1. Surgery: Surgical removal of the tumor may be possible for some types of mediastinal neoplasms.
2. Radiation therapy: High-energy beams can be used to kill cancer cells.
3. Chemotherapy: Drugs can be used to kill cancer cells.
4. Targeted therapy: Drugs that target specific molecules involved in the growth and spread of cancer cells.
5. Immunotherapy: A type of treatment that uses the body's immune system to fight cancer.

Prognosis for Mediastinal Neoplasms
---------------------------------

The prognosis for mediastinal neoplasms depends on the type and location of the tumor, as well as the patient's overall health. In general, the prognosis is good for benign tumors, while the prognosis is guarded for malignant tumors. Factors that can affect the prognosis include:

1. Tumor size and location
2. Type of tumor
3. Extent of cancer spread
4. Patient's age and overall health
5. Response to treatment

Lifestyle Changes for Patients with Mediastinal Neoplasms
---------------------------------------------------

Patients with mediastinal neoplasms may need to make lifestyle changes to help manage their symptoms and improve their quality of life. These can include:

1. Eating a healthy diet
2. Getting regular exercise
3. Avoiding smoking and alcohol
4. Managing stress
5. Getting enough rest and sleep
6. Attending follow-up appointments with the doctor

Conclusion
----------

Mediastinal neoplasms are tumors that occur in the mediastinum, a region of the chest between the lungs. They can be benign or malignant, and their symptoms and treatment options vary depending on the type and location of the tumor. If you have been diagnosed with a mediastinal neoplasm, it is important to work closely with your healthcare team to determine the best course of treatment and manage any symptoms you may be experiencing. With appropriate treatment and lifestyle changes, many patients with mediastinal neoplasms can achieve long-term survival and a good quality of life.

1. Squamous cell carcinoma: This is the most common type of tongue cancer, accounting for about 90% of all cases. It usually starts on the front two-thirds of the tongue and can spread to other parts of the mouth and throat.
2. Verrucous carcinoma: This type of cancer is less aggressive than squamous cell carcinoma but can still invade surrounding tissues. It typically occurs on the lateral or back part of the tongue.
3. Papillary carcinoma: This type of cancer is rare and usually affects young people. It starts in the mucous glands on the surface of the tongue and tends to grow slowly.
4. Lymphoma: This type of cancer affects the immune system and can occur in various parts of the body, including the tongue. There are different subtypes of lymphoma that can affect the tongue, such as Hodgkin's lymphoma and non-Hodgkin's lymphoma.
5. Mucoepidermoid carcinoma: This is a rare type of cancer that usually affects children and young adults. It tends to grow slowly and can occur anywhere on the tongue, but it is most common on the front part of the tongue.

The symptoms of tongue neoplasms can vary depending on the type and location of the tumor. Common symptoms include:

* A lump or mass on the tongue that may be painful or tender to the touch
* Bleeding or discharge from the tongue
* Difficulty speaking, swallowing, or moving the tongue
* Pain in the tongue or mouth that does not go away
* A sore throat or ear pain

If you suspect you may have a tongue neoplasm, it is important to see a doctor for an evaluation. A biopsy can be performed to determine the type of tumor and develop a treatment plan. Treatment options can vary depending on the type and location of the tumor, but may include surgery, radiation therapy, chemotherapy, or a combination of these.

Benign ileal neoplasms include:

1. Adenomas: These are growths that are similar to colon polyps and can develop into colon cancer if left untreated.
2. Villous adenomas: These are benign tumors that grow on the villi, which are small projections that line the inside of the intestine.
3. Lipomas: These are slow-growing, non-cancerous growths that are made up of fat cells.

Malignant ileal neoplasms include:

1. Adenocarcinoma: This is the most common type of small intestine cancer and accounts for about 95% of all cases. It can occur in any part of the small intestine, but is more common in the duodenum (the first part of the small intestine).
2. Squamous cell carcinoma: This type of cancer occurs in the upper parts of the small intestine and is less common than adenocarcinoma.
3. Neuroendocrine tumors: These are rare tumors that occur in the hormone-producing cells of the small intestine and can produce excess hormones that can cause symptoms such as diarrhea, abdominal pain, and weight loss.

Ileal neoplasms can cause a variety of symptoms depending on their size, location, and type. These may include:

* Abdominal pain or discomfort
* Diarrhea or constipation
* Weight loss or loss of appetite
* Fatigue or weakness
* Nausea or vomiting
* Abnormal bleeding or discharge from the rectum

If you suspect that you may have an ileal neoplasm, it is important to seek medical attention as soon as possible. A healthcare professional can perform a series of tests and examinations to diagnose and determine the appropriate treatment for your condition. These may include:

1. Endoscopy: A flexible tube with a camera and light on the end is inserted through the mouth or rectum to visualize the inside of the small intestine and look for any abnormalities.
2. Imaging tests: Such as X-rays, CT scans, or MRI scans to visualize the small intestine and look for any tumors or other abnormalities.
3. Biopsy: A sample of tissue is removed from the small intestine and examined under a microscope to determine if there are any cancer cells present.
4. Blood tests: To check for certain substances in the blood that can indicate the presence of a neoplasm.
5. Genetic testing: To look for genetic changes that may indicate the presence of a neoplasm.

Treatment for ileal neoplasms depends on the type, size, location, and stage of the tumor, as well as the patient's overall health. Treatment options may include:

1. Surgery: To remove the tumor and any affected tissue.
2. Chemotherapy: To kill cancer cells with drugs.
3. Radiation therapy: To kill cancer cells with high-energy X-rays or other forms of radiation.
4. Targeted therapy: To use drugs or other substances to target specific molecules on the surface of cancer cells.
5. Supportive care: To manage symptoms and side effects, such as pain, nausea, and vomiting.

It's important for patients with ileal neoplasms to work closely with their healthcare team to determine the best course of treatment for their specific condition. With prompt and appropriate treatment, many people with ileal neoplasms can achieve long-term survival and a good quality of life.

There are several types of stomach neoplasms, including:

1. Adenocarcinoma: This is the most common type of stomach cancer, accounting for approximately 90% of all cases. It begins in the glandular cells that line the stomach and can spread to other parts of the body.
2. Squamous cell carcinoma: This type of cancer begins in the squamous cells that cover the outer layer of the stomach. It is less common than adenocarcinoma but more likely to be found in the upper part of the stomach.
3. Gastric mixed adenocarcinomasquamous cell carcinoma: This type of cancer is a combination of adenocarcinoma and squamous cell carcinoma.
4. Lymphoma: This is a cancer of the immune system that can occur in the stomach. It is less common than other types of stomach cancer but can be more aggressive.
5. Carcinomas of the stomach: These are malignant tumors that arise from the epithelial cells lining the stomach. They can be subdivided into adenocarcinoma, squamous cell carcinoma, and others.
6. Gastric brunner's gland adenoma: This is a rare type of benign tumor that arises from the Brunner's glands in the stomach.
7. Gastric polyps: These are growths that occur on the lining of the stomach and can be either benign or malignant.

The symptoms of stomach neoplasms vary depending on the location, size, and type of tumor. Common symptoms include abdominal pain, nausea, vomiting, weight loss, and difficulty swallowing. Diagnosis is usually made through a combination of endoscopy, imaging studies (such as CT or PET scans), and biopsy. Treatment depends on the type and stage of the tumor and may include surgery, chemotherapy, radiation therapy, or a combination of these. The prognosis for stomach neoplasms varies depending on the type and stage of the tumor, but early detection and treatment can improve outcomes.

These tumors can be benign or malignant, and their growth and behavior vary depending on the type of cancer. Malignant tumors can invade the surrounding tissues and spread to other parts of the body through the bloodstream or lymphatic system, causing serious complications and potentially life-threatening consequences.

The risk factors for developing urinary bladder neoplasms include smoking, exposure to certain chemicals, recurrent bladder infections, and a family history of bladder cancer. The symptoms of these tumors can include blood in the urine, pain during urination, frequent urination, and abdominal pain.

Diagnosis of urinary bladder neoplasms is typically made through a combination of imaging tests such as ultrasound, computed tomography (CT) scan or magnetic resonance imaging (MRI), and cystoscopy, which involves inserting a flexible tube with a camera into the bladder to visualize the tumor.

Treatment options for urinary bladder neoplasms depend on the type of cancer, stage, and location of the tumor. Treatment may include surgery to remove the tumor, chemotherapy, radiation therapy, or a combination of these modalities. Early detection and treatment can improve the prognosis for patients with urinary bladder neoplasms.

Benign spinal cord neoplasms are typically slow-growing and may not cause any symptoms in the early stages. However, as they grow, they can compress or damage the surrounding healthy tissue, leading to a range of symptoms such as pain, numbness, weakness, or paralysis.

Malignant spinal cord neoplasms are more aggressive and can grow rapidly, invading surrounding tissues and spreading to other parts of the body. They can cause similar symptoms to benign tumors, as well as other symptoms such as fever, nausea, and weight loss.

The diagnosis of spinal cord neoplasms is based on a combination of clinical findings, imaging studies (such as MRI or CT scans), and biopsy. Treatment options vary depending on the type and location of the tumor, but may include surgery, radiation therapy, and chemotherapy.

The prognosis for spinal cord neoplasms depends on the type and location of the tumor, as well as the patient's overall health. In general, benign tumors have a better prognosis than malignant tumors, and early diagnosis and treatment can improve outcomes. However, even with successful treatment, some patients may experience long-term neurological deficits or other complications.

Benign vaginal neoplasms include:

1. Vaginal papilloma: A small, finger-like growth on the wall of the vagina.
2. Vaginal polyps: Growths that protrude from the wall of the vagina.
3. Vaginal cysts: Fluid-filled sacs that can develop in the vaginal wall.

Malignant vaginal neoplasms include:

1. Vaginal squamous cell carcinoma: Cancer that develops in the thin, flat cells that line the vagina.
2. Adenocarcinoma of the vagina: Cancer that develops in the glandular cells that line the vagina.
3. Melanoma of the vagina: Rare cancer that develops in the pigment-producing cells of the vagina.
4. Sarcoma of the vagina: Cancer that develops in the connective tissue of the vagina.

Causes and risk factors:
The exact cause of vaginal neoplasms is not known, but certain factors can increase the risk of developing them, such as:

1. HPV (human papillomavirus) infection: A common sexually transmitted virus that can lead to cancer.
2. Smoking: Can increase the risk of developing cancer.
3. Weakened immune system: Can increase the risk of developing cancer.
4. Family history of cancer: Can increase the risk of developing cancer.

Symptoms:
The symptoms of vaginal neoplasms can vary depending on the type and location of the tumor, but may include:

1. Abnormal bleeding or discharge
2. Pain during sex
3. Itching or burning sensation in the vagina
4. A lump or mass in the vagina
5. Difficulty urinating
6. Painful urination
7. Vaginal wall thickening

Diagnosis:
A diagnosis of vaginal neoplasm is typically made through a combination of physical examination, imaging tests such as ultrasound or MRI, and a biopsy to confirm the presence of cancer cells.

Treatment:
The treatment of vaginal neoplasms depends on the type and stage of the cancer, but may include:

1. Surgery: Removal of the tumor and surrounding tissue.
2. Radiation therapy: Use of high-energy rays to kill cancer cells.
3. Chemotherapy: Use of drugs to kill cancer cells.
4. Hysterectomy: Removal of the uterus and/or vagina.
5. Pelvic exenteration: Removal of the pelvic organs, including the bladder, rectum, and reproductive organs.

Prognosis:
The prognosis for vaginal neoplasms depends on the type and stage of the cancer at the time of diagnosis. In general, the earlier the cancer is detected and treated, the better the prognosis.

Complications:
Some possible complications of vaginal neoplasms include:

1. Recurrence of the cancer
2. Infection
3. Incontinence or other urinary problems
4. Sexual dysfunction
5. Emotional distress

Prevention:
There is no sure way to prevent vaginal neoplasms, but some risk factors can be reduced by:

1. Practicing safe sex to reduce the risk of HPV infection
2. Getting regular Pap smears to detect and treat precancerous changes early
3. Avoiding tobacco and limiting alcohol consumption
4. Maintaining a healthy diet and exercising regularly
5. Getting vaccinated against HPV if you are under 26 years old

Note: This information is intended for educational purposes only and should not be considered medical advice. If you have any concerns or questions about vaginal neoplasms, you should consult a healthcare professional for personalized advice and treatment.

Examples and Observations:

Oxyphil adenomas are rare in the small bowel (less than 1% of all small intestinal tumors) but are more common in the duodenum and proximal jejunum. They usually manifest as multiple, submucosal nodules that can vary in size from a few millimeters to several centimeters in diameter. [2]

The presence of oxyphil adenomas in the stomach is rare (less than 1% of all gastric tumors) and most often occurs as multiple, small, submucosal nodules. However, larger adenomas may also be present. [3]

Synonyms: oxyphil cell adenoma; oxyphil cell tumor; oxyphil polyp. [1]

Notes:

* Oxyphil adenomas are often associated with familial adenomatous polyposis (FAP) and Turcot syndrome. [2]

References:

[1] Dorland's Medical Dictionary for Health Care Professionals. © 2008 Saunders, an imprint of Elsevier Inc. All rights reserved. Used with permission.

[2] Oxyphil Adenoma. The Merck Manual of Diagnosis and Therapy, Professional Edition. © 2015 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. Used with permission.

[3] Oxyphil Adenoma. Gastrointestinal Tumors: benign and malignant tumors of the digestive system, including colorectal cancer, stomach cancer, pancreatic cancer, liver cancer, biliary tract cancer, and soft tissue sarcomas. © 2015 Springer International Publishing Switzerland. All rights reserved. Used with permission.

This definition of 'Neoplasm Recurrence, Local' is from the Healthcare Professionals edition of the Merriam-Webster Medical Dictionary, copyright © 2007 by Merriam-Webster, Inc.

Some common types of nervous system neoplasms include:

1. Brain tumors: These are abnormal growths that develop in the brain, including gliomas (such as glioblastoma), meningiomas, and acoustic neuromas.
2. Spinal cord tumors: These are abnormal growths that develop in the spinal cord, including astrocytomas, oligodendrogliomas, and metastatic tumors.
3. Nerve sheath tumors: These are abnormal growths that develop in the covering of nerves, such as neurofibromas and schwannomas.
4. Pineal gland tumors: These are abnormal growths that develop in the pineal gland, a small endocrine gland located in the brain.

Symptoms of nervous system neoplasms can vary depending on their location and size, but may include headaches, seizures, weakness or numbness in the arms or legs, and changes in vision, speech, or balance. Diagnosis is typically made through a combination of imaging studies (such as MRI or CT scans) and tissue biopsy. Treatment options vary depending on the type and location of the tumor, but may include surgery, radiation therapy, and chemotherapy.

In summary, nervous system neoplasms are abnormal growths that can develop in the brain, spinal cord, and nerves, and can have a significant impact on the body. Diagnosis and treatment require a comprehensive approach, involving a team of medical professionals with expertise in neurology, neurosurgery, radiation oncology, and other related specialties.

Neoplastic metastasis can occur in any type of cancer but are more common in solid tumors such as carcinomas (breast, lung, colon). It is important for cancer diagnosis and prognosis because metastasis indicates that the cancer has spread beyond its original site and may be more difficult to treat.

Metastases can appear at any distant location but commonly found sites include the liver, lungs, bones, brain, and lymph nodes. The presence of metastases indicates a higher stage of cancer which is associated with lower survival rates compared to localized cancer.

There are several types of muscle neoplasms, including:

1. Leiomyoma: A benign tumor that develops in the smooth muscle tissue of the uterus. It is the most common type of uterine tumor and is usually found in women over the age of 30.
2. Rhabdomyosarcoma: A rare type of cancerous muscle tumor that can develop in children and young adults. It can occur in any part of the body, but is most commonly found in the head, neck, or genitourinary tract.
3. Liposarcoma: A rare type of cancerous muscle tumor that develops in the fat cells of the soft tissue. It can occur in any part of the body and is more common in older adults.
4. Fibromyxoid tumor: A rare benign tumor that develops in the muscles and connective tissue. It usually affects the arms or legs and can be diagnosed at any age, but is most commonly found in children and young adults.
5. Alveolar soft part sarcoma: A rare type of cancerous muscle tumor that develops in the soft tissue of the body. It is more common in younger adults and can occur anywhere in the body, but is most commonly found in the legs or arms.

The symptoms of muscle neoplasms vary depending on the location and size of the tumor. They may include pain, swelling, redness, and limited mobility in the affected area. Diagnosis is usually made through a combination of imaging tests such as X-rays, CT scans, or MRI, and a biopsy to confirm the presence of cancerous cells.

Treatment for muscle neoplasms depends on the type and location of the tumor, as well as the stage of the disease. Surgery is often the first line of treatment, followed by radiation therapy or chemotherapy if the tumor is malignant. In some cases, observation and monitoring may be recommended if the tumor is benign and not causing any symptoms.

It's important to note that muscle neoplasms are relatively rare, and most muscle masses are benign and non-cancerous. However, it's always best to consult a medical professional if you notice any unusual lumps or bumps on your body to determine the cause and appropriate treatment.

Examples of experimental liver neoplasms include:

1. Hepatocellular carcinoma (HCC): This is the most common type of primary liver cancer and can be induced experimentally by injecting carcinogens such as diethylnitrosamine (DEN) or dimethylbenz(a)anthracene (DMBA) into the liver tissue of animals.
2. Cholangiocarcinoma: This type of cancer originates in the bile ducts within the liver and can be induced experimentally by injecting chemical carcinogens such as DEN or DMBA into the bile ducts of animals.
3. Hepatoblastoma: This is a rare type of liver cancer that primarily affects children and can be induced experimentally by administering chemotherapy drugs to newborn mice or rats.
4. Metastatic tumors: These are tumors that originate in other parts of the body and spread to the liver through the bloodstream or lymphatic system. Experimental models of metastatic tumors can be studied by injecting cancer cells into the liver tissue of animals.

The study of experimental liver neoplasms is important for understanding the underlying mechanisms of liver cancer development and progression, as well as identifying potential therapeutic targets for the treatment of this disease. Animal models can be used to test the efficacy of new drugs or therapies before they are tested in humans, which can help to accelerate the development of new treatments for liver cancer.

Hemangiosarcoma is a malignant tumor that grows rapidly and can invade surrounding tissues and organs. It can also spread to other parts of the body through the bloodstream or lymphatic system, a process called metastasis.

The symptoms of hemangiosarcoma depend on the location of the tumor, but they may include:

* Pain in the affected area
* Swelling or mass in the abdomen or other areas where the tumor is located
* Difficulty breathing if the tumor is in the lungs
* Fatigue
* Weakness
* Loss of appetite
* Weight loss

Hemangiosarcoma is diagnosed through a combination of imaging tests such as ultrasound, CT scan, MRI, and PET scan, and a biopsy to confirm the presence of cancer cells. Treatment options for hemangiosarcoma depend on the location and stage of the disease, but they may include:

* Surgery to remove the tumor and any affected tissues
* Chemotherapy to kill cancer cells
* Radiation therapy to destroy cancer cells

The prognosis for hemangiosarcoma is generally poor, as it is a aggressive and difficult-to-treat disease. However, with early detection and appropriate treatment, some patients may have a better outcome.

There are several subtypes of carcinoma, including:

1. Adenocarcinoma: This type of carcinoma originates in glandular cells, which produce fluids or mucus. Examples include breast cancer, prostate cancer, and colon cancer.
2. Squamous cell carcinoma: This type of carcinoma originates in squamous cells, which are found on the surface layers of skin and mucous membranes. Examples include head and neck cancers, cervical cancer, and anal cancer.
3. Basal cell carcinoma: This type of carcinoma originates in the deepest layer of skin, called the basal layer. It is the most common type of skin cancer and tends to grow slowly.
4. Neuroendocrine carcinoma: This type of carcinoma originates in cells that produce hormones and neurotransmitters. Examples include lung cancer, pancreatic cancer, and thyroid cancer.
5. Small cell carcinoma: This type of carcinoma is a highly aggressive form of lung cancer that spreads quickly to other parts of the body.

The signs and symptoms of carcinoma depend on the location and stage of the cancer. Some common symptoms include:

* A lump or mass
* Pain
* Skin changes, such as a new mole or a change in the color or texture of the skin
* Changes in bowel or bladder habits
* Abnormal bleeding

The diagnosis of carcinoma typically involves a combination of imaging tests, such as X-rays, CT scans, MRI scans, and PET scans, and a biopsy, which involves removing a small sample of tissue for examination under a microscope. Treatment options for carcinoma depend on the location and stage of the cancer and may include surgery, radiation therapy, chemotherapy, or a combination of these.

In conclusion, carcinoma is a type of cancer that originates in epithelial cells and can occur in various parts of the body. Early detection and treatment are important for improving outcomes.

References:

1. American Cancer Society. (2022). Carcinoma. Retrieved from
2. Mayo Clinic. (2022). Carcinoma. Retrieved from
3. MedlinePlus. (2022). Carcinoma. Retrieved from

Adenocarcinoma is a term used to describe a variety of different types of cancer that arise in glandular tissue, including:

1. Colorectal adenocarcinoma (cancer of the colon or rectum)
2. Breast adenocarcinoma (cancer of the breast)
3. Prostate adenocarcinoma (cancer of the prostate gland)
4. Pancreatic adenocarcinoma (cancer of the pancreas)
5. Lung adenocarcinoma (cancer of the lung)
6. Thyroid adenocarcinoma (cancer of the thyroid gland)
7. Skin adenocarcinoma (cancer of the skin)

The symptoms of adenocarcinoma depend on the location of the cancer and can include:

1. Blood in the stool or urine
2. Abdominal pain or discomfort
3. Changes in bowel habits
4. Unusual vaginal bleeding (in the case of endometrial adenocarcinoma)
5. A lump or thickening in the breast or elsewhere
6. Weight loss
7. Fatigue
8. Coughing up blood (in the case of lung adenocarcinoma)

The diagnosis of adenocarcinoma is typically made through a combination of imaging tests, such as CT scans, MRI scans, and PET scans, and a biopsy, which involves removing a sample of tissue from the affected area and examining it under a microscope for cancer cells.

Treatment options for adenocarcinoma depend on the location of the cancer and can include:

1. Surgery to remove the tumor
2. Chemotherapy, which involves using drugs to kill cancer cells
3. Radiation therapy, which involves using high-energy X-rays or other particles to kill cancer cells
4. Targeted therapy, which involves using drugs that target specific molecules on cancer cells to kill them
5. Immunotherapy, which involves using drugs that stimulate the immune system to fight cancer cells.

The prognosis for adenocarcinoma is generally good if the cancer is detected and treated early, but it can be more challenging to treat if the cancer has spread to other parts of the body.

Myelodysplastic features include:

1. Inadequate production of healthy blood cells
2. Immature and abnormal blood cells in the bone marrow
3. Increased risk of infection and bleeding
4. Anemia
5. Fatigue
6. Easy bruising and bleeding
7. Recurring infections

Myeloproliferative features include:

1. Overproduction of one or more types of blood cells, such as white blood cells, red blood cells, or platelets
2. Enlargement of the spleen
3. Bone pain
4. Fatigue
5. Shortness of breath
6. Easy bruising and bleeding

The most common type of myelodysplastic-myeloproliferative disease is called myelofibrosis, which is characterized by the overproduction of bone marrow cells and scarring of the bone marrow. Other types include polycythemia vera, essential thrombocythemia, and primary myelofibrosis.

Myelodysplastic-myeloproliferative diseases can be difficult to diagnose and treat, and may require a combination of chemotherapy, immunotherapy, and other supportive therapies. The prognosis for these diseases varies depending on the specific type and severity of the disorder, as well as the patient's overall health.

Peripheral nervous system neoplasms can arise in various parts of the PNS, including:

1. Nerve sheath (Schwann cells): These tumors are called schwannomas or neurilemmomas.
2. Perineural tissue (perineurial cells): These tumors are called perineuriomas.
3. Nerve fibers (neurons): These tumors are called neurofibromas or nerve sheath tumors.
4. Miscellaneous (other types of cells): These tumors are called miscellaneous peripheral nervous system neoplasms.

Some common symptoms of peripheral nervous system neoplasms include:

* Painless lumps or masses in the neck, arm, or leg
* Weakness or numbness in the affected limb
* Tingling or burning sensations in the affected area
* Difficulty with coordination and balance
* Problems with vision or hearing

Peripheral nervous system neoplasms can be diagnosed through a variety of tests, including:

1. Imaging studies (MRI, CT scan, PET scan) to visualize the tumor and determine its location and size.
2. Biopsy to collect a tissue sample for further examination under a microscope.
3. Electromyography (EMG) to test the function of the nerves and muscles.
4. Genetic testing to look for specific genetic changes that may be associated with the tumor.

Treatment options for peripheral nervous system neoplasms depend on the type, size, location, and aggressiveness of the tumor, as well as the patient's overall health and preferences. Some common treatment options include:

1. Surgery to remove the tumor and any affected tissue.
2. Radiation therapy to kill cancer cells and shrink the tumor.
3. Chemotherapy to destroy cancer cells throughout the body.
4. Targeted therapy to specifically target cancer cells with drugs or other substances.
5. Observation and monitoring, as some peripheral nervous system neoplasms may be slow-growing and may not require immediate treatment.

It's important for individuals to seek medical attention if they experience any symptoms that may indicate a peripheral nervous system neoplasm. Early diagnosis and treatment can improve outcomes and increase the chances of successful treatment.

The symptoms of cerebral ventricle neoplasms depend on their size, location, and growth rate. They may include headaches, seizures, weakness or numbness in the arms or legs, and changes in personality or cognitive function. As the tumor grows, it can press on surrounding brain tissue and disrupt normal brain function.

Diagnosis of cerebral ventricle neoplasms typically involves a combination of imaging studies such as CT or MRI scans, and tissue sampling through a biopsy procedure. Treatment options for cerebral ventricle neoplasms depend on the type and location of the tumor, as well as the patient's overall health status. Surgery, radiation therapy, and chemotherapy may be used alone or in combination to treat these tumors.

Examples of types of cerebral ventricle neoplasms include:

1. Choroid plexus papilloma: A benign tumor that arises from the choroid plexus, a layer of tissue that lines the ventricles and produces cerebrospinal fluid.
2. Choroid plexus carcinoma: A malignant tumor that arises from the choroid plexus.
3. Ventricular ependymoma: A tumor that arises from the ependyma, a layer of tissue that lines the ventricles and helps to move cerebrospinal fluid through the brain.
4. Subependymal giant cell astrocytoma (SEGA): A rare benign tumor that arises from the subependymal layer of tissue, which is located beneath the ependyma.

Overall, cerebral ventricle neoplasms are a complex and diverse group of brain tumors that can have significant impacts on the brain and nervous system. Treatment options vary depending on the specific type of tumor and the individual patient's needs.

Paranasal sinus neoplasms refer to tumors or abnormal growths that occur within the paranasal sinuses, which are air-filled cavities within the skull that drain into the nasal passages. These neoplasms can be benign or malignant and can affect various structures in the head and neck, including the sinuses, nasal passages, eyes, and brain.

Types of Paranasal Sinus Neoplasms:

There are several types of paranasal sinus neoplasms, including:

1. Nasal cavity squamous cell carcinoma: This is the most common type of paranasal sinus cancer and arises from the lining of the nasal cavity.
2. Maxillary sinus adenoid cystic carcinoma: This type of tumor is slow-growing and usually affects the maxillary sinus.
3. Esthesioneuroepithelioma: This rare type of tumor arises from the lining of the nasal cavity and is more common in women than men.
4. Sphenoid sinus mucocele: This type of tumor is usually benign and occurs in the sphenoid sinus.
5. Osteochondroma: This is a rare type of benign tumor that arises from the bone and cartilage of the paranasal sinuses.

Symptoms of Paranasal Sinus Neoplasms:

The symptoms of paranasal sinus neoplasms can vary depending on the size, location, and type of tumor. Common symptoms include:

1. Nasal congestion or blockage
2. Headaches
3. Pain or pressure in the face, especially in the cheeks, eyes, or forehead
4. Double vision or other vision problems
5. Numbness or weakness in the face
6. Discharge of fluid from the nose or eyes
7. Swelling of the eyelids or face
8. Coughing up blood

Diagnosis of Paranasal Sinus Neoplasms:

The diagnosis of paranasal sinus neoplasms is based on a combination of physical examination, imaging studies, and biopsy. The following tests may be used to help diagnose a paranasal sinus tumor:

1. Computed tomography (CT) scan or magnetic resonance imaging (MRI): These imaging tests can provide detailed pictures of the paranasal sinuses and any tumors that may be present.
2. Endoscopy: A thin, lighted tube with a camera on the end can be inserted through the nostrils to examine the inside of the nasal cavity and paranasal sinuses.
3. Biopsy: A sample of tissue from the suspected tumor site can be removed and examined under a microscope to confirm the diagnosis.
4. Nasal endoscopy: A flexible tube with a camera on the end can be inserted through the nostrils to examine the inside of the nasal cavity and paranasal sinuses.

Treatment of Paranasal Sinus Neoplasms:

The treatment of paranasal sinus neoplasms depends on the type, location, size, and aggressiveness of the tumor, as well as the patient's overall health. The following are some of the treatment options for paranasal sinus neoplasms:

1. Surgery: Surgical removal of the tumor is often the first line of treatment for paranasal sinus neoplasms. The type of surgery used depends on the location and extent of the tumor.
2. Radiation therapy: Radiation therapy may be used alone or in combination with surgery to treat paranasal sinus neoplasms that are difficult to remove with surgery or have spread to other parts of the skull base.
3. Chemotherapy: Chemotherapy may be used in combination with radiation therapy to treat paranasal sinus neoplasms that are aggressive and have spread to other parts of the body.
4. Endoscopic surgery: This is a minimally invasive procedure that uses an endoscope (a thin, lighted tube with a camera on the end) to remove the tumor through the nostrils or mouth.
5. Skull base surgery: This is a more invasive procedure that involves removing the tumor and any affected bone or tissue in the skull base.
6. Reconstruction: After removal of the tumor, reconstructive surgery may be necessary to restore the natural anatomy of the skull base and nasal cavity.
7. Observation: In some cases, small, benign tumors may not require immediate treatment and can be monitored with regular imaging studies to see if they grow or change over time.

It is important to note that the most appropriate treatment plan for a patient with a paranasal sinus neoplasm will depend on the specific characteristics of the tumor and the individual patient's needs and medical history. Patients should work closely with their healthcare team to determine the best course of treatment for their specific condition.

Benign pleural neoplasms include:

1. Pleomorphic adenoma: A rare, slow-growing tumor that usually occurs in the soft tissues of the chest wall.
2. Pneumoschisis: A condition where there is a tear or separation in the membrane that lines the lung, which can cause air to leak into the pleural space and create a benign tumor.
3. Pleural plaques: Calcified deposits that form in the pleura as a result of inflammation or injury.

Malignant pleural neoplasms include:

1. Mesothelioma: A rare and aggressive cancer that originates in the pleura, usually caused by exposure to asbestos.
2. Lung cancer: Cancer that spreads to the pleura from another part of the body, such as the lungs.
3. Metastatic tumors: Tumors that have spread to the pleura from another part of the body, such as the breast or colon.

Pleural neoplasms can cause a variety of symptoms, including chest pain, shortness of breath, coughing, and fatigue. Diagnosis is typically made through a combination of imaging tests, such as CT scans and PET scans, and a biopsy to confirm the presence of cancerous cells. Treatment options for pleural neoplasms depend on the type and stage of the tumor, and may include surgery, chemotherapy, and radiation therapy.

There are different types of Breast Neoplasms such as:

1. Fibroadenomas: These are benign tumors that are made up of glandular and fibrous tissues. They are usually small and round, with a smooth surface, and can be moved easily under the skin.

2. Cysts: These are fluid-filled sacs that can develop in both breast tissue and milk ducts. They are usually benign and can disappear on their own or be drained surgically.

3. Ductal Carcinoma In Situ (DCIS): This is a precancerous condition where abnormal cells grow inside the milk ducts. If left untreated, it can progress to invasive breast cancer.

4. Invasive Ductal Carcinoma (IDC): This is the most common type of breast cancer and starts in the milk ducts but grows out of them and invades surrounding tissue.

5. Invasive Lobular Carcinoma (ILC): It originates in the milk-producing glands (lobules) and grows out of them, invading nearby tissue.

Breast Neoplasms can cause various symptoms such as a lump or thickening in the breast or underarm area, skin changes like redness or dimpling, change in size or shape of one or both breasts, discharge from the nipple, and changes in the texture or color of the skin.

Treatment options for Breast Neoplasms may include surgery such as lumpectomy, mastectomy, or breast-conserving surgery, radiation therapy which uses high-energy beams to kill cancer cells, chemotherapy using drugs to kill cancer cells, targeted therapy which uses drugs or other substances to identify and attack cancer cells while minimizing harm to normal cells, hormone therapy, immunotherapy, and clinical trials.

It is important to note that not all Breast Neoplasms are cancerous; some are benign (non-cancerous) tumors that do not spread or grow.

Types of orbital neoplasms include:

1. Benign tumors:
* Meningioma (a tumor that arises from the meninges, the protective covering of the brain and spinal cord)
* Hemangiopericytic hyperplasia (a benign proliferation of blood vessels)
* Lipoma (a fatty tumor)
* Pleomorphic adenoma (a benign tumor that can grow in the orbit and other parts of the body)
2. Malignant tumors:
* Orbital lymphoma (cancer of the immune system that affects the eye)
* Melanoma (a type of skin cancer that can spread to the eye)
* Osteosarcoma (a type of bone cancer that can arise in the orbit)
* Rhabdomyosarcoma (a type of muscle cancer that can occur in the orbit)

Symptoms of orbital neoplasms may include:

1. Protrusion or bulging of the eye
2. Double vision or other vision problems
3. Pain or discomfort in the eye or orbit
4. Swelling or redness in the eye or orbit
5. Difficulty moving the eye

Diagnosis of orbital neoplasms typically involves a combination of imaging tests such as CT or MRI scans, and biopsy (removing a small sample of tissue for examination under a microscope). Treatment options vary depending on the type and severity of the tumor, but may include:

1. Surgery to remove the tumor
2. Radiation therapy to kill any remaining cancer cells
3. Chemotherapy to treat cancer that has spread to other parts of the body
4. Observation and monitoring to track the progress of the tumor

It's important to seek medical attention if you experience any symptoms of orbital neoplasms, as early diagnosis and treatment can improve outcomes and help preserve vision and eye function.

Examples of abdominal neoplasms include:

1. Colorectal cancer: A type of cancer that originates in the colon or rectum.
2. Stomach cancer: A type of cancer that originates in the stomach.
3. Small intestine cancer: A type of cancer that originates in the small intestine.
4. Liver cancer: A type of cancer that originates in the liver.
5. Pancreatic cancer: A type of cancer that originates in the pancreas.
6. Kidney cancer: A type of cancer that originates in the kidneys.
7. Adrenal gland cancer: A type of cancer that originates in the adrenal glands.
8. Gastrointestinal stromal tumors (GISTs): A type of tumor that originates in the digestive system, often in the stomach or small intestine.
9. Leiomyosarcoma: A type of cancer that originates in the smooth muscle tissue of the abdominal organs.
10. Lymphoma: A type of cancer that originates in the immune system and can affect the abdominal organs.

Abdominal neoplasms can cause a wide range of symptoms, including abdominal pain, weight loss, fatigue, and changes in bowel movements. Diagnosis is typically made through a combination of imaging tests such as CT scans, MRI scans, and endoscopy, along with biopsies to confirm the presence of cancerous cells. Treatment options for abdominal neoplasms depend on the type and location of the tumor, and may include surgery, chemotherapy, radiation therapy, or a combination of these.

Symptoms of cerebellar neoplasms can include:

* Headaches
* Nausea and vomiting
* Dizziness and loss of balance
* Weakness or paralysis in the arms or legs
* Coordination problems and difficulty walking
* Double vision or other visual disturbances
* Speech difficulties
* Seizures

Cerebellar neoplasms can be caused by genetic mutations, exposure to radiation, or viral infections. They can also occur spontaneously without any known cause.

Diagnosis of cerebellar neoplasms usually involves a combination of imaging tests such as CT or MRI scans, and tissue sampling through biopsy. Treatment options for cerebellar neoplasms depend on the type, size, and location of the tumor, as well as the patient's overall health.

Treatment options may include:

* Surgery to remove the tumor
* Radiation therapy to kill remaining cancer cells
* Chemotherapy to kill cancer cells
* Targeted therapy to attack specific molecules that are involved in the growth and spread of the tumor.

Prognosis for cerebellar neoplasms varies depending on the type, size, and location of the tumor, as well as the patient's overall health. In general, the prognosis is better for patients with benign tumors that are located in the outer layers of the cerebellum, and worse for those with malignant tumors that are located in the deeper layers.

Overall, cerebellar neoplasms are a complex and rare type of brain tumor that require specialized care and treatment from a team of medical professionals.

There are many types of lipoma, with different names depending on their location and the tissues in which they grow. Common types include:

-Intramuscular lipoma: These occur within muscles and can feel firm or hard to the touch.

-Subcutaneous lipoma: These grow just beneath the skin and are usually soft to the touch.

-Mixed lipoma: These contain both fat cells and other types of tissue, such as muscle fibers.

-Spindle cell lipoma: These lipomas have a characteristic spindle or cylindrical shape under a microscope.

There are several ways to diagnose a lipoma, including physical examination, ultrasound imaging, and biopsy. Treatment for lipoma usually involves monitoring the tumor over time, as it will likely shrink or stay the same size without any intervention. However, if a lipoma grows quickly, becomes painful, or is causing discomfort or functional problems, surgical removal may be necessary.

In conclusion, lipomas are noncancerous growths that occur just beneath the skin or within muscles and connective tissues. They are usually painless unless pressed, but they can still cause discomfort or functional problems if large enough. While surgery is sometimes required to remove a lipoma, it is usually not necessary as long as the tumor remains small and doesn't grow rapidly over time.

There are several types of facial neoplasms, including:

1. Basal cell carcinoma: This is the most common type of skin cancer and typically appears as a small, fleshy bump or a flat, scaly patch on the face.
2. Squamous cell carcinoma: This type of skin cancer can appear as a firm, flat or raised bump on the face and can be more aggressive than basal cell carcinoma.
3. Melanoma: This is the most serious type of skin cancer and can appear as a dark spot or mole on the face.
4. Sebaceous gland carcinoma: This rare type of facial neoplasm develops in the oil-producing glands of the face.
5. Eyelid tumors: These can include basal cell carcinoma, squamous cell carcinoma, and melanoma, as well as other types of benign tumors such as papillomas and pyogenic granulomas.
6. Parotid gland tumors: These can include pleomorphic adenoma, a type of benign tumor that is the most common parotid gland tumor, and malignant tumors such as pleomorphic carcinoma.
7. Salivary gland tumors: These can include benign tumors such as pleomorphic adenoma and Warthin's tumor, as well as malignant tumors such as mucoepidermoid carcinoma and adenoid cystic carcinoma.
8. Osteosarcoma: This is a rare type of bone cancer that can affect the facial bones.
9. Chondrosarcoma: This is a type of cartilage cancer that can affect the facial bones and can be benign or malignant.
10. Lymphoma: This is a type of cancer that affects the immune system and can occur in various parts of the body, including the face.

Treatment for facial tumors depends on the type, location, and stage of the tumor, as well as the patient's overall health and preferences. Treatment options may include surgery, radiation therapy, chemotherapy, or a combination of these. Early detection and treatment are important for achieving the best possible outcomes.

1. Carcinomas of the breast, lung, colon, prostate, and skin.
2. Sarcomas of the soft tissue (e.g., muscle, fat), bone, and connective tissue.
3. Lymphomas in the lymph nodes, spleen, and other lymphoid tissues.
4. Melanomas in the skin and eyes.
5. Leukemias in the blood and bone marrow.
6. Brain tumors in the central nervous system.
7. Digestive tract cancers (e.g., colon, rectal, pancreatic)
8. Uterine cancer in the female reproductive system
9. Bladder cancer in the urinary tract
10. Kidney cancer in the renal system.

This classification is important for several reasons:

1. It helps doctors determine the type of cancer and its potential behavior and prognosis.
2. It guides treatment decisions, such as surgery, chemotherapy, or radiation therapy.
3. It allows researchers to study specific types of cancer and identify new treatments and therapies.
4. It helps track the incidence and prevalence of various cancers in different populations and geographic regions.

Overall, neoplasms by site are a crucial aspect of cancer diagnosis and treatment, and understanding their characteristics is essential for improving patient outcomes and advancing cancer research.

Types of Bronchial Neoplasms:

1. Adenocarcinoma: This is the most common type of lung cancer and accounts for approximately 40% of all lung cancers. It originates in the glandular cells that line the bronchi.
2. Squamous Cell Carcinoma: This type of lung cancer originates in the squamous cells that line the bronchi. It is the second most common type of lung cancer, accounting for approximately 25% of all lung cancers.
3. Small Cell Lung Cancer (SCLC): This type of lung cancer is highly aggressive and accounts for approximately 10% of all lung cancers. It originates in the small cells that line the bronchi.
4. Large Cell Carcinoma: This type of lung cancer is rare and accounts for approximately 5% of all lung cancers. It originates in the large cells that line the bronchi.
5. Bronchioloalveolar Carcinoma (BAC): This type of lung cancer originates in the small air sacs (alveoli) and is rare, accounting for approximately 2% of all lung cancers.
6. Lymphoma: This type of cancer originates in the immune system cells that line the bronchi. It is rare, accounting for approximately 1% of all lung cancers.
7. Carcinoid Tumors: These are rare types of lung cancer that originate in the neuroendocrine cells that line the bronchi. They are typically slow-growing and less aggressive than other types of lung cancer.
8. Secondary Cancers: These are cancers that have spread to the lungs from other parts of the body, such as breast cancer or colon cancer.

Diagnosis of Bronchial Neoplasms:

1. Medical History and Physical Examination: A thorough medical history and physical examination are essential for diagnosing bronchial neoplasms. The doctor will ask questions about the patient's symptoms, risk factors, and medical history.
2. Chest X-Ray: A chest X-ray is often the first diagnostic test performed to evaluate the lungs for any abnormalities.
3. Computed Tomography (CT) Scan: A CT scan is a more detailed imaging test that uses X-rays and computer technology to produce cross-sectional images of the lungs. It can help identify the size, location, and extent of the tumor.
4. Positron Emission Tomography (PET) Scan: A PET scan is a diagnostic test that uses small amounts of radioactive material to visualize the metabolic activity of the cells in the lungs. It can help identify the presence of cancerous cells and determine the effectiveness of treatment.
5. Biopsy: A biopsy involves taking a sample of tissue from the lung and examining it under a microscope for cancerous cells. It is a definitive diagnostic test for bronchial neoplasms.
6. Bronchoscopy: Bronchoscopy is a procedure in which a thin, flexible tube with a camera on the end is inserted through the nose or mouth and guided to the lungs. It can help identify any abnormalities in the airways and obtain a biopsy sample.
7. Magnetic Resonance Imaging (MRI): An MRI uses magnetic fields and radio waves to produce detailed images of the lungs and surrounding tissues. It is not as commonly used for diagnosing bronchial neoplasms as other imaging tests, but it may be recommended in certain cases.
8. Ultrasound: An ultrasound uses high-frequency sound waves to produce images of the lungs and surrounding tissues. It is not typically used as a diagnostic test for bronchial neoplasms, but it may be used to evaluate the spread of cancer to other parts of the body.

It's important to note that the specific diagnostic tests and procedures used will depend on the individual case and the suspicion of malignancy. Your doctor will discuss the best course of action with you based on your symptoms, medical history, and test results.

Peritoneal neoplasms are relatively rare, but they can be aggressive and difficult to treat. The most common types of peritoneal neoplasms include:

1. Peritoneal mesothelioma: This is the most common type of peritoneal neoplasm and arises from the mesothelial cells that line the abdominal cavity. It is often associated with asbestos exposure.
2. Ovarian cancer: This type of cancer originates in the ovaries and can spread to the peritoneum.
3. Appendiceal cancer: This type of cancer arises in the appendix and can spread to the peritoneum.
4. Pseudomyxoma peritonei: This is a rare type of cancer that originates in the abdominal cavity and resembles a mucin-secreting tumor.
5. Primary peritoneal cancer: This type of cancer originates in the peritoneum itself and can be of various types, including adenocarcinoma, squamous cell carcinoma, and sarcoma.

The symptoms of peritoneal neoplasms vary depending on the location and size of the tumor, but may include abdominal pain, distension, and difficulty eating or passing stool. Treatment options for peritoneal neoplasms depend on the type and stage of the cancer, but may include surgery, chemotherapy, and radiation therapy. Prognosis for peritoneal neoplasms is generally poor, with a five-year survival rate of around 20-30%.

There are several types of malignant histiocytic disorders, including:

1. Histiocytosis X (HX): This is a rare and aggressive form of histiocytosis that typically affects children and young adults. It is characterized by the overgrowth of abnormal histiocytes in the bone marrow, lymph nodes, spleen, and other organs.
2. Langerhans cell histiocytosis (LCH): This is a rare form of histiocytosis that affects children and young adults. It is characterized by the overgrowth of abnormal Langerhans cells in various parts of the body, including the skin, bone, and lymph nodes.
3. Eosinophilic granuloma (EG): This is a rare form of histiocytosis that affects children and young adults. It is characterized by the overgrowth of eosinophils in various parts of the body, including the skin, bone, and lymph nodes.
4. Sinus histiocytosis with massive lymphadenopathy (SHML): This is a rare form of histiocytosis that affects children and young adults. It is characterized by the overgrowth of abnormal histiocytes in the sinuses and lymph nodes.
5. Histiocytic sarcoma: This is a rare and aggressive form of histiocytosis that can affect both children and adults. It is characterized by the overgrowth of abnormal histiocytes in various parts of the body, including the skin, bone, and lymph nodes.

The symptoms of malignant histiocytic disorders vary depending on the specific type of disorder and the location of the affected cells. Some common symptoms include:

* Skin rashes or lesions
* Bone pain or swelling
* Lymph node enlargement
* Fatigue
* Fever
* Weight loss
* Night sweats
* Recurrent infections

Diagnosis of malignant histiocytic disorders is based on a combination of clinical findings, laboratory tests, and imaging studies. Laboratory tests may include:

1. Blood tests: To assess the number and function of histiocytes in the blood.
2. Bone marrow biopsy: To evaluate the bone marrow for abnormal histiocytes.
3. Imaging studies: Such as X-rays, CT scans, or MRI scans to evaluate the extent of disease in various organs and tissues.
4. Genetic testing: To identify genetic mutations that may be associated with the disorder.

Treatment of malignant histiocytic disorders depends on the specific type of disorder and the severity of symptoms. Treatment options may include:

1. Chemotherapy: To kill cancer cells and reduce symptoms such as fever, pain, and swelling.
2. Radiation therapy: To destroy cancer cells in specific areas of the body.
3. Immunotherapy: To stimulate the immune system to attack cancer cells.
4. Targeted therapy: To specifically target cancer-causing genes or proteins.
5. Stem cell transplantation: To replace damaged bone marrow with healthy stem cells.

Prognosis for malignant histiocytic disorders varies depending on the specific type of disorder and the severity of symptoms. In general, the prognosis is poorer for disorders that are not responsive to treatment or that progress rapidly. However, with early diagnosis and appropriate treatment, some patients can achieve long-term remission or even be cured.

* Bladder cancer
* Kidney cancer
* Prostate cancer
* Testicular cancer
* Ureteral cancer
* Uterine cancer
* Vaginal cancer
* Penile cancer

These types of cancers are typically diagnosed and treated by urologists, who specialize in the urinary tract and male reproductive system. Treatment options may include surgery, chemotherapy, radiation therapy, or a combination of these.

Note: This definition is intended for use in medical and scientific contexts, and may not be suitable for general or non-expert audiences.

Types of Spinal Neoplasms:

1. Benign tumors: Meningiomas, schwannomas, and osteochondromas are common types of benign spinal neoplasms. These tumors usually grow slowly and do not spread to other parts of the body.
2. Malignant tumors: Primary bone cancers (chordoma, chondrosarcoma, and osteosarcoma) and metastatic cancers (cancers that have spread to the spine from another part of the body) are types of malignant spinal neoplasms. These tumors can grow rapidly and spread to other parts of the body.

Causes and Risk Factors:

1. Genetic mutations: Some genetic disorders, such as neurofibromatosis type 1 and tuberous sclerosis complex, increase the risk of developing spinal neoplasms.
2. Previous radiation exposure: People who have undergone radiation therapy in the past may have an increased risk of developing a spinal tumor.
3. Family history: A family history of spinal neoplasms can increase an individual's risk.
4. Age and gender: Spinal neoplasms are more common in older adults, and males are more likely to be affected than females.

Symptoms:

1. Back pain: Pain is the most common symptom of spinal neoplasms, which can range from mild to severe and may be accompanied by other symptoms such as numbness, weakness, or tingling in the arms or legs.
2. Neurological deficits: Depending on the location and size of the tumor, patients may experience neurological deficits such as paralysis, loss of sensation, or difficulty with balance and coordination.
3. Difficulty with urination or bowel movements: Patients may experience changes in their bladder or bowel habits due to the tumor pressing on the spinal cord or nerve roots.
4. Weakness or numbness: Patients may experience weakness or numbness in their arms or legs due to compression of the spinal cord or nerve roots by the tumor.
5. Fractures: Spinal neoplasms can cause fractures in the spine, which can lead to a loss of height, an abnormal curvature of the spine, or difficulty with movement and balance.

Diagnosis:

1. Medical history and physical examination: A thorough medical history and physical examination can help identify the presence of symptoms and determine the likelihood of a spinal neoplasm.
2. Imaging studies: X-rays, CT scans, MRI scans, or PET scans may be ordered to visualize the spine and detect any abnormalities.
3. Biopsy: A biopsy may be performed to confirm the diagnosis and determine the type of tumor present.
4. Laboratory tests: Blood tests may be ordered to assess liver function, electrolyte levels, or other parameters that can help evaluate the patient's overall health.

Treatment:

1. Surgery: Surgical intervention is often necessary to remove the tumor and relieve pressure on the spinal cord or nerve roots.
2. Radiation therapy: Radiation therapy may be used before or after surgery to kill any remaining cancer cells.
3. Chemotherapy: Chemotherapy may be used in combination with radiation therapy or as a standalone treatment for patients who are not candidates for surgery.
4. Supportive care: Patients may require supportive care, such as physical therapy, pain management, and rehabilitation, to help them recover from the effects of the tumor and any treatment-related complications.

Prognosis:

The prognosis for patients with spinal neoplasms depends on several factors, including the type and location of the tumor, the extent of the disease, and the patient's overall health. In general, the prognosis is better for patients with slow-growing tumors that are confined to a specific area of the spine, as compared to those with more aggressive tumors that have spread to other parts of the body.

Survival rates:

The survival rates for patients with spinal neoplasms vary depending on the type of tumor and other factors. According to the American Cancer Society, the 5-year survival rate for primary spinal cord tumors is about 60%. However, this rate can be as high as 90% for patients with slow-growing tumors that are confined to a specific area of the spine.

Lifestyle modifications:

There are no specific lifestyle modifications that can cure spinal neoplasms, but certain changes may help improve the patient's quality of life and overall health. These may include:

1. Exercise: Gentle exercise, such as yoga or swimming, can help improve mobility and strength.
2. Diet: A balanced diet that includes plenty of fruits, vegetables, whole grains, and lean protein can help support overall health.
3. Rest: Getting enough rest and avoiding strenuous activities can help the patient recover from treatment-related fatigue.
4. Managing stress: Stress management techniques, such as meditation or deep breathing exercises, can help reduce anxiety and improve overall well-being.
5. Follow-up care: Regular follow-up appointments with the healthcare provider are crucial to monitor the patient's condition and make any necessary adjustments to their treatment plan.

In conclusion, spinal neoplasms are rare tumors that can develop in the spine and can have a significant impact on the patient's quality of life. Early diagnosis is essential for effective treatment, and survival rates vary depending on the type of tumor and other factors. While there are no specific lifestyle modifications that can cure spinal neoplasms, certain changes may help improve the patient's overall health and well-being. It is important for patients to work closely with their healthcare provider to develop a personalized treatment plan and follow-up care to ensure the best possible outcome.

Examples of Skull Neoplasms include:

1. Meningioma: A benign tumor that arises from the meninges, the protective covering of the brain and spinal cord.
2. Acoustic neuroma: A benign tumor that grows on the nerve that connects the inner ear to the brain.
3. Pineal parenchymal tumors: Tumors that arise in the pineal gland, a small endocrine gland located in the brain.
4. Craniopharyngiomas: Benign tumors that arise near the pituitary gland, which regulates hormone production.
5. Medulloblastoma: A malignant tumor that arises in the cerebellum, a part of the brain that controls movement and coordination.
6. Germ cell tumors: Tumors that arise from immature cells that form in the embryo. These can be benign or malignant.
7. PNETs (primitive neuroectodermal tumors): Malignant tumors that arise from early forms of nerve cells.
8. Astrocytomas: Tumors that arise from the supportive tissue of the brain called astrocytes. These can be benign or malignant.
9. Oligodendrogliomas: Tumors that arise from the supportive tissue of the brain called oligodendrocytes. These can be benign or malignant.
10. Melanotic neuroectodermal tumors: Rare, malignant tumors that contain pigmented cells.

There are several types of vulvar neoplasms, including:

1. Vulvar intraepithelial neoplasia (VIN): This is a precancerous condition that affects the squamous cells on the surface of the vulva. VIN can progress to vulvar cancer if left untreated.
2. Vulvar squamous cell carcinoma: This is the most common type of vulvar cancer and arises from the squamous cells that line the vulva.
3. Vulvar adenocarcinoma: This type of vulvar cancer originates in the glandular cells that are found near the opening of the vagina.
4. Vulvar melanoma: This is a rare type of vulvar cancer that arises from the pigment-producing cells called melanocytes.
5. Lymphoma: This is a type of cancer that affects the immune system and can occur in the vulva.

The symptoms of vulvar neoplasms can vary depending on the type and location of the growth, but may include:

* A visible lump or lesion on the vulva
* Itching, burning, or pain in the affected area
* Discharge or bleeding from the vulva
* Changes in the color or texture of the skin on the vulva

If you suspect you have a vulvar neoplasm, it is important to see a healthcare provider for an accurate diagnosis and treatment. A physical examination and biopsy may be performed to determine the type and extent of the growth. Treatment options will depend on the type and stage of the neoplasm, but may include surgery, radiation therapy, or chemotherapy.

A benign or malignant growth that arises from neural tissue, such as brain, spinal cord, or nerves. These tumors can be primary (arising within the nervous system) or secondary (metastasizing to the nervous system from another site in the body). Examples of neuroepithelial neoplasms include gliomas (e.g., astrocytomas, oligodendrogliomas), medulloblastoma, and neuroblastoma.

Note: This term is used to describe tumors that are derived from neural tissue, but not all tumors in this category are necessarily cancerous. Some may be benign or precancerous.

Some common types of ear neoplasms include:

1. Acoustic neuroma: This is a type of benign tumor that grows on the nerve that connects the inner ear to the brain. It is usually slow-growing and can cause symptoms such as hearing loss, tinnitus (ringing in the ears), and balance problems.
2. Osteosarcoma: This is a type of malignant bone cancer that can affect the middle ear. It is rare and typically affects children and young adults.
3. Cholesteatoma: This is a benign tumor that grows in the middle ear and can cause symptoms such as hearing loss, ear discharge, and facial weakness or paralysis.
4. Meningioma: This is a type of tumor that grows on the membranes that cover the brain and spinal cord. It can affect the ear and cause symptoms such as hearing loss, tinnitus, and balance problems.
5. Carcinoma ex pleomorphic adenoma (CEP): This is a rare type of malignant tumor that develops in the salivary glands near the ear. It can cause symptoms such as facial weakness or paralysis, hearing loss, and difficulty swallowing.

Ear neoplasms can be diagnosed through a variety of tests, including imaging studies (such as CT or MRI scans), biopsies, and auditory brainstem implantation. Treatment options for ear neoplasms depend on the type and location of the tumor, as well as the severity of the symptoms. Some common treatment options include surgery, radiation therapy, and chemotherapy.

Benign lip neoplasms include:

1. Lipoma: a benign tumor composed of fat cells that is usually slow-growing and painless.
2. Pyogenic granuloma: a benign growth caused by an overgrowth of capillaries and inflammatory cells in response to trauma or irritation.
3. Sebaceous gland hyperplasia: an enlargement of the sebaceous glands on the lips, which can cause a soft, keratinized nodule.

Malignant lip neoplasms include:

1. Squamous cell carcinoma: the most common type of malignant lip tumor, which arises from the squamous cells that line the surface of the lips.
2. Basal cell carcinoma: a slow-growing malignancy that originates in the basal cells of the epidermis.
3. Adenoid cystic carcinoma: a rare, aggressive malignancy that usually affects the minor salivary glands of the lips.
4. Melanoma: a rare and highly aggressive malignancy that arises from the pigment-producing cells (melanocytes) in the skin.

The diagnosis of lip neoplasms is based on a combination of clinical examination, imaging studies (such as ultrasound or MRI), and biopsy. Treatment options depend on the type and stage of the neoplasm, but may include surgical excision, radiation therapy, and/or chemotherapy. Early detection and treatment are important to prevent local tissue damage and potential metastasis.

Example sentence: "The patient was diagnosed with a fibroma in her uterus and underwent surgery to have it removed."

Some common types of adrenal gland neoplasms include:

1. Adrenocortical carcinoma: A rare and aggressive malignancy that arises in the outer layer of the adrenal cortex.
2. Adrenocortical adenoma: A benign tumor that arises in the outer layer of the adrenal cortex.
3. Pheochromocytoma: A rare tumor that arises in the inner part of the adrenal medulla and produces excessive amounts of hormones such as epinephrine and norepinephrine.
4. Paraganglioma: A rare tumor that arises in the sympathetic nervous system, often near the adrenal glands.

Symptoms of adrenal gland neoplasms can include:

* Weight gain or weight loss
* High blood pressure
* Fatigue
* Abdominal pain
* Headache
* Nausea and vomiting
* Palpitations

Diagnosis of adrenal gland neoplasms typically involves imaging tests such as computed tomography (CT) scans, magnetic resonance imaging (MRI), and positron emission tomography (PET) scans, as well as hormone level assessments. Treatment options vary depending on the type and size of the tumor, and may include surgery, chemotherapy, and hormone therapy.

Pelvic neoplasms can be benign (non-cancerous) or malignant (cancerous). Benign pelvic tumors are typically not life-threatening, but they can cause symptoms such as pain, bleeding, and infertility. Malignant pelvic tumors are cancerous and can be more serious, potentially spreading to other parts of the body (metastasizing) if left untreated.

There are several types of pelvic neoplasms, including:

1. Uterine fibroids: benign growths in the uterus that are common in women of childbearing age.
2. Endometrial polyps: benign growths in the lining of the uterus.
3. Ovarian tumors: including benign cysts and malignant ovarian cancer.
4. Cervical dysplasia: abnormal cell growth in the cervix that can potentially develop into cervical cancer if left untreated.
5. Vaginal tumors: rare, but can be either benign or malignant.
6. Rectal tumors: including benign polyps and malignant rectal cancer.
7. Bladder tumors: including benign tumors such as transitional cell carcinoma and malignant bladder cancer.

The symptoms of pelvic neoplasms can vary depending on the location and type of tumor, but may include:

1. Abnormal vaginal bleeding
2. Pain in the pelvis or lower abdomen
3. Difficulty urinating or defecating
4. Persistent pelvic pain
5. Unusual discharge from the vagina
6. Changes in bowel movements or bladder function

Diagnosis of pelvic neoplasms typically involves a combination of imaging tests such as ultrasound, CT scans and MRI scans, along with a biopsy to confirm the presence of cancer cells. Treatment options for pelvic neoplasms depend on the type and location of the tumor, but may include surgery, radiation therapy, chemotherapy or a combination of these.

Benign gingival neoplasms include:

1. Pyogenic granuloma: A type of benign tumor that is usually caused by bacterial infection and presents as a red, bleeding mass on the gum.
2. Peripheral ossifying fibroma: A slow-growing, non-cancerous tumor that forms in the gums and can cause tooth mobility or pain.
3. Fibroma: A benign tumor that is usually inherited and can occur anywhere in the body, including the gums.

Malignant gingival neoplasms include:

1. Squamous cell carcinoma: The most common type of oral cancer, which can arise from pre-existing conditions such as poorly fitting dentures, smoking, or alcohol consumption.
2. Adenoid cystic carcinoma: A rare type of oral cancer that can grow slowly and invade surrounding tissues, often with a good prognosis if treated early.
3. Melanotic neuroectodermal tumor (MNET): A rare, aggressive tumor that usually occurs in the gums of young adults and has a poor prognosis if not treated early.

Precancerous changes in the gingiva include:

1. Leukoplakia: A condition where thick, white patches form on the gums due to chronic irritation or exposure to tobacco or other carcinogens.
2. Erythroplakia: A precancerous condition characterized by red, flat patches on the gums that can progress to squamous cell carcinoma if left untreated.
3. Oral submucous fibrosis (OSMF): A chronic condition where the gums become thick and fibrous due to inflammation and scarring, which can increase the risk of developing oral cancer.

It is important to note that not all precancerous changes will progress to cancer, but if left untreated, they can increase the risk of developing oral cancer. Regular dental check-ups and early detection are key in preventing and treating oral cancer.

Types of Gallbladder Neoplasms:

1. Adenoma: A benign tumor that grows in the gallbladder wall and can become malignant over time if left untreated.
2. Cholangiocarcinoma: A rare and aggressive malignant tumor that arises in the gallbladder or bile ducts.
3. Gallbladder cancer: A general term used to describe any type of cancer that develops in the gallbladder, including adenocarcinoma, squamous cell carcinoma, and other rare types.

Causes and Risk Factors:

1. Genetics: A family history of gallbladder disease or certain genetic conditions can increase the risk of developing gallbladder neoplasms.
2. Chronic inflammation: Long-standing inflammation in the gallbladder, such as that caused by gallstones or chronic bile duct obstruction, can increase the risk of developing cancer.
3. Obesity: Being overweight or obese may increase the risk of developing gallbladder neoplasms.
4. Age: The risk of developing gallbladder neoplasms increases with age, with most cases occurring in people over the age of 50.

Symptoms and Diagnosis:

1. Abdominal pain: Pain in the upper right abdomen is a common symptom of gallbladder neoplasms.
2. Jaundice: Yellowing of the skin and eyes can occur if the cancer blocks the bile ducts.
3. Weight loss: Unexplained weight loss can be a symptom of some types of gallbladder neoplasms.
4. Fatigue: Feeling tired or weak can be a symptom of some types of gallbladder neoplasms.

Diagnosis is typically made through a combination of imaging tests such as CT scans, MRI scans, and PET scans, and a biopsy to confirm the presence of cancer cells.

Treatment:

1. Surgery: Surgery is the primary treatment for gallbladder neoplasms. The type of surgery depends on the stage and location of the cancer.
2. Chemotherapy: Chemotherapy may be used in combination with surgery to treat advanced or aggressive cancers.
3. Radiation therapy: Radiation therapy may be used in combination with surgery to treat advanced or aggressive cancers.
4. Watchful waiting: For early-stage cancers, a wait-and-watch approach may be taken, where the patient is monitored regularly with imaging tests to see if the cancer progresses.

Prognosis:
The prognosis for gallbladder neoplasms depends on the stage and location of the cancer at the time of diagnosis. In general, the earlier the cancer is detected and treated, the better the prognosis. For early-stage cancers, the 5-year survival rate is high, while for advanced cancers, the prognosis is poor.

Complications:

1. Bile duct injury: During surgery, there is a risk of damaging the bile ducts, which can lead to complications such as bile leakage or bleeding.
2. Infection: There is a risk of infection after surgery, which can be serious and may require hospitalization.
3. Pancreatitis: Gallbladder cancer can cause inflammation of the pancreas, leading to pancreatitis.
4. Jaundice: Cancer of the gallbladder can block the bile ducts, leading to jaundice and other complications.
5. Spread of cancer: Gallbladder cancer can spread to other parts of the body, such as the liver or lymph nodes, which can reduce the chances of a cure.

Example sentences:

1. The patient's neoplasm seeding had spread to her liver and bones, making treatment more challenging.
2. Researchers are studying the mechanisms of neoplasm seeding in order to develop new therapies for cancer.

Fibroepithelial neoplasms can occur in various parts of the body, including the skin, breast, uterus, and prostate gland. They can also arise in the conjunctiva, the membrane that covers the white part of the eye.

Some examples of fibroepithelial neoplasms include:

* Fibroma: a benign tumor made up of fibrous and epithelial tissue.
* Fibrosarcoma: a malignant tumor that arises in the soft tissue, including the skin and connective tissue.
* Desmoid tumor: a rare, benign tumor that occurs in the connective tissue of the abdomen or extremities.
* Papilloma: a benign tumor that grows on the surface of the skin or mucous membranes.

Fibroepithelial neoplasms can cause a variety of symptoms, depending on their location and size. These may include pain, swelling, redness, and difficulty moving the affected area. Diagnosis is typically made through a combination of physical examination, imaging studies (such as ultrasound or MRI), and biopsy.

Treatment for fibroepithelial neoplasms varies depending on the type and location of the tumor, as well as its size and malignant potential. Options may include surgical removal, radiation therapy, and/or chemotherapy. In some cases, no treatment may be necessary, and the tumor may be monitored with regular check-ups to ensure that it does not grow or become more aggressive over time.

Examples of connective tissue neoplasms include:

1. Osteosarcoma: a malignant tumor that arises in the bone.
2. Chondrosarcoma: a malignant tumor that arises in cartilage.
3. Liposarcoma: a malignant tumor that arises in fat cells.
4. Hemangiosarcoma: a malignant tumor that arises in the blood vessels.
5. Melanoma: a malignant tumor that arises from the pigment-producing cells of the skin.
6. Giant cell tumor of bone: a benign tumor that arises in the bone and can be aggressive.
7. Multiple myeloma: a cancer of the plasma cells, which are a type of white blood cell found in the bone marrow.
8. Fibrous dysplasia: a benign condition where abnormal growth of connective tissue replaces normal bone and can cause deformity or fracture.

These types of neoplasms are rare, but they can be aggressive and may require surgery, chemotherapy, or radiation therapy for treatment.

NETs can be benign (non-cancerous) or malignant (cancerous). Malignant NETs can spread to other parts of the body through a process called metastasis, which can lead to serious health complications.

The symptoms of NETs vary depending on their location and size, but may include:

* Abdominal pain or discomfort
* Diarrhea or constipation
* Fatigue
* Weakness
* Shortness of breath
* Skin changes such as flushing or sweating
* Headaches
* Seizures

The diagnosis of NETs is based on a combination of imaging tests such as CT scans, MRI scans, and PET scans, as well as biopsy samples. Treatment options for NETs depend on the type, size, location, and stage of the tumor, but may include:

* Medications to slow or stop hormone production
* Chemotherapy to shrink the tumor
* Radiation therapy to kill cancer cells
* Surgery to remove the tumor

Overall, NETs are rare and can be challenging to diagnose and treat. However, with advances in medical technology and ongoing research, there are more effective treatment options available for patients with NETs.

PMF is a chronic disease that worsens over time, and it can lead to complications such as bleeding, infection, and bone damage. Treatment options include medications to reduce symptoms and slow the progression of the disease, as well as blood transfusions and splenectomy (removal of the spleen) in severe cases. The median age at diagnosis is around 60 years old, and the disease affects approximately 2-5 cases per million people per year.

Sources:

* American Cancer Society. (2019). What is primary myelofibrosis? Retrieved from
* Leukemia and Lymphoma Society. (n.d.). Primary Myelofibrosis. Retrieved from

The exact cause of polycythemia vera is not known, but it is believed to be due to a genetic mutation in the JAK2 gene, which is involved in the signaling pathways that regulate blood cell production. The condition typically affects adults over the age of 60 and is more common in men than women.

Symptoms of polycythemia vera can include:

* Fatigue
* Weakness
* Shortness of breath
* Headaches
* Dizziness
* Itching
* Night sweats
* Weight loss

Diagnosis of polycythemia vera is typically made based on a combination of physical examination, medical history, and laboratory tests, including:

* Complete blood count (CBC) to measure the levels of red blood cells, white blood cells, and platelets
* Blood chemistry tests to assess liver function and other body chemicals
* Genetic testing to look for the JAK2 mutation
* Bone marrow biopsy to examine the bone marrow tissue for abnormalities

Treatment for polycythemia vera usually involves phlebotomy (the removal of blood from the body) to reduce the number of red blood cells and relieve symptoms such as itching and night sweats. In some cases, medications may be used to reduce the production of blood cells or to treat specific symptoms. Regular monitoring by a healthcare provider is important to detect any changes in the condition and to prevent complications.

Overall, polycythemia vera is a chronic and progressive disease that can have significant impact on quality of life if left untreated. Early diagnosis and appropriate treatment can help manage symptoms and improve outcomes for patients with this condition.

1. Primary essential thrombocythemia (PET): This is the more common form, usually occurring spontaneously without any identifiable cause. Symptoms may include headache, migraine, seizures, and stroke-like episodes.
2. Secondary essential thrombocythemia: This form is caused by another medical condition or medication that stimulates the production of platelets. Symptoms are similar to those of PET, but there may be an underlying cause such as a tumor or an adverse reaction to medication.

Treatment for essential thrombocythemia includes medications to reduce platelet count and prevent blood clots, as well as close monitoring and management of any underlying causes. In some cases, surgery may be necessary to remove a tumor or other contributing factor.

There are several types of trophoblastic neoplasms, including:

1. Hydatidiform mole (also known as a molar pregnancy): This is a benign tumor that develops from the placental cells and can cause symptoms such as vaginal bleeding, abdominal pain, and rapid growth of the uterus.
2. Invasive mole: This is a rare type of trophoblastic neoplasm that can invade nearby tissues and organs, and it has the potential to become a more aggressive and malignant form of cancer called choriocarcinoma.
3. Choriocarcinoma: This is a malignant tumor that originates from the placental cells and can spread to other parts of the body, such as the lungs, liver, and bones. It is a rare form of cancer, but it is highly aggressive and can be difficult to treat.
4. Placental-site trophoblastic tumors (PSTTs): These are rare tumors that develop at the site where the placenta attaches to the uterus. They can be benign or malignant, and they can invade nearby tissues and organs.

The symptoms of trophoblastic neoplasms can vary depending on the type and location of the tumor. Some common symptoms include:

* Vaginal bleeding or spotting
* Abdominal pain or cramping
* Rapid growth of the uterus
* Weakness and fatigue
* Nausea and vomiting
* Pelvic pressure or discomfort

The diagnosis of trophoblastic neoplasms is based on a combination of imaging studies, such as ultrasound and CT scans, and tissue sampling, such as biopsy or hysterectomy. Treatment options for trophoblastic neoplasms depend on the type and stage of the disease, but may include:

* Surgery to remove the tumor and any affected tissues
* Chemotherapy to kill cancer cells
* Radiation therapy to destroy cancer cells
* Hormone therapy to stop the growth of hormones that support the tumor.

Some common types of head and neck neoplasms include:

1. Oral cavity cancer: Cancer that develops in the mouth, tongue, lips, or floor of the mouth.
2. Oropharyngeal cancer: Cancer that develops in the throat, including the base of the tongue, soft palate, and tonsils.
3. Hypopharyngeal cancer: Cancer that develops in the lower part of the throat, near the esophagus.
4. Laryngeal cancer: Cancer that develops in the voice box (larynx).
5. Paranasal sinus cancer: Cancer that develops in the air-filled cavities around the eyes and nose.
6. Salivary gland cancer: Cancer that develops in the salivary glands, which produce saliva to moisten food and keep the mouth lubricated.
7. Thyroid gland cancer: Cancer that develops in the butterfly-shaped gland in the neck that regulates metabolism and growth.

The risk factors for developing head and neck neoplasms include tobacco use, heavy alcohol consumption, human papillomavirus (HPV) infection, poor diet, and exposure to environmental carcinogens such as asbestos or radiation. Symptoms of head and neck neoplasms can vary depending on the location and size of the tumor, but may include a lump or swelling, pain, difficulty swallowing, bleeding, and changes in voice or breathing.

Diagnosis of head and neck neoplasms typically involves a combination of physical examination, imaging tests such as CT scans or MRI, and biopsy to confirm the presence of cancer cells. Treatment options can include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy, depending on the type, location, and stage of the cancer.

Overall, head and neck neoplasms can have a significant impact on quality of life, and early detection and treatment are important for improving outcomes. If you suspect any changes in your head or neck, it is essential to consult with a healthcare professional for an accurate diagnosis and appropriate treatment.

1. Hantavirus pulmonary syndrome (HPS): This is a severe respiratory disease caused by the hantavirus, which is found in the urine and saliva of infected rodents. Symptoms of HPS can include fever, headache, muscle pain, and difficulty breathing.
2. Leptospirosis: This is a bacterial infection caused by the bacterium Leptospira, which is found in the urine of infected rodents. Symptoms can include fever, headache, muscle pain, and jaundice (yellowing of the skin and eyes).
3. Rat-bite fever: This is a bacterial infection caused by the bacterium Streptobacillus moniliformis, which is found in the saliva of infected rodents. Symptoms can include fever, headache, muscle pain, and swollen lymph nodes.
4. Lymphocytic choriomeningitis (LCM): This is a viral infection caused by the lymphocytic choriomeningitis virus (LCMV), which is found in the urine and saliva of infected rodents. Symptoms can include fever, headache, muscle pain, and meningitis (inflammation of the membranes surrounding the brain and spinal cord).
5. Tularemia: This is a bacterial infection caused by the bacterium Francisella tularensis, which is found in the urine and saliva of infected rodents. Symptoms can include fever, headache, muscle pain, and swollen lymph nodes.

These are just a few examples of the many diseases that can be transmitted to humans through contact with rodents. It is important to take precautions when handling or removing rodents, as they can pose a serious health risk. If you suspect that you have been exposed to a rodent-borne disease, it is important to seek medical attention as soon as possible.

The most common types of thoracic neoplasms include:

1. Lung cancer: This is the most common type of thoracic neoplasm and can be divided into two main categories: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
2. Mesothelioma: This is a rare type of cancer that affects the lining of the chest cavity, known as the pleura. It is often caused by exposure to asbestos.
3. Thymic carcinoma: This is a rare type of cancer that originates in the thymus gland, which is located in the chest behind the sternum.
4. Thymoma: This is a benign tumor that originates in the thymus gland.
5. Mediastinal neoplasms: These are tumors that occur in the mediastinum, which is the tissue in the middle of the chest cavity that separates the two lungs. Examples include thyroid carcinoma and lymphoma.

Thoracic neoplasms can cause a wide range of symptoms, including coughing, chest pain, difficulty breathing, and fatigue. Diagnosis is typically made through a combination of imaging tests such as X-rays, CT scans, and PET scans, as well as biopsies to confirm the presence of cancerous cells. Treatment options vary depending on the type and location of the neoplasm, but may include surgery, radiation therapy, chemotherapy, or a combination of these.

Cecal neoplasms refer to abnormal growths or tumors that occur in the cecum, which is a part of the large intestine. The cecum is a pouch-like structure located at the junction of the small and large intestines. Cecal neoplasms can be benign (non-cancerous) or malignant (cancerous).

Types of Cecal Neoplasms

There are several types of cecal neoplasms, including:

1. Adenoma: A benign tumor that arises from the glandular cells lining the cecum.
2. Villous adenoma: A type of adenoma that is characterized by the growth of villi, which are finger-like projections of epithelial tissue.
3. Tubulovillous adenoma: A type of adenoma that is characterized by the growth of tubular and villous structures.
4. Mucinous cystic neoplasm: A benign tumor that arises from the mucin-secreting cells lining the cecum.
5. Intraepithelial neoplasms: Precancerous changes that occur in the epithelial cells lining the cecum.
6. Carcinoma: A malignant tumor that arises from the epithelial cells lining the cecum.
7. Squamous cell carcinoma: A type of carcinoma that is characterized by the growth of squamous cells.
8. Adenocarcinoma: A type of carcinoma that is characterized by the growth of glandular cells.

Causes and Risk Factors

The exact causes of cecal neoplasms are not known, but several risk factors have been identified, including:

1. Age: The risk of developing cecal neoplasms increases with age.
2. Family history: Having a family history of colon cancer or other gastrointestinal cancers increases the risk of developing cecal neoplasms.
3. Inflammatory bowel disease: People with inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease, are at higher risk of developing cecal neoplasms.
4. Genetic mutations: Some genetic mutations, such as those associated with familial adenomatous polyposis (FAP) and Lynch syndrome, increase the risk of developing cecal neoplasms.
5. Diet and lifestyle factors: A diet high in processed meat and low in fiber may increase the risk of developing cecal neoplasms.

Symptoms

Cecal neoplasms may not cause any symptoms in the early stages, but as they grow, they can cause a variety of symptoms, including:

1. Abdominal pain or discomfort
2. Changes in bowel movements (such as diarrhea or constipation)
3. Blood in the stool
4. Weakness and fatigue
5. Loss of appetite
6. Unexplained weight loss

Diagnosis

The diagnosis of cecal neoplasms is based on a combination of clinical findings, imaging studies, and pathological examination of tissue samples. The following tests may be used to diagnose cecal neoplasms:

1. Endoscopy: A flexible tube with a camera and light on the end is inserted through the mouth or rectum to visualize the inside of the cecum and collect tissue samples.
2. Imaging studies: Computed tomography (CT) scans, magnetic resonance imaging (MRI), or positron emission tomography (PET) scans may be used to identify any abnormalities in the cecum and surrounding tissues.
3. Biopsy: A sample of tissue is taken from the cecum during endoscopy or surgery and examined under a microscope for cancer cells.
4. Blood tests: Blood tests may be used to check for certain substances in the blood that are associated with cancer, such as carcinoembryonic antigen (CEA).

Treatment

The treatment of cecal neoplasms depends on the type and stage of the cancer. The following options may be considered:

1. Surgery: Surgical removal of the cancerous tissue may be recommended for early-stage cancers.
2. Chemotherapy: Chemotherapy may be used in combination with surgery or as a standalone treatment for more advanced cancers.
3. Radiation therapy: Radiation therapy may be used in combination with chemotherapy or surgery to treat cancer that has spread to other parts of the body.
4. Targeted therapy: Targeted therapy may be used to treat specific genetic mutations that are driving the growth of the cancer.

Prognosis

The prognosis for cecal neoplasms depends on the type and stage of the cancer at the time of diagnosis. In general, early-stage cancers have a better prognosis than more advanced cancers. Factors that may affect prognosis include:

1. Type of cancer: The type of cancer present in the cecum can impact prognosis. For example, adenocarcinoma has a better prognosis than squamous cell carcinoma.
2. Stage of cancer: Cancers that have spread to other parts of the body (metastasized) have a poorer prognosis than those that are localized to the cecum.
3. Age and overall health: Older patients or those with underlying health conditions may have a poorer prognosis than younger, healthier individuals.
4. Treatment options: The effectiveness of treatment can also impact prognosis. Patients who receive early and appropriate treatment may have a better prognosis than those who do not receive timely treatment.

Survival rate

The survival rate for cecal neoplasms is generally lower than for other types of gastrointestinal cancers. According to the American Cancer Society, the 5-year survival rate for cecal cancer is approximately 20%. This means that of patients diagnosed with cecal cancer, about 20% are still alive 5 years after their initial diagnosis. However, it's important to note that this is a general estimate and individual prognosis can vary based on a variety of factors.

Lifestyle changes

There are several lifestyle changes that may help reduce the risk of developing cecal neoplasms or improve outcomes for those who have been diagnosed:

1. Maintain a healthy diet and weight: Eating a balanced diet high in fruits, vegetables, and whole grains can help reduce the risk of developing cecal cancer. Additionally, maintaining a healthy weight can help reduce the risk of developing many types of cancer.
2. Exercise regularly: Regular physical activity has been shown to reduce the risk of developing many types of cancer, including cecal cancer.
3. Avoid tobacco and excessive alcohol consumption: Tobacco use and excessive alcohol consumption have both been linked to an increased risk of developing cecal cancer. Quitting smoking and limiting alcohol intake can help reduce the risk of developing this disease.
4. Manage chronic conditions: Chronic conditions such as diabetes, obesity, and inflammatory bowel disease can increase the risk of developing cecal cancer. Managing these conditions through lifestyle changes and medication can help reduce the risk of developing this disease.
5. Get regular screenings: Regular screenings for colon cancer, such as colonoscopies, can help detect cecal cancer at an early stage when it is more treatable.
6. Consider aspirin therapy: Some studies have suggested that taking a low-dose aspirin every day may help reduce the risk of developing colorectal cancer, including cecal cancer. However, aspirin therapy is not right for everyone, and individuals should talk to their doctor before starting any new medication.
7. Don't delay symptoms: If you experience any symptoms that may be related to cecal cancer, such as abdominal pain or changes in bowel movements, don't delay seeking medical attention. These symptoms can also be caused by other conditions, but it is important to get them checked out by a healthcare professional.

It is important to note that these recommendations are not a guarantee against developing cecal cancer, and individuals should talk to their doctor about their specific risk factors and any additional steps they can take to reduce their risk of developing this disease.

There are several subtypes of B-cell leukemia, including:

1. Chronic lymphocytic leukemia (CLL): This is the most common type of B-cell leukemia, and it typically affects older adults. CLL is a slow-growing cancer that can progress over time.
2. Acute lymphoblastic leukemia (ALL): This is a fast-growing and aggressive form of B-cell leukemia that can affect people of all ages. ALL is often treated with chemotherapy and sometimes with bone marrow transplantation.
3. Burkitt lymphoma: This is an aggressive form of B-cell leukemia that typically affects older adults in Africa and Asia. Burkitt lymphoma can be treated with chemotherapy and sometimes with bone marrow transplantation.
4. Hairy cell leukemia: This is a rare type of B-cell leukemia that is characterized by the presence of hair-like projections on the surface of cancer cells. Hairy cell leukemia can be treated with chemotherapy and sometimes with bone marrow transplantation.

The diagnosis of B-cell leukemia is based on a combination of physical examination, medical history, laboratory tests, and biopsies. Treatment options for B-cell leukemia include chemotherapy, bone marrow transplantation, and in some cases, targeted therapy with drugs that specifically target cancer cells. The prognosis for B-cell leukemia varies depending on the subtype of the disease and the patient's overall health.

The term "hemangioendothelioma" was first used by the American pathologist and researcher, Dr. Albert Sabin, in the 1920s. Since then, it has been widely accepted as a descriptive term for this type of tumor.

The word "hemangioendothelioma" is derived from the Greek words "haima," meaning blood, "angios," meaning vessel, and "endo," meaning within. The suffix "-oma" indicates a swelling or tumor.

Hemangioendotheliomas are typically slow-growing and may not cause any symptoms in the early stages. However, as they grow, they can compress surrounding tissues and disrupt normal organ function. They can also bleed spontaneously or after minor trauma, leading to hematuria (blood in the urine) or hematemesis (vomiting blood).

Hemangioendotheliomas are usually diagnosed by a combination of imaging studies such as CT scans, MRI, and angiography, along with biopsy and histopathological examination. Treatment options for hemangioendotheliomas depend on the location, size, and severity of the tumor, but may include surgical resection, embolization, or radiation therapy.

In summary, hemangioendothelioma is a rare and benign vascular tumor that originates from endothelial cells lining blood vessels. The term was first introduced by Dr. Albert Sabin in the 1920s, and it has since been widely accepted as a descriptive term for this type of tumor.

The digestive system neoplasms are a group of abnormal growths or tumors that occur in the organs and tissues of the gastrointestinal (GI) tract. These neoplasms can be benign or malignant, and their impact on the body can range from minimal to life-threatening.

Types:

There are several types of digestive system neoplasms, including:

1. Colorectal cancer: A malignant tumor that develops in the colon or rectum.
2. Gastric cancer: A malignant tumor that develops in the stomach.
3. Pancreatic cancer: A malignant tumor that develops in the pancreas.
4. Small intestine cancer: A rare type of cancer that develops in the small intestine.
5. Esophageal cancer: A malignant tumor that develops in the esophagus.
6. Liver cancer (hepatocellular carcinoma): A malignant tumor that develops in the liver.
7. Anal canal cancer: A rare type of cancer that develops in the anus.
8. Gallbladder cancer: A rare type of cancer that develops in the gallbladder.

Causes and risk factors:

The exact cause of digestive system neoplasms is not always known, but certain risk factors can increase the likelihood of developing these conditions. These include:

1. Age: The risk of developing digestive system neoplasms increases with age.
2. Family history: Having a family history of these conditions can increase the risk.
3. Inflammatory bowel disease: People with inflammatory bowel disease, such as ulcerative colitis or Crohn's disease, are at higher risk of developing colorectal cancer.
4. Diets high in fat and low in fiber: A diet high in fat and low in fiber may increase the risk of developing colon cancer.
5. Smoking: Smoking can increase the risk of developing several types of digestive system neoplasms, including colorectal cancer and pancreatic cancer.
6. Alcohol consumption: Heavy alcohol consumption may increase the risk of developing liver cancer.
7. Obesity: Being overweight or obese may increase the risk of developing several types of digestive system neoplasms, including colorectal cancer and pancreatic cancer.
8. Infection with certain viruses: Some viruses, such as human papillomavirus (HPV) and hepatitis B and C, can increase the risk of developing certain types of digestive system neoplasms.

Symptoms and diagnosis:

The symptoms of digestive system neoplasms vary depending on the location and size of the tumor. Some common symptoms include:

1. Blood in the stool or vomit
2. Abdominal pain or discomfort
3. Weight loss
4. Fatigue
5. Loss of appetite
6. Jaundice (yellowing of the skin and eyes)

If a patient experiences any of these symptoms, they should see a healthcare provider for further evaluation. A diagnosis of digestive system neoplasms is typically made through a combination of imaging tests such as CT scans, MRI scans, endoscopy, and biopsy. Treatment options:

The treatment of digestive system neoplasms depends on the type, size, location, and stage of the tumor. Some common treatment options include:

1. Surgery: Surgery is often the first line of treatment for many types of digestive system neoplasms. The goal of surgery is to remove the tumor and any affected tissue.
2. Chemotherapy: Chemotherapy is a type of cancer treatment that uses drugs to kill cancer cells. It may be used before or after surgery, or as a palliative therapy to relieve symptoms.
3. Radiation therapy: Radiation therapy uses high-energy rays to kill cancer cells. It may be used alone or in combination with other treatments.
4. Targeted therapy: Targeted therapy is a type of cancer treatment that targets specific molecules involved in the growth and spread of cancer cells. Examples of targeted therapies used to treat digestive system neoplasms include bevacizumab, which targets vascular endothelial growth factor (VEGF) and aflibercept, which targets vascular endothelial growth factor receptor 2 (VEGFR2).
5. Immunotherapy: Immunotherapy is a type of cancer treatment that uses the body's immune system to fight cancer cells. Examples of immunotherapies used to treat digestive system neoplasms include pembrolizumab, which targets programmed death-1 (PD-1) and nivolumab, which targets PD-1 and CTLA-4.
6. Stenting or embolization: These procedures involve placing a small tube or particles into the blood vessels to block the flow of blood to the tumor, which can cause it to shrink or stop growing.
7. Palliative care: Palliative care is a type of treatment that focuses on relieving symptoms and improving quality of life for people with advanced cancer. It may include medications, radiation therapy, or other interventions to manage pain, bleeding, or other complications.
8. Clinical trials: These are research studies that involve testing new treatments or combinations of treatments to see if they are effective and safe. Participating in a clinical trial may give patients access to innovative therapies that are not yet widely available.

It's important to note that the specific treatment plan for digestive system neoplasms will depend on the type, location, size, and stage of the cancer, as well as other individual factors such as the patient's age, overall health, and preferences. Patients should discuss their treatment options with their healthcare provider to determine the best course of action for their specific situation.

Adenocarcinoma, follicular accounts for approximately 15% of all thyroid cancers and is more common in women than men. This type of cancer tends to be less aggressive than other types of thyroid cancer, such as papillary carcinoma, but it can still recur (come back) after treatment and spread to other parts of the body (metastasize).

Treatment options for adenocarcinoma, follicular include surgery to remove the tumor, radioactive iodine therapy, and hormone therapy. The prognosis is generally good for patients with this type of cancer, especially if it is detected early and treated appropriately.

In summary, adenocarcinoma, follicular is a type of thyroid cancer that originates in the glands (follicles) of the thyroid gland. It tends to be less aggressive than other types of thyroid cancer but can still recur and spread to other parts of the body. Treatment options include surgery, radioactive iodine therapy, and hormone therapy.

Benign jejal neoplasms include:

1. Adenomas: These are benign tumors that grow on the lining of the jejunum and can become cancerous over time if left untreated.
2. Villous adenomas: These are benign tumors that grow on the villi, which are small projections on the lining of the small intestine that increase the surface area for nutrient absorption.
3. GISTs (gastrointestinal stromal tumors): These are rare benign tumors that can occur in the jejunum and other parts of the digestive system.

Malignant jejal neoplasms include:

1. Adenocarcinomas: These are cancerous tumors that grow on the lining of the jejunum and can invade surrounding tissues and organs.
2. Lymphoma: This is a type of cancer that affects the immune system and can occur in the jejunum.
3. Leiomyosarcomas: These are rare cancerous tumors that grow on the muscular walls of the jejunum.

Jejunal neoplasms can cause symptoms such as abdominal pain, diarrhea, nausea, and vomiting, depending on their location and size. They can also cause anemia, bleeding, and blockage of the intestine if they become large enough to obstruct the passage of food and fluids.

Jejunal neoplasms are diagnosed through a combination of endoscopy, imaging tests such as CT scans or MRI, and biopsy. Treatment options depend on the type and location of the neoplasm, and can include surgery, chemotherapy, and radiation therapy.

Definition:
A type of cancer that arises from cells of the neuroendocrine system, which are cells that produce hormones and neurotransmitters. These tumors can occur in various parts of the body, such as the lungs, digestive tract, and pancreas. They tend to grow slowly and can produce excess hormones or neurotransmitters, leading to a variety of symptoms. Carcinoma, neuroendocrine tumors are relatively rare but are becoming more commonly diagnosed.

Synonyms:

* Neuroendocrine carcinoma
* Neuroendocrine tumor
* Carcinoid tumor

Note: The term "carcinoma" refers to a type of cancer that arises from epithelial cells, while the term "neuroendocrine" refers to the fact that these tumors originate in cells of the neuroendocrine system.

Translation:

English: Neuroendocrine carcinoma
German: Neuroendokrines Karzinom
French: Tumeur carcinoïde neuroendocrine
Spanish: Carcinoma neuendocrino
Italian: Carcinoma neuroendocrino

The exact cause of neurilemmoma is not known, but it is believed to be related to genetic mutations that occur during fetal development. Some cases have been associated with neurofibromatosis type 2, a genetic disorder that affects the growth and development of nerve tissue.

Neurilemmoma typically manifests as a slow-growing mass or lump in the affected area. Symptoms can include pain, numbness, tingling, or weakness in the affected limb or organ, depending on the location of the tumor. In some cases, neurilemmoma can cause hormonal imbalances or disrupt normal nerve function.

Diagnosis of neurilemmoma usually involves a combination of physical examination, imaging studies such as MRI or CT scans, and a biopsy to confirm the presence of malignant cells. Treatment options for neurilemmoma include surgical removal of the tumor, radiation therapy, and in some cases, observation with periodic monitoring. The prognosis for patients with neurilemmoma is generally good if the tumor is removed completely, but recurrence is possible in some cases.

Benign CNS neoplasms include:

1. Meningiomas: These are the most common type of benign CNS tumor, arising from the meninges (the membranes covering the brain and spinal cord).
2. Acoustic neuromas: These tumors arise from the nerve cells that connect the inner ear to the brain.
3. Pineal gland tumors: These are rare tumors that occur in the pineal gland, a small gland located in the brain.
4. Craniopharyngiomas: These are rare tumors that arise from the remnants of the embryonic pituitary gland and can cause a variety of symptoms including headaches, vision loss, and hormonal imbalances.

Malignant CNS neoplasms include:

1. Gliomas: These are the most common type of malignant CNS tumor and arise from the supporting cells of the brain called glial cells. Examples of gliomas include astrocytomas, oligodendrogliomas, and medulloblastomas.
2. Lymphomas: These are cancers of the immune system that can occur in the CNS.
3. Melanomas: These are rare tumors that arise from the pigment-producing cells of the skin and can spread to other parts of the body, including the CNS.
4. Metastatic tumors: These are tumors that have spread to the CNS from other parts of the body, such as the breast, lung, or colon.

The diagnosis and treatment of central nervous system neoplasms depend on the type, size, location, and severity of the tumor, as well as the patient's overall health and medical history. Treatment options can include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy.

The prognosis for CNS neoplasms varies depending on the type of tumor and the effectiveness of treatment. In general, gliomas have a poorer prognosis than other types of CNS tumors, with five-year survival rates ranging from 30% to 60%. Lymphomas and melanomas have better prognoses, with five-year survival rates of up to 80%. Metastatic tumors have a more guarded prognosis, with five-year survival rates depending on the primary site of the cancer.

In summary, central nervous system neoplasms are abnormal growths of tissue in the brain and spinal cord that can cause a variety of symptoms and can be benign or malignant. The diagnosis and treatment of these tumors depend on the type, size, location, and severity of the tumor, as well as the patient's overall health and medical history. The prognosis for CNS neoplasms varies depending on the type of tumor and the effectiveness of treatment, but in general, gliomas have a poorer prognosis than other types of CNS tumors.

Sarcomas can arise in any part of the body, but they are most common in the arms and legs. They can also occur in the abdomen, chest, or head and neck. There are many different types of sarcoma, each with its own unique characteristics and treatment options.

The causes of sarcoma are not fully understood, but genetic mutations, exposure to radiation, and certain chemicals have been linked to an increased risk of developing the disease. Sarcomas can be challenging to diagnose and treat, as they often grow slowly and may not cause symptoms until they are advanced.

Treatment for sarcoma typically involves a combination of surgery, radiation therapy, and chemotherapy. The specific treatment plan will depend on the type of sarcoma, its location, and the stage of the disease. In some cases, amputation may be necessary to remove the tumor.

Prognosis for sarcoma varies depending on the type of cancer, the size and location of the tumor, and the stage of the disease. In general, the prognosis is best for patients with early-stage sarcoma that is confined to a small area and has not spread to other parts of the body.

Overall, sarcoma is a rare and complex form of cancer that requires specialized treatment and care. While the prognosis can vary depending on the specific type of cancer and the stage of the disease, advances in medical technology and treatment options have improved outcomes for many patients with sarcoma.

Carcinosarcomas are typically slow-growing and can occur in various parts of the body, including the abdomen, pelvis, and extremities. They can be difficult to diagnose because they often have a mix of cancerous and noncancerous cells, making it challenging to determine the exact type of tumor.

The treatment of carcinosarcoma depends on the location, size, and stage of the tumor, as well as the patient's overall health. Surgery is often the first line of treatment, followed by radiation therapy and/or chemotherapy. In some cases, a combination of all three may be necessary.

Overall, carcinosarcoma is a rare and aggressive form of cancer that requires careful management and coordinated care from a multidisciplinary team of healthcare professionals. With proper treatment, many patients with carcinosarcoma can achieve long-term survival and a good quality of life.

Example sentences:

1. The patient was diagnosed with a rare form of cancer called carcinosarcoma, which is a combination of both carcinoma and sarcoma.
2. The carcinosarcoma had spread to the patient's lymph nodes and required aggressive treatment, including surgery, radiation therapy, and chemotherapy.
3. Due to the rarity of carcinosarcoma, the oncologist consulted with a team of specialists to develop a personalized treatment plan for the patient.

Adenomas, liver cell are relatively rare and account for only 1-3% of all primary liver tumors. They tend to affect middle-aged adults, and the exact cause is not known. However, certain factors such as cirrhosis, hepatitis B and C, and exposure to certain chemicals have been linked to an increased risk of developing an adenoma.

The diagnosis of an adenoma, liver cell is based on a combination of imaging studies such as ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI) and a biopsy to confirm the presence of malignant cells. Treatment usually involves surgical removal of the tumor, and in some cases, embolization may be used to shrink the tumor before surgery.

It is important to note that not all liver cell adenomas are benign, and some may be premalignant or even malignant. Therefore, it is important to follow up with a healthcare professional regularly after diagnosis to monitor for any changes in the tumor.

Some common types of pituitary neoplasms include:

1. Adenomas: These are benign tumors that grow slowly and often do not cause any symptoms in the early stages.
2. Craniopharyngiomas: These are rare, slow-growing tumors that can be benign or malignant. They can affect the pituitary gland, the hypothalamus, and other areas of the brain.
3. Pituitary carcinomas: These are malignant tumors that grow quickly and can spread to other parts of the body.
4. Pituitary metastases: These are tumors that have spread to the pituitary gland from another part of the body, such as breast cancer or lung cancer.

Symptoms of pituitary neoplasms can vary depending on the size and location of the tumor, but they may include:

* Headaches
* Vision changes, such as blurred vision or loss of peripheral vision
* Hormonal imbalances, which can lead to a variety of symptoms including fatigue, weight gain or loss, and irregular menstrual cycles
* Cognitive changes, such as memory loss or difficulty with concentration
* Pressure on the brain, which can cause nausea, vomiting, and weakness or numbness in the limbs

Diagnosis of pituitary neoplasms typically involves a combination of imaging tests, such as MRI or CT scans, and hormone testing to determine the level of hormones in the blood. Treatment options can vary depending on the type and size of the tumor, but they may include:

* Watchful waiting: Small, benign tumors may not require immediate treatment and can be monitored with regular imaging tests.
* Medications: Hormone replacement therapy or medications to control hormone levels may be used to manage symptoms.
* Surgery: Tumors can be removed through a transsphenoidal surgery, which involves removing the tumor through the nasal cavity and sphenoid sinus.
* Radiation therapy: May be used to treat residual tumor tissue after surgery or in cases where the tumor cannot be completely removed with surgery.

Overall, pituitary neoplasms are rare and can have a significant impact on the body if left untreated. If you suspect you may have a pituitary neoplasm, it is important to seek medical attention for proper diagnosis and treatment.

Symptoms of histiocytic sarcoma may include swelling or lumps in the neck, underarm, or groin area, as well as fatigue, fever, and weight loss. The diagnosis is usually made through a combination of physical examination, imaging tests (such as CT scans or MRI), and biopsy. Treatment typically involves a combination of surgery, chemotherapy, and radiation therapy, and may vary depending on the location and extent of the cancer.

Histiocytic sarcoma is rare, accounting for only about 1-2% of all childhood cancers. While it is generally considered to be a more aggressive form of cancer, the prognosis has improved significantly in recent years with advances in treatment and surgical techniques. With appropriate treatment, many children with histiocytic sarcoma can achieve long-term survival and a good quality of life.

Keratoacanthoma are thought to be caused by a combination of genetic and environmental factors, such as exposure to UV radiation from the sun or tanning beds. They can occur at any age, but are most common in adults over the age of 50.

While keratoacanthomas are not cancerous and do not spread to other parts of the body, they can be challenging to diagnose and treat. Biopsy is often necessary to confirm the diagnosis, and treatment options may include observation, cryotherapy (freezing), or surgical excision.

In rare cases, keratoacanthomas can evolve into a type of skin cancer called squamous cell carcinoma. Therefore, it is important for individuals with this condition to have regular follow-up appointments with their healthcare provider to monitor for any changes.

Pseudomyxoma peritonei can occur in anyone, but it is most common in women between the ages of 20 and 50. The exact cause of this condition is not known, but it may be linked to genetic changes or previous abdominal surgery.

Symptoms of pseudomyxoma peritonei can include abdominal pain, bloating, nausea, and vomiting. These symptoms are often persistent and can worsen over time. In some cases, the tumors can become large enough to compress nearby organs, leading to additional complications such as bowel obstruction or kidney damage.

If you suspect that you may have pseudomyxoma peritonei, your doctor will begin by performing a physical exam and taking a medical history. Imaging tests such as CT scans or PET scans may also be ordered to help visualize the tumors and determine their extent. A diagnosis of pseudomyxoma peritonei is typically made based on the presence of mucin-secreting tumors on the peritoneum, along with other characteristic features such as the absence of a primary tumor site.

Treatment for pseudomyxoma peritonei usually involves surgery to remove as many of the tumors as possible. In some cases, chemotherapy or radiation therapy may also be recommended to help shrink the tumors before surgery or to kill any remaining cancer cells after surgery.

The prognosis for pseudomyxoma peritonei is generally good if the condition is detected and treated early. However, if the tumors are allowed to grow and spread, the outlook can be poorer. In rare cases, the tumors may recur even after successful treatment.

There are several different types of leukemia, including:

1. Acute Lymphoblastic Leukemia (ALL): This is the most common type of leukemia in children, but it can also occur in adults. It is characterized by an overproduction of immature white blood cells called lymphoblasts.
2. Acute Myeloid Leukemia (AML): This type of leukemia affects the bone marrow's ability to produce red blood cells, platelets, and other white blood cells. It can occur at any age but is most common in adults.
3. Chronic Lymphocytic Leukemia (CLL): This type of leukemia affects older adults and is characterized by the slow growth of abnormal white blood cells called lymphocytes.
4. Chronic Myeloid Leukemia (CML): This type of leukemia is caused by a genetic mutation in a gene called BCR-ABL. It can occur at any age but is most common in adults.
5. Hairy Cell Leukemia: This is a rare type of leukemia that affects older adults and is characterized by the presence of abnormal white blood cells called hairy cells.
6. Myelodysplastic Syndrome (MDS): This is a group of disorders that occur when the bone marrow is unable to produce healthy blood cells. It can lead to leukemia if left untreated.

Treatment for leukemia depends on the type and severity of the disease, but may include chemotherapy, radiation therapy, targeted therapy, or stem cell transplantation.

The most common types are:

1. Testicular cancer
2. Prostate cancer
3. Penile cancer
4. Urethral cancer
5. Bladder cancer
6. Kidney cancer
7. Epididymal cancer

These cancers usually present with symptoms such as:

1. Lump in the scrotum or testicle
2. Difficulty passing urine
3. Blood in semen or urine
4. Painful urination
5. Weak flow of urine
6. Abnormal bleeding from the penis
7. Pain in the lower abdomen or back

Diagnosis is made through:

1. Physical examination and medical history
2. Blood tests (such as PSA)
3. Imaging studies (such as ultrasound, CT scan, MRI)
4. Biopsy

Treatment options vary depending on the type and stage of cancer but may include:

1. Surgery
2. Radiation therapy
3. Chemotherapy
4. Hormone therapy

Examples of infratentorial neoplasms include:

1. Cerebellar astrocytomas
2. Brain stem gliomas
3. Vestibular schwannomas (acoustic neuromas)
4. Meningiomas
5. Metastatic tumors to the infratentorial region

Infratentorial neoplasms can cause a wide range of symptoms depending on their size, location, and degree of malignancy. Common symptoms include headache, nausea, vomiting, balance problems, weakness or numbness in the arms or legs, double vision, and difficulty with speech or swallowing.

Infratentorial neoplasms are diagnosed using a combination of imaging techniques such as CT or MRI scans, and tissue biopsy may be necessary to confirm the diagnosis. Treatment options for infratentorial neoplasms depend on the type, size, and location of the tumor, but may include surgery, radiation therapy, and chemotherapy.

Biliary tract neoplasms refer to abnormal growths or tumors that occur in the biliary tract, which includes the liver, gallbladder, and bile ducts. These tumors can be benign (non-cancerous) or malignant (cancerous).

There are several types of biliary tract neoplasms, including:

1. Cholangiocarcinoma: This is a rare type of cancer that originates in the cells lining the bile ducts. It can occur in the liver or outside the liver.
2. Gallbladder cancer: This type of cancer occurs in the gallbladder and is relatively rare.
3. Hepatocellular carcinoma (HCC): This is the most common type of primary liver cancer, which means it originates in the liver rather than spreading from another part of the body.
4. Bile duct cancer: This type of cancer occurs in the bile ducts that carry bile from the liver and gallbladder to the small intestine.

Biliary tract neoplasms can cause a variety of symptoms, including abdominal pain, jaundice (yellowing of the skin and eyes), weight loss, fatigue, and itching. These symptoms can be non-specific and may resemble those of other conditions, making diagnosis challenging.

Diagnosis of biliary tract neoplasms usually involves a combination of imaging tests such as ultrasound, CT scans, MRI, and PET scans, as well as biopsies to confirm the presence of cancer cells. Treatment options for biliary tract neoplasms depend on the type, size, location, and stage of the tumor, and may include surgery, chemotherapy, radiation therapy, or a combination of these.

Iris neoplasms refer to abnormal growths or tumors that occur in the iris, which is the colored part of the eye. These growths can be benign (non-cancerous) or malignant (cancerous).

Types of Iris Neoplasms[2]

There are several types of iris neoplasms, including:

1. Iridescent tumors: These are benign growths that are usually found in the periphery of the iris and can cause changes in the color and shape of the eye.
2. Melanocytic tumors: These are malignant growths that develop from the pigment-producing cells (melanocytes) in the iris. They can be either benign or malignant.
3. Metastatic tumors: These are tumors that have spread to the eye from another part of the body, usually through the bloodstream.

Symptoms of Iris Neoplasms[3]

The symptoms of iris neoplasms can vary depending on the type and location of the growth. Common symptoms include:

1. Changes in eye color or shape
2. Blurred vision or double vision
3. Sensitivity to light
4. Eye pain or discomfort
5. Redness or swelling of the eye

Diagnosis and Treatment of Iris Neoplasms[4]

Iris neoplasms can be diagnosed with a comprehensive eye exam, which may include imaging tests such as ultrasound or MRI. The treatment of iris neoplasms depends on the type and severity of the growth. Benign tumors may not require treatment, while malignant tumors may need to be removed with surgery. In some cases, radiation therapy or chemotherapy may be recommended.

Prognosis of Iris Neoplasms[5]

The prognosis for iris neoplasms depends on the type and stage of the growth. In general, the earlier the diagnosis and treatment, the better the outcome. Benign tumors tend to have a good prognosis, while malignant tumors can be more aggressive and may have a poorer prognosis if left untreated.

Prevention of Iris Neoplasms[6]

There is no known prevention for iris neoplasms, as the causes are not fully understood. However, early detection and treatment can improve outcomes. Regular eye exams can help detect any changes in the iris, and prompt treatment can help prevent complications.

In conclusion, iris neoplasms are rare growths that can occur in the iris of the eye. While the symptoms can be concerning, the prognosis is generally good if diagnosed and treated early. Regular eye exams can help detect any changes in the iris and prevent complications. If you experience any unusual symptoms, it's important to see an eye doctor right away for a comprehensive exam.

Examples of precancerous conditions include:

1. Dysplasia: This is a condition where abnormal cells are present in the tissue, but have not yet invaded surrounding tissues. Dysplasia can be found in organs such as the cervix, colon, and breast.
2. Carcinoma in situ (CIS): This is a condition where cancer cells are present in the tissue, but have not yet invaded surrounding tissues. CIS is often found in organs such as the breast, prostate, and cervix.
3. Atypical hyperplasia: This is a condition where abnormal cells are present in the tissue, but they are not yet cancerous. Atypical hyperplasia can be found in organs such as the breast and uterus.
4. Lobular carcinoma in situ (LCIS): This is a condition where cancer cells are present in the milk-producing glands of the breasts, but have not yet invaded surrounding tissues. LCIS is often found in both breasts and can increase the risk of developing breast cancer.
5. Adenomas: These are small growths on the surface of the colon that can become malignant over time if left untreated.
6. Leukoplakia: This is a condition where thick, white patches develop on the tongue or inside the mouth. Leukoplakia can be a precancerous condition and may increase the risk of developing oral cancer.
7. Oral subsquamous carcinoma: This is a type of precancerous lesion that develops in the mouth and can progress to squamous cell carcinoma if left untreated.
8. Cervical intraepithelial neoplasia (CIN): This is a condition where abnormal cells are present on the surface of the cervix, but have not yet invaded surrounding tissues. CIN can progress to cancer over time if left untreated.
9. Vulvar intraepithelial neoplasia (VIN): This is a condition where abnormal cells are present on the vulva, but have not yet invaded surrounding tissues. VIN can progress to cancer over time if left untreated.
10. Penile intraepithelial neoplasia (PIN): This is a condition where abnormal cells are present on the penis, but have not yet invaded surrounding tissues. PIN can progress to cancer over time if left untreated.

It is important to note that not all precancerous conditions will develop into cancer, and some may resolve on their own without treatment. However, it is important to follow up with a healthcare provider to monitor any changes and determine the best course of treatment.

There are several types of urethral neoplasms, including:

1. Urethral papillomas: These are small, non-cancerous growths that resemble a wart and typically occur in the distal (outer) part of the urethra.
2. Urethral polyps: These are soft, growths that can occur in any part of the urethra and are usually benign.
3. Urethral carcinomas: These are malignant tumors that arise from the epithelial lining of the urethra. They can be superficial (confined to the surface) or invasive (penetrate deeper into the tissue).
4. Urethral melanoma: This is a rare type of malignant tumor that arises from the pigment-producing cells of the urethra. It is more common in men than women and typically affects the distal part of the urethra.

The symptoms of urethral neoplasms can vary depending on the size and location of the growth, but may include:

* Blood in the urine
* Painful urination
* Frequent urination
* Difficulty starting or stopping the flow of urine
* Pain in the pelvic area

Diagnosis of urethral neoplasms typically involves a combination of physical examination, urine cytology (examination of cells in the urine), and imaging studies such as ultrasound or MRI. A biopsy may also be performed to confirm the diagnosis.

Treatment options for urethral neoplasms depend on the type and location of the growth, but may include:

* Surgery to remove the tumor
* Cryotherapy (freezing of the tumor)
* Laser therapy
* Chemotherapy or radiation therapy for more advanced cases

Early detection and treatment of urethral neoplasms are important to improve outcomes and minimize complications. Regular screening and follow-up with a healthcare provider can help identify any abnormalities in the urinary tract and allow for prompt treatment if needed.

The most common types of laryngeal neoplasms include:

1. Vocal cord nodules and polyps: These are benign growths that develop on the vocal cords due to overuse, misuse, or trauma.
2. Laryngeal papillomatosis: This is a condition where warts grow on the vocal cords, often caused by the human papillomavirus (HPV).
3. Adenoid cystic carcinoma: This is a rare type of cancer that develops in the salivary glands near the larynx.
4. Squamous cell carcinoma: This is the most common type of cancer that develops in the larynx, often due to smoking or heavy alcohol consumption.
5. Verrucous carcinoma: This is a rare type of cancer that develops on the vocal cords and is often associated with chronic inflammation.
6. Lymphoma: This is a type of cancer that affects the immune system, and can develop in the larynx.
7. Melanoma: This is a rare type of cancer that develops from pigment-producing cells called melanocytes.

Symptoms of laryngeal neoplasms can include hoarseness or difficulty speaking, breathing difficulties, and ear pain. Diagnosis is typically made through a combination of physical examination, imaging tests such as CT scans or MRI, and biopsy. Treatment options vary depending on the type and severity of the neoplasm, but may include surgery, radiation therapy, or chemotherapy.

The tumor usually grows slowly and may not cause any symptoms in its early stages. However, as it progresses, it can cause abdominal pain, bloating, and irregular vaginal bleeding. GCTs are generally diagnosed through a combination of pelvic examination, imaging studies such as ultrasound or computed tomography (CT), and biopsy.

There are several subtypes of GCT, including:

1. Granulosa cell tumor with stromal element (GCT-SE): This is the most common type of GCT and accounts for about 70% of all cases. It is characterized by the presence of stromal cells, which are connective tissue cells that provide support and structure to the tumor.
2. Granulosa cell tumor without stromal element (GCT-wSE): This type of GCT lacks stromal cells and accounts for about 30% of all cases. It tends to be more aggressive than GCT-SE and is more likely to spread to other parts of the body.
3. Mucinous granulosa cell tumor (MGCT): This is a rare subtype of GCT that produces mucin, a type of protein that is found in the ovary. MGCTs tend to be slower-growing than other types of GCT and have a better prognosis.

Treatment for GCT typically involves surgery to remove the tumor, followed by radiation therapy and/or chemotherapy to destroy any remaining cancer cells. The prognosis for GCT is generally good, with a 5-year survival rate of about 80% for women with early-stage disease. However, the prognosis can be poorer for women with more advanced stages of the disease.

In summary, granulosa cell tumor is a rare type of ovarian cancer that originates from the granulosa cells of the ovary. It can present in different forms and has a good prognosis if treated early. Treatment typically involves surgery, radiation therapy, and/or chemotherapy.

Examples of mammary neoplasms in animals include:

* Mammary adenocarcinoma: A type of tumor that develops in the mammary gland of animals and is characterized by the growth of abnormal cells that produce milk.
* Mammary fibroadenoma: A benign tumor that develops in the mammary gland of animals and is characterized by the growth of fibrous and glandular tissue.
* Inflammatory mammary carcinoma: A type of tumor that develops in the mammary gland of animals and is characterized by the presence of inflammatory cells and abnormal cells.

These tumors can be caused by a variety of factors, including genetic mutations, hormonal imbalances, and exposure to certain environmental agents. They can also be induced experimentally using chemical carcinogens or viruses.

The study of mammary neoplasms in animals is important for understanding the molecular mechanisms underlying breast cancer development and progression, as well as for identifying potential therapeutic targets and developing new treatments.

PEComas can be benign or malignant, and they can affect individuals of all ages and backgrounds. The exact cause of PEComas is not fully understood, but they are thought to arise from genetic mutations that occur in the perivascular epithelioid cells.

The symptoms of PEComas vary depending on their location and size, but they can include pain, swelling, and difficulty moving the affected limb. If the tumor is benign, it may not cause any symptoms at all and may only be discovered incidentally during a routine medical exam or imaging study.

The diagnosis of PEComa is based on a combination of clinical findings, imaging studies, and pathological analysis of a biopsy sample. Imaging studies such as CT or MRI scans can help identify the location and size of the tumor, while a biopsy can confirm the presence of perivascular epithelioid cells and rule out other types of soft tissue tumors.

Treatment of PEComas depends on the size, location, and aggressiveness of the tumor, as well as the patient's overall health. Benign PEComas can be monitored with regular imaging studies and may not require any treatment at all, while malignant PEComas may require surgical resection or other therapies such as chemotherapy or radiation therapy.

Overall, perivascular epithelioid cell neoplasms are a rare and diverse group of soft tissue tumors that can affect individuals of all ages and backgrounds. While they can be challenging to diagnose and treat, advances in imaging technology and surgical techniques have improved outcomes for patients with PEComas.

This cancer is known for its aggressive behavior and early metastasis to regional lymph nodes, bones, and distant organs such as the liver and lungs. The prognosis is generally poor, with a 5-year survival rate of about 50%. The treatment options include surgery, radiation therapy, and chemotherapy, and the choice of treatment depends on the stage and location of the tumor.

Adenoid cystic carcinoma is also known as adenoid cystic cancer, cylindromatosis, or basaloid squamous cell carcinoma. It is a rare malignancy that requires specialized knowledge and management by head and neck surgeons and oncologists.

There are several subtypes of astrocytoma, including:

1. Low-grade astrocytoma: These tumors grow slowly and are less aggressive. They can be treated with surgery, radiation therapy, or chemotherapy.
2. High-grade astrocytoma: These tumors grow more quickly and are more aggressive. They are often resistant to treatment and may recur after initial treatment.
3. Anaplastic astrocytoma: These are the most aggressive type of astrocytoma, growing rapidly and spreading to other parts of the brain.
4. Glioblastoma (GBM): This is the most common and deadliest type of primary brain cancer, accounting for 55% of all astrocytomas. It is highly aggressive and resistant to treatment, often recurring after initial surgery, radiation, and chemotherapy.

The symptoms of astrocytoma depend on the location and size of the tumor. Common symptoms include headaches, seizures, weakness or numbness in the arms or legs, and changes in personality or behavior.

Astrocytomas are diagnosed through a combination of imaging tests such as MRI or CT scans, and tissue biopsy. Treatment options vary depending on the type and location of the tumor, but may include surgery, radiation therapy, chemotherapy, or a combination of these.

The prognosis for astrocytoma varies based on the subtype and location of the tumor, as well as the patient's age and overall health. In general, low-grade astrocytomas have a better prognosis than high-grade tumors. However, even with treatment, the survival rate for astrocytoma is generally lower compared to other types of cancer.

Mesenchymomas are relatively rare compared to other types of tumors, but they can be challenging to diagnose and treat due to their diverse clinical presentation and biological behavior. Mesenchymal tumors can be classified into several subtypes based on their histopathology and immunohistochemical features.

Surgery is the primary treatment for mesenchymomas, but the prognosis and outcome can vary depending on the type, size, location, and stage of the tumor. Radiation therapy and chemotherapy may also be used in combination with surgery to improve treatment outcomes. The long-term follow-up of patients with mesenchymomas is essential to monitor for recurrences and to assess the effectiveness of treatment.

Rectal neoplasms refer to abnormal growths or tumors that occur in the rectum, which is the lower part of the digestive system. These growths can be benign (non-cancerous) or malignant (cancerous).

Types of Rectal Neoplasms:

There are several types of rectal neoplasms, including:

1. Adenoma: A benign growth that is usually found in the colon and rectum. It is a common precursor to colorectal cancer.
2. Carcinoma: A malignant tumor that arises from the epithelial cells lining the rectum. It is the most common type of rectal cancer.
3. Rectal adenocarcinoma: A type of carcinoma that originates in the glandular cells lining the rectum.
4. Rectal squamous cell carcinoma: A type of carcinoma that originates in the squamous cells lining the rectum.
5. Rectal melanoma: A rare type of carcinoma that originates in the pigment-producing cells (melanocytes) of the rectum.

Causes and Risk Factors:

The exact causes of rectal neoplasms are not known, but several factors can increase the risk of developing these growths. These include:

1. Age: The risk of developing rectal neoplasms increases with age, with most cases occurring in people over the age of 50.
2. Family history: Having a family history of colorectal cancer or polyps can increase the risk of developing rectal neoplasms.
3. Inflammatory bowel disease: People with inflammatory bowel disease, such as ulcerative colitis and Crohn's disease, are at higher risk of developing rectal neoplasms.
4. Diet: A diet high in fat and low in fiber may increase the risk of developing rectal neoplasms.
5. Lifestyle factors: Factors such as smoking, obesity, and lack of physical activity may also increase the risk of developing rectal neoplasms.

Symptoms:

The symptoms of rectal neoplasms can vary depending on the type and location of the growth. Some common symptoms include:

1. Blood in the stool
2. Changes in bowel movements (such as diarrhea or constipation)
3. Abdominal pain or discomfort
4. Weakness and fatigue
5. Loss of appetite

Diagnosis:

To diagnose rectal neoplasms, a doctor may perform several tests, including:

1. Digital rectal exam (DRE): A doctor will insert a gloved finger into the rectum to feel for any abnormalities.
2. Colonoscopy: A flexible tube with a camera and light on the end is inserted through the anus and into the rectum to examine the inside of the rectum and colon for polyps or other abnormalities.
3. Imaging tests: Such as X-rays, CT scans, or MRI scans to visualize the growth and determine its location and size.
4. Biopsy: A sample of tissue is removed from the rectum and examined under a microscope for cancer cells.

Treatment:

The treatment of rectal neoplasms depends on the type, location, and stage of the growth. Some common treatments include:

1. Polypectomy: Removal of polyps through a colonoscopy or surgery.
2. Local excision: Surgical removal of the tumor and a small amount of surrounding tissue.
3. Radiation therapy: High-energy beams are used to kill cancer cells.
4. Chemotherapy: Drugs are used to kill cancer cells.
5. Immunotherapy: A treatment that uses the body's immune system to fight cancer.

Prognosis:

The prognosis for rectal neoplasms depends on the type, location, and stage of the growth. In general, the earlier the diagnosis and treatment, the better the prognosis. However, some types of rectal neoplasms can be more aggressive and difficult to treat, and may have a poorer prognosis.

Prevention:

There is no sure way to prevent rectal neoplasms, but there are several screening tests that can help detect them early, including:

1. Colonoscopy: A test in which a flexible tube with a camera and light on the end is inserted into the rectum and colon to examine for polyps or cancer.
2. Fecal occult blood test (FOBT): A test that checks for blood in the stool.
3. Flexible sigmoidoscopy: A test similar to a colonoscopy, but only examines the lower part of the colon and rectum.
4. Digital rectal exam (DRE): An examination of the rectum using a gloved finger to feel for any abnormalities.

It is important to talk to your doctor about your risk for rectal neoplasms and any screening tests that may be appropriate for you. Early detection and treatment can improve the prognosis for these types of growths.

* Peripheral T-cell lymphoma (PTCL): This is a rare type of T-cell lymphoma that can develop in the skin, lymph nodes, or other organs.
* Cutaneous T-cell lymphoma (CTCL): This is a type of PTCL that affects the skin and can cause lesions, rashes, and other skin changes.
* Anaplastic large cell lymphoma (ALCL): This is a rare subtype of PTCL that can develop in the lymph nodes, spleen, or bone marrow.
* Adult T-cell leukemia/lymphoma (ATLL): This is a rare and aggressive subtype of PTCL that is caused by the human T-lymphotropic virus type 1 (HTLV-1).

Symptoms of T-cell lymphoma can include:

* Swollen lymph nodes
* Fever
* Fatigue
* Weight loss
* Night sweats
* Skin lesions or rashes

Treatment options for T-cell lymphoma depend on the subtype and stage of the cancer, but may include:

* Chemotherapy
* Radiation therapy
* Immunotherapy
* Targeted therapy

Prognosis for T-cell lymphoma varies depending on the subtype and stage of the cancer, but in general, the prognosis for PTCL is poorer than for other types of non-Hodgkin lymphoma. However, with prompt and appropriate treatment, many people with T-cell lymphoma can achieve long-term remission or even be cured.

Types of Esophageal Neoplasms:

1. Barrett's Esophagus: This is a precancerous condition that occurs when the cells lining the esophagus undergo abnormal changes, increasing the risk of developing esophageal cancer.
2. Adenocarcinoma: This is the most common type of esophageal cancer, accounting for approximately 70% of all cases. It originates in the glands that line the esophagus.
3. Squamous Cell Carcinoma: This type of cancer accounts for about 20% of all esophageal cancers and originates in the squamous cells that line the esophagus.
4. Other rare types: Other rare types of esophageal neoplasms include lymphomas, sarcomas, and carcinoid tumors.

Causes and Risk Factors:

1. Gastroesophageal reflux disease (GERD): Long-standing GERD can lead to the development of Barrett's esophagus, which is a precancerous condition that increases the risk of developing esophageal cancer.
2. Obesity: Excess body weight is associated with an increased risk of developing esophageal cancer.
3. Diet: A diet high in processed meats and low in fruits and vegetables may increase the risk of developing esophageal cancer.
4. Alcohol consumption: Heavy alcohol consumption is a known risk factor for esophageal cancer.
5. Smoking: Cigarette smoking is a major risk factor for esophageal cancer.
6. Family history: Having a family history of esophageal cancer or other cancers may increase an individual's risk.
7. Age: The risk of developing esophageal cancer increases with age, with most cases occurring in people over the age of 50.
8. Other medical conditions: Certain medical conditions, such as achalasia, may increase the risk of developing esophageal cancer.

Symptoms and Diagnosis:

1. Dysphagia (difficulty swallowing): This is the most common symptom of esophageal cancer, and can be caused by a narrowing or blockage of the esophagus due to the tumor.
2. Chest pain or discomfort: Pain in the chest or upper back can be a symptom of esophageal cancer.
3. Weight loss: Losing weight without trying can be a symptom of esophageal cancer.
4. Coughing or hoarseness: If the tumor is obstructing the airway, it can cause coughing or hoarseness.
5. Fatigue: Feeling tired or weak can be a symptom of esophageal cancer.
6. Diagnosis: A diagnosis of esophageal cancer is typically made through a combination of endoscopy, imaging tests (such as CT scans), and biopsies.

Treatment Options:

1. Surgery: Surgery is the primary treatment for esophageal cancer, and can involve removing the tumor and some surrounding tissue, or removing the entire esophagus and replacing it with a section of stomach or intestine.
2. Chemotherapy: Chemotherapy involves using drugs to kill cancer cells, and is often used in combination with surgery to treat esophageal cancer.
3. Radiation therapy: Radiation therapy uses high-energy X-rays to kill cancer cells, and can be used alone or in combination with surgery or chemotherapy.
4. Targeted therapy: Targeted therapy drugs are designed to target specific molecules that are involved in the growth and spread of cancer cells, and can be used in combination with other treatments.

Prognosis and Survival Rate:

1. The prognosis for esophageal cancer is generally poor, with a five-year survival rate of around 20%.
2. Factors that can improve the prognosis include early detection, small tumor size, and absence of spread to lymph nodes or other organs.
3. The overall survival rate for esophageal cancer has not improved much over the past few decades, but advances in treatment have led to a slight increase in survival time for some patients.

Lifestyle Changes and Prevention:

1. Avoiding tobacco and alcohol: Tobacco and alcohol are major risk factors for esophageal cancer, so avoiding them can help reduce the risk of developing the disease.
2. Maintaining a healthy diet: Eating a balanced diet that is high in fruits, vegetables, and whole grains can help protect against esophageal cancer.
3. Managing obesity: Obesity is a risk factor for esophageal cancer, so maintaining a healthy weight through diet and exercise can help reduce the risk of developing the disease.
4. Reducing exposure to pollutants: Exposure to certain chemicals and pollutants, such as pesticides and asbestos, has been linked to an increased risk of esophageal cancer. Avoiding these substances can help reduce the risk of developing the disease.
5. Getting regular screening: Regular screening for Barrett's esophagus, a precancerous condition that can develop in people with gastroesophageal reflux disease (GERD), can help detect and treat esophageal cancer early, when it is most treatable.

Current Research and Future Directions:

1. Targeted therapies: Researchers are working on developing targeted therapies that can specifically target the genetic mutations that drive the growth of esophageal cancer cells. These therapies may be more effective and have fewer side effects than traditional chemotherapy.
2. Immunotherapy: Immunotherapy, which uses the body's immune system to fight cancer, is being studied as a potential treatment for esophageal cancer. Researchers are working on developing vaccines and other immunotherapies that can help the body recognize and attack cancer cells.
3. Precision medicine: With the help of advanced genomics and precision medicine, researchers are working to identify specific genetic mutations that drive the growth of esophageal cancer in each patient. This information can be used to develop personalized treatment plans that are tailored to the individual patient's needs.
4. Early detection: Researchers are working on developing new methods for early detection of esophageal cancer, such as using machine learning algorithms to analyze medical images and detect signs of cancer at an early stage.
5. Lifestyle modifications: Studies have shown that lifestyle modifications, such as quitting smoking and maintaining a healthy diet, can help reduce the risk of developing esophageal cancer. Researchers are working on understanding the specific mechanisms by which these modifications can help prevent the disease.

In conclusion, esophageal cancer is a complex and aggressive disease that is often diagnosed at an advanced stage. However, with advances in technology, research, and treatment options, there is hope for improving outcomes for patients with this disease. By understanding the risk factors, early detection methods, and current treatments, as well as ongoing research and future directions, we can work towards a future where esophageal cancer is more manageable and less deadly.

1. Feline Leukemia Virus (FeLV): This is a highly contagious virus that weakens the immune system, making cats more susceptible to other infections and cancer.
2. Feline Immunodeficiency Virus (FIV): Similar to HIV in humans, this virus attacks the immune system and can lead to a range of secondary infections and diseases.
3. Feline Infectious Peritonitis (FIP): A viral disease that causes fluid accumulation in the abdomen and chest, leading to difficulty breathing and abdominal pain.
4. Feline Lower Urinary Tract Disease (FLUTD): A group of conditions that affect the bladder and urethra, including urinary tract infections and kidney stones.
5. Feline Diabetes: Cats can develop diabetes, which can lead to a range of complications if left untreated, including urinary tract infections, kidney disease, and blindness.
6. Feline Hyperthyroidism: An overactive thyroid gland that can cause weight loss, anxiety, and heart problems if left untreated.
7. Feline Cancer: Cats can develop various types of cancer, including lymphoma, leukemia, and skin cancer.
8. Dental disease: Cats are prone to dental problems, such as tartar buildup, gum disease, and tooth resorption.
9. Obesity: A common problem in cats, obesity can lead to a range of health issues, including diabetes, arthritis, and heart disease.
10. Behavioral disorders: Cats can develop behavioral disorders such as anxiety, stress, and aggression, which can impact their quality of life and relationships with humans.

It's important to note that many of these diseases can be prevented or managed with proper care, including regular veterinary check-ups, vaccinations, parasite control, a balanced diet, exercise, and mental stimulation. Additionally, early detection and treatment can significantly improve the outcome for cats with health issues.

Common types of genital neoplasms in females include:

1. Vulvar intraepithelial neoplasia (VIN): A precancerous condition that affects the vulva, the external female genital area.
2. Cervical dysplasia: Precancerous changes in the cells of the cervix, which can progress to cancer if left untreated.
3. Endometrial hyperplasia: Abnormal growth of the uterine lining, which can sometimes develop into endometrial cancer.
4. Endometrial adenocarcinoma: Cancer that arises in the glands of the uterine lining.
5. Ovarian cancer: Cancer that originates in the ovaries.
6. Vaginal cancer: Cancer that occurs in the vagina.
7. Cervical cancer: Cancer that occurs in the cervix.
8. Uterine leiomyosarcoma: A rare type of cancer that occurs in the uterus.
9. Uterine clear cell carcinoma: A rare type of cancer that occurs in the uterus.
10. Mesothelioma: A rare type of cancer that affects the lining of the abdominal cavity, including the female reproductive organs.

Treatment for genital neoplasms in females depends on the type and stage of the disease, and may include surgery, radiation therapy, chemotherapy, or a combination of these. Early detection and treatment are important to improve outcomes and reduce the risk of complications.

The submandibular glands are located beneath the jawbone and produce saliva to aid in digestion. When abnormal cells grow in these glands, it can lead to various types of tumors, including benign and malignant ones. Submandibular gland neoplasms refer to any type of tumor or growth that develops in the submandibular glands.

Types of Submandibular Gland Neoplasms:

There are several types of submandibular gland neoplasms, including:

1. Pleomorphic adenoma: This is the most common type of benign tumor that develops in the submandibular glands. It can grow slowly over time and may or may not cause symptoms.
2. Warthin's tumor: This is a type of benign tumor that is more common in older adults. It typically grows slowly and does not spread to other parts of the body.
3. Mucoepidermoid carcinoma: This is a type of malignant tumor that can grow quickly and spread to other parts of the body. It is rare and usually occurs in people under the age of 40.
4. Acinic cell carcinoma: This is a rare type of malignant tumor that typically affects children and young adults. It grows slowly and has a good prognosis if treated early.
5. Adenoid cystic carcinoma: This is a rare type of malignant tumor that can grow slowly over time and invade surrounding tissues.

Symptoms of Submandibular Gland Neoplasms:

The symptoms of submandibular gland neoplasms vary depending on the size and location of the tumor. Some common symptoms include:

1. Swelling in the neck or jaw
2. Pain or tenderness in the neck, jaw, or ear
3. Difficulty swallowing or eating
4. Numbness or weakness in the face
5. Persistent earaches or hearing loss

Diagnosis of Submandibular Gland Neoplasms:

To diagnose a submandibular gland neoplasm, your doctor will begin with a physical examination and ask questions about your symptoms and medical history. They may also order one or more of the following tests:

1. Fine needle aspiration biopsy: This test involves inserting a thin needle into the tumor to collect a sample of cells for testing.
2. Imaging tests: Such as CT scans, MRI scans, and PET scans to visualize the size and location of the tumor.
3. Endoscopy: A flexible tube with a light and camera on the end is inserted through the mouth or nose to examine the inside of the mouth and throat.
4. Blood tests: To check for certain substances in the blood that can indicate the presence of a neoplasm.

Treatment of Submandibular Gland Neoplasms:

The treatment of submandibular gland neoplasms depends on the type, size, location, and stage of the tumor. Some common treatment options include:

1. Surgery: To remove the tumor and some surrounding tissue.
2. Radiation therapy: High-energy beams to kill cancer cells.
3. Chemotherapy: Drugs to kill cancer cells.
4. Observation: Monitoring the tumor with regular checkups and imaging tests to see if it grows or changes.
5. Endocrine therapy: Medications to reduce the production of hormones that can stimulate the growth of the tumor.

Prognosis of Submandibular Gland Neoplasms:

The prognosis for submandibular gland neoplasms varies based on the type and stage of the tumor. In general, benign tumors have a good prognosis and are unlikely to spread or recur. Malignant tumors, on the other hand, can be more aggressive and may have a poorer prognosis if left untreated.

Prevention of Submandibular Gland Neoplasms:

There is no known way to prevent submandibular gland neoplasms entirely, but early detection and treatment can improve outcomes. Regular dental checkups and self-exams can help identify any abnormalities or changes in the submandibular gland early on. Additionally, avoiding risk factors such as smoking and excessive alcohol consumption can reduce the likelihood of developing a malignant tumor.

Conclusion:

Submandibular gland neoplasms are rare but can be serious conditions that require prompt diagnosis and treatment. While the prognosis varies based on the type and stage of the tumor, early detection and intervention can improve outcomes. Understanding the causes, risk factors, symptoms, diagnosis, treatment options, and prevention strategies for submandibular gland neoplasms can help individuals take a more proactive approach to their health and seek medical attention if they experience any unusual symptoms in the neck or jaw area.

Papillomas can occur anywhere on the body, but they are most commonly found on the face, neck, and scalp. They may appear as small bumps or growths that look like a wart. In some cases, papillomas may be associated with human papillomavirus (HPV) infection.

Papillomas are typically diagnosed through a physical examination of the affected area. In some cases, a biopsy may be performed to confirm the diagnosis and rule out other potential causes. Treatment for papillomas usually involves removal of the growth through a minor surgical procedure or cryotherapy (freezing).

Papillomas are not cancerous and do not typically pose any long-term health risks. However, they may be unsightly and can cause psychological distress for some people. In these cases, treatment may be sought for cosmetic reasons. It is important to note that papillomas should not be confused with squamous cell carcinoma, a type of skin cancer that can resemble a papilloma in appearance but has the potential to be more aggressive and harmful.

The symptoms of myoepithelioma may vary depending on the location of the tumor, but they can include:

* A painless lump or swelling in the affected area
* Pain or tenderness in the affected area
* Difficulty swallowing or speaking (if the tumor is located in the parotid gland)
* Numbness or weakness in the face (if the tumor is located in the parotid gland)

The diagnosis of myoepithelioma usually involves a combination of imaging tests such as ultrasound, CT scan or MRI and a biopsy to confirm the presence of cancer cells.

Treatment for myoepithelioma may involve surgery, radiation therapy, or chemotherapy, depending on the size, location, and stage of the tumor. The prognosis for myoepithelioma is generally good if the tumor is diagnosed early and treated appropriately. However, the cancer can recur in some cases, so regular follow-up appointments with a doctor are important to monitor for any signs of recurrence.

In summary, Myoepithelioma is a rare type of cancer that develops in the myoepithelial cells and typically affects the parotid gland. It can cause various symptoms such as painless lump or swelling, pain or tenderness in the affected area and difficulty swallowing or speaking. The diagnosis is confirmed by imaging tests and biopsy and treatment options include surgery, radiation therapy and chemotherapy.

Malignant prostatic neoplasms are cancerous tumors that can be aggressive and spread to other parts of the body (metastasize). The most common type of malignant prostatic neoplasm is adenocarcinoma of the prostate, which accounts for approximately 95% of all prostate cancers. Other types of malignant prostatic neoplasms include sarcomas and small cell carcinomas.

Prostatic neoplasms can be diagnosed through a variety of tests such as digital rectal examination (DRE), prostate-specific antigen (PSA) test, imaging studies (ultrasound, CT scan or MRI), and biopsy. Treatment options for prostatic neoplasms depend on the type, stage, and grade of the tumor, as well as the patient's age and overall health. Treatment options can include active surveillance, surgery (robotic-assisted laparoscopic prostatectomy or open prostatectomy), radiation therapy (external beam radiation therapy or brachytherapy), and hormone therapy.

In summary, Prostatic Neoplasms are tumors that occur in the prostate gland, which can be benign or malignant. The most common types of malignant prostatic neoplasms are adenocarcinoma of the prostate, and other types include sarcomas and small cell carcinomas. Diagnosis is done through a variety of tests, and treatment options depend on the type, stage, and grade of the tumor, as well as the patient's age and overall health.

There are several types of eyelid neoplasms, including:

1. Basal cell carcinoma: This is the most common type of skin cancer, and it usually occurs on the skin around the nose and forehead. It can also occur on the eyelids.
2. Squamous cell carcinoma: This type of cancer usually occurs on sun-exposed areas, such as the face, ears, and hands. It can also occur on the eyelids.
3. Melanoma: This is a rare but aggressive type of cancer that can occur on any skin surface, including the eyelids.
4. Lymphoma: This is a type of cancer that affects the immune system, and it can occur in the eyelid tissue.
5. Sebaceous gland carcinoma: This is a rare type of cancer that affects the oil-producing glands in the eyelids.
6. Hemangiopericytic sarcoma: This is a rare type of cancer that affects the blood vessels in the eyelids.
7. Xanthelasma: This is a benign growth that occurs on the eyelids and is usually associated with high cholesterol levels.
8. Pyogenic granuloma: This is a benign growth that can occur on the eyelids and is usually caused by an infection.

Symptoms of eyelid neoplasms can include:

* A lump or bump on the eyelid
* Redness, swelling, or discharge from the eyelid
* Pain or tenderness in the eyelid
* Difficulty moving the eye or vision problems

If you suspect that you have an eyelid neoplasm, it is important to see an eye doctor as soon as possible for a proper diagnosis and treatment. Your doctor will perform a comprehensive examination of your eyes, including a visual examination of the eyelids, and may also use diagnostic tests such as imaging studies or biopsies to determine the cause of your symptoms. Treatment for eyelid neoplasms depends on the specific type of cancer or other condition that is present, and may include surgery, chemotherapy, radiation therapy, or other treatments.

Some common types of hypothalamic neoplasms include:

1. Hypothalamic hamartoma: A benign tumor that usually develops in children and is characterized by abnormal growth of brain tissue.
2. Pineal parenchymal tumors: Tumors that originate in the pineal gland, a small endocrine gland located in the hypothalamus. These tumors can be benign or malignant and can cause symptoms such as headaches, vision problems, and hormonal imbalances.
3. Hypothalamic astrocytomas: Malignant tumors that originate in the brain tissue of the hypothalamus and can spread to other parts of the brain.
4. Craniopharyngiomas: Benign tumors that develop near the pituitary gland, a small endocrine gland located at the base of the brain that regulates various bodily functions. These tumors can cause symptoms such as headaches, vision problems, and hormonal imbalances.

The symptoms of hypothalamic neoplasms can vary depending on their size, location, and type, but may include:

1. Headaches
2. Vision problems
3. Hormonal imbalances
4. Seizures
5. Weight gain or loss
6. Fatigue
7. Changes in mood or behavior
8. Cognitive impairment
9. Endocrine dysfunction

The diagnosis of hypothalamic neoplasms is based on a combination of clinical evaluation, imaging studies such as MRI or CT scans, and tissue sampling through biopsy or surgery. Treatment options for these tumors depend on the type, size, and location of the tumor, and may include:

1. Observation: Small, benign tumors may not require immediate treatment and can be monitored with regular check-ups.
2. Surgery: To remove the tumor, either through a traditional open procedure or minimally invasive techniques.
3. Radiation therapy: To destroy any remaining tumor cells after surgery.
4. Chemotherapy: To shrink the tumor before surgery or to treat recurrences.
5. Hormone replacement therapy: To replace hormones that are deficient due to hypopituitarism.

The prognosis for hypothalamic neoplasms depends on the type and location of the tumor, as well as the patient's overall health. In general, benign tumors have a good prognosis, while malignant tumors are more challenging to treat and may have a poorer outcome.

The symptoms of oligodendroglioma can vary depending on the location and size of the tumor, but may include headaches, seizures, weakness or numbness in the arms or legs, and changes in personality or behavior.

Oligodendrogliomas are diagnosed through a combination of imaging tests such as MRI or CT scans, and tissue biopsy. Treatment options for oligodendroglioma can include surgery to remove the tumor, radiation therapy, and chemotherapy with drugs such as temozolomide.

Prognosis for oligodendroglioma depends on the location, size, and aggressiveness of the tumor, as well as the age and overall health of the patient. In general, benign oligodendrogliomas have a good prognosis, while malignant ones are more difficult to treat and can be associated with a poorer outcome.

There is ongoing research into new treatments for oligodendroglioma, including clinical trials of innovative drugs and therapies.

The tumor usually appears as a firm, raised nodule that may be tan, pink, or skin-colored. It may be accompanied by a small amount of hair growth. The edges of the tumor are usually well-defined and the surface is smooth.

Histiocytoma, benign fibrous is also known as "histiocyte-rich cutaneous lesion" or "benign fibrous histiocytoma." It is generally not cancerous and does not spread to other parts of the body. Treatment usually involves surgical removal of the tumor.

The exact cause of histiocytoma, benign fibrous is not known, but it may be associated with genetic mutations or exposure to certain environmental factors. The condition is relatively rare and affects mostly children and young adults.

Meningioma can occur in various locations within the brain, including the cerebrum, cerebellum, brainstem, and spinal cord. The most common type of meningioma is the meningothelial meningioma, which arises from the arachnoid membrane, one of the three layers of the meninges. Other types of meningioma include the dural-based meningioma, which originates from the dura mater, and the fibrous-cap meningioma, which is characterized by a fibrous cap covering the tumor.

The symptoms of meningioma can vary depending on the location and size of the tumor, but they often include headaches, seizures, weakness or numbness in the arms or legs, and changes in vision, memory, or cognitive function. As the tumor grows, it can compress the brain tissue and cause damage to the surrounding structures, leading to more severe symptoms such as difficulty speaking, walking, or controlling movement.

The diagnosis of meningioma typically involves a combination of imaging studies such as MRI or CT scans, and tissue sampling through biopsy or surgery. Treatment options for meningioma depend on the size, location, and aggressiveness of the tumor, but may include surgery, radiation therapy, and chemotherapy. Overall, the prognosis for meningioma is generally good, with many patients experiencing a good outcome after treatment. However, some types of meningioma can be more aggressive and difficult to treat, and the tumor may recur in some cases.

Carcinoid tumors are usually found in the appendix, small intestine, rectum, or other parts of the gastrointestinal tract. They can also occur in the lungs, pancreas, or other organs. These tumors tend to grow slowly and often do not cause any symptoms until they have grown quite large.

Carcinoid tumors are diagnosed through a combination of imaging tests such as CT scans, MRI scans, and endoscopies, along with a biopsy to confirm the presence of cancer cells. Treatment for carcinoid tumors depends on the location, size, and stage of the tumor, as well as the patient's overall health. Treatment options may include surgery, chemotherapy, radiation therapy, or a combination of these.

Some of the symptoms that may be associated with carcinoid tumors include:

* Flushing (redness and warmth of the skin)
* Wheezing
* Shortness of breath
* Abdominal pain
* Diarrhea
* Weight loss

Carcinoid tumors are relatively rare, accounting for only about 1% to 5% of all cancer cases. However, they tend to be more common in certain parts of the world, such as North America and Europe. The exact cause of carcinoid tumors is not known, but they are thought to be linked to genetic mutations that occur during fetal development.

Overall, while carcinoid tumors are rare and can be challenging to diagnose and treat, advances in medical technology and cancer research have improved the outlook for patients with these types of tumors. With early detection and appropriate treatment, many people with carcinoid tumors can achieve long-term survival and a good quality of life.

There are several subtypes of lymphoma, B-cell, including:

1. Diffuse large B-cell lymphoma (DLBCL): This is the most common type of B-cell lymphoma and typically affects older adults.
2. Follicular lymphoma: This type of lymphoma grows slowly and often does not require treatment for several years.
3. Marginal zone lymphoma: This type of lymphoma develops in the marginal zone of the spleen or other lymphoid tissues.
4. Hodgkin lymphoma: This is a type of B-cell lymphoma that is characterized by the presence of Reed-Sternberg cells, which are abnormal cells that can be identified under a microscope.

The symptoms of lymphoma, B-cell can vary depending on the subtype and the location of the tumor. Common symptoms include swollen lymph nodes, fatigue, fever, night sweats, and weight loss.

Treatment for lymphoma, B-cell usually involves chemotherapy, which is a type of cancer treatment that uses drugs to kill cancer cells. Radiation therapy may also be used in some cases. In some cases, bone marrow or stem cell transplantation may be recommended.

Prognosis for lymphoma, B-cell depends on the subtype and the stage of the disease at the time of diagnosis. In general, the prognosis is good for patients with early-stage disease, but the cancer can be more difficult to treat if it has spread to other parts of the body.

Prevention of lymphoma, B-cell is not possible, as the exact cause of the disease is not known. However, avoiding exposure to certain risk factors, such as viral infections and pesticides, may help reduce the risk of developing the disease. Early detection and treatment can also improve outcomes for patients with lymphoma, B-cell.

Lymphoma, B-cell is a type of cancer that affects the immune system and can be treated with chemotherapy and other therapies. The prognosis varies depending on the subtype and stage of the disease at diagnosis. Prevention is not possible, but early detection and treatment can improve outcomes for patients with this condition.

Benign maxillary sinus tumors may include:

* Papilloma: A benign growth that resembles a finger-like protrusion and is usually slow-growing and non-aggressive.
* Pyogenic granuloma: A type of benign bacterial infection that can cause localized tissue growth and inflammation.
* Osteoid osteoma: A rare, benign tumor that forms in the bone and can cause pain and swelling.

Malignant maxillary sinus tumors are more aggressive and can include:

* Squamous cell carcinoma: A type of skin cancer that can occur in the maxillary sinus and can be treated with surgery, radiation therapy, or chemotherapy.
* Adenoid cystic carcinoma: A rare, malignant tumor that can grow slowly over time and can be difficult to treat.
* Esthesioneuroblastoma: A rare, malignant tumor that originates in the nasal cavity and can extend into the maxillary sinus.

The symptoms of maxillary sinus neoplasms can vary depending on the size and location of the tumor, but may include:

* Pain or swelling in the face or neck
* Difficulty breathing through the nose
* Nasal congestion or discharge
* Eye problems such as double vision or protrusion
* Headaches or facial pain

The diagnosis of maxillary sinus neoplasms is typically made using a combination of imaging studies, such as CT scans or MRI, and tissue biopsy. Treatment options can range from observation to surgery, radiation therapy, or chemotherapy, depending on the type and stage of the tumor.

Source: National Cancer Institute - "Sertoli Cell Tumors" [online].

Note: This definition is a summary of the medical definition of Sertoli Cell Tumor and may not be comprehensive or up-to-date. For accurate and current information, it is recommended to consult a qualified medical professional or healthcare provider.

There are many different types of cysts that can occur in the body, including:

1. Sebaceous cysts: These are small, usually painless cysts that form in the skin, particularly on the face, neck, or torso. They are filled with a thick, cheesy material and can become inflamed or infected.
2. Ovarian cysts: These are fluid-filled sacs that form on the ovaries. They are common in women of childbearing age and can cause pelvic pain, bloating, and other symptoms.
3. Kidney cysts: These are fluid-filled sacs that form in the kidneys. They are usually benign but can cause problems if they become large or infected.
4. Dermoid cysts: These are small, usually painless cysts that form in the skin or organs. They are filled with skin cells, hair follicles, and other tissue and can become inflamed or infected.
5. Pilar cysts: These are small, usually painless cysts that form on the scalp. They are filled with a thick, cheesy material and can become inflamed or infected.
6. Epidermoid cysts: These are small, usually painless cysts that form just under the skin. They are filled with a thick, cheesy material and can become inflamed or infected.
7. Mucous cysts: These are small, usually painless cysts that form on the fingers or toes. They are filled with a clear, sticky fluid and can become inflamed or infected.
8. Baker's cyst: This is a fluid-filled cyst that forms behind the knee. It can cause swelling and pain in the knee and is more common in women than men.
9. Tarlov cysts: These are small, fluid-filled cysts that form in the spine. They can cause back pain and other symptoms, such as sciatica.
10. ganglion cysts: These are noncancerous lumps that form on the joints or tendons. They are filled with a thick, clear fluid and can cause pain, swelling, and limited mobility.

It's important to note that this is not an exhaustive list and there may be other types of cysts that are not included here. If you suspect that you have a cyst, it's always best to consult with a healthcare professional for proper diagnosis and treatment.

The cancer cells of this type are thought to arise from abnormalities in the cells that line the ducts of the salivary glands. These abnormal cells grow and divide uncontrollably, forming a mass that can obstruct the flow of saliva and cause symptoms such as pain, swelling, and difficulty eating or speaking.

Mucoepidermoid carcinoma is typically diagnosed with a combination of imaging studies, such as CT scans, MRI, and PET scans, and a biopsy, where a sample of tissue is removed from the tumor and examined under a microscope for cancer cells. Treatment typically involves surgery to remove the tumor, followed by radiation therapy and/or chemotherapy to kill any remaining cancer cells.

Prognosis for this type of cancer is generally good if it is diagnosed early and treated promptly, but it can be challenging to treat if it has spread to other parts of the body.

The exact cause of leiomyosarcoma is not known, but it is believed to be linked to genetic mutations that occur in the smooth muscle cells. It can occur at any age, but it is more common in women, especially after menopause.

Symptoms of leiomyosarcoma may include:

* Abnormal bleeding or discharge from the uterus or cervix
* Pelvic pain or discomfort
* A mass or lump in the abdomen or pelvis
* Weakness, fatigue, or fever

If leiomyosarcoma is suspected, a healthcare provider may perform a variety of tests to confirm the diagnosis, including:

* Pelvic examination and imaging tests, such as ultrasound, computed tomography (CT) scan, or magnetic resonance imaging (MRI) to visualize the tumor.
* Biopsy, where a sample of tissue is removed from the suspected tumor and examined under a microscope for cancer cells.

Treatment options for leiomyosarcoma depend on the location, size, and stage of the cancer, as well as the patient's age and overall health. Surgery is often the primary treatment, and may involve removing the uterus, cervix, or other affected organs. Radiation therapy and chemotherapy may also be used to kill any remaining cancer cells.

Overall, leiomyosarcoma is a rare and aggressive form of cancer that requires prompt medical attention if symptoms persist or worsen over time. With proper treatment, many people with leiomyosarcoma can achieve long-term survival and a good quality of life.

Sigmoid neoplasms refer to abnormal growths or tumors that occur in the sigmoid colon, which is the lower part of the large intestine. These growths can be benign (non-cancerous) or malignant (cancerous).

Types of Sigmoid Neoplasms[1]

There are several types of sigmoid neoplasms, including:

1. Adenomas: These are benign growths that can develop into cancer over time if left untreated.
2. Carcinomas: These are malignant tumors that can invade nearby tissues and spread to other parts of the body.
3. Polyps: These are abnormal growths that can be either benign or malignant.
4. Villous adenomas: These are benign growths that are typically found in the sigmoid colon.

Causes and Risk Factors[1]

The exact cause of sigmoid neoplasms is not known, but several factors may increase the risk of developing them, including:

1. Age: The risk of developing sigmoid neoplasms increases with age, with most cases occurring in people over the age of 50.
2. Family history: Having a family history of colon cancer or other gastrointestinal disorders may increase the risk of developing sigmoid neoplasms.
3. Lifestyle factors: Factors such as smoking, alcohol consumption, and a high-fat diet may increase the risk of developing sigmoid neoplasms.
4. Inflammatory bowel disease: People with inflammatory bowel diseases such as ulcerative colitis or Crohn's disease may be at higher risk of developing sigmoid neoplasms.

Symptoms[1]

Sigmoid neoplasms can cause a variety of symptoms, including:

1. Blood in the stool
2. Changes in bowel movements (such as diarrhea or constipation)
3. Abdominal pain or discomfort
4. Weakness and fatigue
5. Loss of appetite

Diagnosis[1]

Sigmoid neoplasms are typically diagnosed using a combination of imaging tests and biopsy. The following tests may be used to diagnose sigmoid neoplasms:

1. Colonoscopy: A colonoscopy is a procedure in which a flexible tube with a camera and light on the end is inserted into the colon to examine the inside of the colon for polyps or other abnormalities.
2. CT scan: A CT scan is a type of imaging test that uses X-rays to create detailed images of the body. It may be used to look for signs of a tumor in the sigmoid colon.
3. MRI: An MRI (magnetic resonance imaging) is a type of imaging test that uses magnetic fields and radio waves to create detailed images of the body. It may be used to look for signs of a tumor in the sigmoid colon.
4. Biopsy: A biopsy is a procedure in which a small sample of tissue is removed from the colon and examined under a microscope for cancer cells.
5. Blood tests: Blood tests may be used to check for signs of anemia, liver function, and other health problems that may be related to sigmoid neoplasms.

Treatment[2]

The treatment of sigmoid neoplasms depends on the type and stage of the cancer. The following are some possible treatments for sigmoid neoplasms:

1. Surgery: Surgery is often the first line of treatment for sigmoid neoplasms. The goal of surgery is to remove the tumor and any affected lymph nodes.
2. Chemotherapy: Chemotherapy is a type of cancer treatment that uses drugs to kill cancer cells. It may be used before or after surgery to treat sigmoid neoplasms.
3. Radiation therapy: Radiation therapy is a type of cancer treatment that uses high-energy X-rays or other particles to kill cancer cells. It may be used before or after surgery to treat sigmoid neoplasms.
4. Targeted therapy: Targeted therapy is a type of cancer treatment that targets specific genes or proteins that are involved in the growth and development of cancer cells. It may be used to treat sigmoid neoplasms that have spread to other parts of the body.
5. Immunotherapy: Immunotherapy is a type of cancer treatment that uses the body's immune system to fight cancer. It may be used to treat sigmoid neoplasms that have spread to other parts of the body.

Prognosis[2]

The prognosis for sigmoid neoplasms depends on the type and stage of the cancer. In general, the prognosis is better for early-stage cancers that are treated with surgery alone. The 5-year survival rate for patients with localized sigmoid neoplasms (cancer that has not spread to other parts of the body) is about 90%. The 5-year survival rate for patients with regional sigmoid neoplasms (cancer that has spread to nearby lymph nodes or tissues) is about 70%. The 5-year survival rate for patients with distant sigmoid neoplasms (cancer that has spread to other parts of the body) is about 30%.

Lifestyle Changes[2]

There are several lifestyle changes that may help reduce the risk of developing sigmoid neoplasms. These include:

1. Eating a healthy diet: A diet high in fruits, vegetables, and whole grains may help reduce the risk of developing sigmoid neoplasms.
2. Maintaining a healthy weight: Being overweight or obese increases the risk of developing sigmoid neoplasms. Maintaining a healthy weight through diet and exercise may help reduce this risk.
3. Exercising regularly: Regular physical activity may help reduce the risk of developing sigmoid neoplasms.
4. Limiting alcohol consumption: Drinking too much alcohol may increase the risk of developing sigmoid neoplasms. Limiting alcohol intake to moderate levels (1 drink per day for women and 2 drinks per day for men) may help reduce this risk.
5. Quitting smoking and avoiding secondhand smoke: Smoking and exposure to secondhand smoke increase the risk of developing sigmoid neoplasms. Quitting smoking and avoiding secondhand smoke may help reduce this risk.
6. Getting regular screenings: Regular screenings for colon cancer, such as colonoscopies, may help detect and treat sigmoid neoplasms before they become cancerous.

It is important to note that these lifestyle changes are not a guarantee against developing sigmoid neoplasms, but they may help reduce the risk. It is also important to talk to a doctor before making any significant changes to your diet or exercise routine.

There are several types of retinal neoplasms, including:

1. Retinal angiomatosis: This is a benign tumor that grows new blood vessels in the retina.
2. Retinal astrocytoma: This is a malignant tumor that arises from the supportive cells of the retina called astrocytes.
3. Retinal melanoma: This is a malignant tumor that arises from the pigment-producing cells of the retina called melanocytes. It is the most common type of primary intraocular cancer (cancer that originates in the eye).
4. Retinal osteochondroma: This is a benign tumor that grows from the supporting tissue of the retina.
5. Retinal sarcoma: This is a malignant tumor that arises from the connective tissue of the retina.

Retinal neoplasms can cause a variety of symptoms, including:

1. Blurred vision
2. Distorted vision
3. Flashes of light
4. Floaters (specks or cobwebs in your vision)
5. Eye pain
6. Redness and swelling of the eye
7. Sensitivity to light
8. Difficulty seeing colors

If you experience any of these symptoms, it is important to see an eye doctor as soon as possible for a comprehensive examination. Retinal neoplasms can be diagnosed through a combination of physical examination, imaging tests such as ultrasound and MRI, and laboratory tests such as blood tests.

Treatment options for retinal neoplasms depend on the type and location of the tumor, as well as the severity of the symptoms. Some common treatment options include:

1. Observation: Small, benign tumors may not require immediate treatment and can be monitored with regular eye exams to see if they grow or change over time.
2. Photocoagulation: This is a procedure that uses laser light to damage the tumor and prevent it from growing further. It can be used to treat retinal melanoma and other types of retinal neoplasms.
3. Cryotherapy: This is a procedure that uses extreme cold to freeze and destroy the tumor. It can be used to treat retinal sarcoma and other types of retinal neoplasms.
4. Surgery: In some cases, surgery may be necessary to remove the tumor. This can involve removing the affected eye (enucleation) or removing only the tumor and a small amount of surrounding tissue (vitrectomy).
5. Chemotherapy: This is a treatment that uses drugs to kill cancer cells. It may be used in combination with other treatments, such as photocoagulation or surgery, to treat retinal neoplasms.

It is important to note that early detection and treatment of retinal neoplasms can help preserve vision and improve outcomes. If you experience any symptoms of a retinal tumor, such as blurred vision, flashes of light, or floaters, it is important to see an eye doctor as soon as possible for an evaluation.

Types of neoplasms, gonadal tissue include:

1. Ovarian neoplasms: These are tumors that occur in the ovaries and can be benign or malignant. Examples of ovarian neoplasms include serous cystadenoma, endometrioid adenocarcinoma, and clear cell carcinoma.
2. Testicular neoplasms: These are tumors that occur in the testes and can be benign or malignant. Examples of testicular neoplasms include seminoma, teratoma, and embryonal carcinoma.
3. Germ cell tumors: These are tumors that develop from immature cells called germ cells. Examples of germ cell tumors include seminoma and teratoma.
4. Sex cord-stromal tumors: These are tumors that develop in the sex cords or stroma of the ovary or testis. Examples of sex cord-stromal tumors include granulosa cell tumor and thecoma.

Symptoms of neoplasms, gonadal tissue can vary depending on the location and type of tumor. Some common symptoms include:

* Abdominal pain or swelling
* Pelvic pain or swelling
* Vaginal bleeding or discharge
* Painful urination
* Weight loss or gain
* Fatigue

Diagnosis of neoplasms, gonadal tissue typically involves a combination of imaging tests such as ultrasound, CT scan, or MRI and biopsy. Treatment options vary depending on the type, size, location, and stage of the tumor and can include surgery, chemotherapy, and radiation therapy.

Neoplasms, nerve tissue can be caused by a variety of factors, such as genetic mutations, exposure to certain chemicals or radiation, or viral infections. Some common types of neoplasms, nerve tissue include:

1. Neurofibromas: These are benign tumors that grow on the nerve sheath and can cause symptoms such as numbness, weakness, or pain.
2. Schwannomas: These are benign tumors that grow on the covering of the nerves and can cause similar symptoms as neurofibromas.
3. Meningiomas: These are benign tumors that grow on the membranes that cover the brain and spinal cord.
4. Neurilemmomas: These are rare, benign tumors that grow on the covering of the nerves.
5. Malignant peripheral nerve sheath tumors (MPNSTs): These are rare, malignant tumors that can grow on the nerve sheath and can cause symptoms such as pain, weakness, or numbness.
6. Gangliocytomas: These are rare, benign tumors that grow on the nerve cells.
7. Plexiform neurofibromas: These are rare, benign tumors that grow on the nerve cells and can cause symptoms such as pain, weakness, or numbness.

Neoplasms, nerve tissue can be diagnosed through a variety of methods, including imaging tests such as MRI or CT scans, and tissue biopsy. Treatment options depend on the type and location of the tumor, and may include surgery, radiation therapy, or chemotherapy.

There are several subtypes of NHL, including:

1. B-cell lymphomas (such as diffuse large B-cell lymphoma and follicular lymphoma)
2. T-cell lymphomas (such as peripheral T-cell lymphoma and mycosis fungoides)
3. Natural killer cell lymphomas (such as nasal NK/T-cell lymphoma)
4. Histiocyte-rich B-cell lymphoma
5. Primary mediastinal B-cell lymphoma
6. Mantle cell lymphoma
7. Waldenström macroglobulinemia
8. Lymphoplasmacytoid lymphoma
9. Myelodysplastic syndrome/myeloproliferative neoplasms (MDS/MPN) related lymphoma

These subtypes can be further divided into other categories based on the specific characteristics of the cancer cells.

Symptoms of NHL can vary depending on the location and size of the tumor, but may include:

* Swollen lymph nodes in the neck, underarm, or groin
* Fever
* Fatigue
* Weight loss
* Night sweats
* Itching
* Abdominal pain
* Swollen spleen

Treatment for NHL typically involves a combination of chemotherapy, radiation therapy, and in some cases, targeted therapy or immunotherapy. The specific treatment plan will depend on the subtype of NHL, the stage of the cancer, and other individual factors.

Overall, NHL is a complex and diverse group of cancers that require specialized care from a team of medical professionals, including hematologists, oncologists, radiation therapists, and other support staff. With advances in technology and treatment options, many people with NHL can achieve long-term remission or a cure.

Precancerous changes in the uterine cervix are called dysplasias, and they can be detected by a Pap smear, which is a routine screening test for women. If dysplasia is found, it can be treated with cryotherapy (freezing), laser therapy, or cone biopsy, which removes the affected cells.

Cervical cancer is rare in developed countries where Pap screening is widely available, but it remains a common cancer in developing countries where access to healthcare and screening is limited. The human papillomavirus (HPV) vaccine has been shown to be effective in preventing cervical precancerous changes and cancer.

Cervical cancer can be treated with surgery, radiation therapy, or chemotherapy, depending on the stage and location of the cancer. The prognosis for early-stage cervical cancer is good, but advanced-stage cancer can be difficult to treat and may have a poor prognosis.

The following are some types of uterine cervical neoplasms:

1. Adenocarcinoma in situ (AIS): This is a precancerous condition that occurs when glandular cells on the surface of the cervix become abnormal and grow out of control.
2. Cervical intraepithelial neoplasia (CIN): This is a precancerous condition that occurs when abnormal cells are found on the surface of the cervix. There are several types of CIN, ranging from mild to severe.
3. Squamous cell carcinoma: This is the most common type of cervical cancer and arises from the squamous cells that line the cervix.
4. Adnexal carcinoma: This is a rare type of cervical cancer that arises from the glands or ducts near the cervix.
5. Small cell carcinoma: This is a rare and aggressive type of cervical cancer that grows rapidly and can spread quickly to other parts of the body.
6. Micropapillary uterine carcinoma: This is a rare type of cervical cancer that grows in a finger-like shape and can be difficult to diagnose.
7. Clear cell carcinoma: This is a rare type of cervical cancer that arises from clear cells and can be more aggressive than other types of cervical cancer.
8. Adenocarcinoma: This is a type of cervical cancer that arises from glandular cells and can be less aggressive than squamous cell carcinoma.
9. Sarcoma: This is a rare type of cervical cancer that arises from the connective tissue of the cervix.

The treatment options for uterine cervical neoplasms depend on the stage and location of the cancer, as well as the patient's overall health and preferences. The following are some common treatments for uterine cervical neoplasms:

1. Hysterectomy: This is a surgical procedure to remove the uterus and may be recommended for early-stage cancers or precancerous changes.
2. Cryotherapy: This is a minimally invasive procedure that uses liquid nitrogen to freeze and destroy abnormal cells in the cervix.
3. Laser therapy: This is a minimally invasive procedure that uses a laser to remove or destroy abnormal cells in the cervix.
4. Cone biopsy: This is a surgical procedure to remove a small cone-shaped sample of tissue from the cervix to diagnose and treat early-stage cancers or precancerous changes.
5. Radiation therapy: This is a non-surgical treatment that uses high-energy rays to kill cancer cells and may be recommended for more advanced cancers or when the cancer has spread to other parts of the body.
6. Chemotherapy: This is a non-surgical treatment that uses drugs to kill cancer cells and may be recommended for more advanced cancers or when the cancer has spread to other parts of the body.
7. Immunotherapy: This is a non-surgical treatment that uses drugs to stimulate the immune system to fight cancer cells and may be recommended for more advanced cancers or when other treatments have failed.
8. Targeted therapy: This is a non-surgical treatment that uses drugs to target specific genes or proteins that contribute to cancer growth and development and may be recommended for more advanced cancers or when other treatments have failed.

It is important to note that the choice of treatment will depend on the stage and location of the cancer, as well as the patient's overall health and preferences. Patients should discuss their treatment options with their doctor and develop a personalized plan that is right for them.

There are several different types of penile neoplasms, including:

1. Penile squamous cell carcinoma: This is the most common type of malignant penile neoplasm, and it arises from the squamous cells that line the shaft of the penis.
2. Penile basal cell carcinoma: This is a slower-growing type of malignant penile neoplasm that arises from the basal cells that are found in the skin of the penis.
3. Penile melanoma: This is a rare and aggressive type of malignant penile neoplasm that arises from the pigment-producing cells called melanocytes.
4. Penile adenocarcinoma: This is a rare type of malignant penile neoplasm that arises from the glandular cells that are found in the penis.
5. Penile lymphoma: This is a rare type of malignant penile neoplasm that arises from the immune system's lymphoid tissue.

The symptoms of penile neoplasms can vary depending on the location and size of the growth, but they may include:

* A firm or hard lump on the penis
* Painless bleeding or discharge from the penis
* Redness or swelling of the skin on the penis
* Difficulty urinating or painful urination
* Pain during sexual activity

If you notice any of these symptoms, it is important to seek medical attention as soon as possible. A healthcare provider will perform a physical examination and may use imaging tests such as ultrasound or biopsy to diagnose the condition. Treatment for penile neoplasms depends on the type and stage of the cancer, but may include surgery, radiation therapy, chemotherapy, or a combination of these. It is important to seek medical attention if you notice any unusual changes in your penis, as early diagnosis and treatment can improve outcomes.

Explanation: Neoplastic cell transformation is a complex process that involves multiple steps and can occur as a result of genetic mutations, environmental factors, or a combination of both. The process typically begins with a series of subtle changes in the DNA of individual cells, which can lead to the loss of normal cellular functions and the acquisition of abnormal growth and reproduction patterns.

Over time, these transformed cells can accumulate further mutations that allow them to survive and proliferate despite adverse conditions. As the transformed cells continue to divide and grow, they can eventually form a tumor, which is a mass of abnormal cells that can invade and damage surrounding tissues.

In some cases, cancer cells can also break away from the primary tumor and travel through the bloodstream or lymphatic system to other parts of the body, where they can establish new tumors. This process, known as metastasis, is a major cause of death in many types of cancer.

It's worth noting that not all transformed cells will become cancerous. Some forms of cellular transformation, such as those that occur during embryonic development or tissue regeneration, are normal and necessary for the proper functioning of the body. However, when these transformations occur in adult tissues, they can be a sign of cancer.

See also: Cancer, Tumor

Word count: 190

1. Carcinomas: These are the most common type of cancer and arise from epithelial cells, which line the surfaces of organs and glands. Examples of carcinomas include breast cancer, lung cancer, and colon cancer.
2. Sarcomas: These are cancers that arise from connective tissue cells, such as bone, cartilage, and fat. Examples of sarcomas include osteosarcoma (bone cancer) and soft tissue sarcoma.
3. Lymphomas and leukemias: These are cancers of the immune system and blood, respectively. Examples of lymphomas include Hodgkin's lymphoma and non-Hodgkin's lymphoma, while examples of leukemias include acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL).
4. Melanomas: These are cancers that arise from pigment-producing cells called melanocytes. Examples of melanomas include skin melanoma and eye melanoma.
5. Adenocarcinomas: These are cancers that arise from glandular cells, which produce fluids or mucus. Examples of adenocarcinomas include breast cancer, prostate cancer, and pancreatic cancer.
6. Squamous cell carcinomas: These are cancers that arise from squamous cells, which make up the outer layer of the skin and mucous membranes. Examples of squamous cell carcinomas include head and neck cancer and cervical cancer.
7. Neuroendocrine tumors: These are cancers that arise from cells that produce hormones and neurotransmitters. Examples of neuroendocrine tumors include pancreatic neuroendocrine tumors and lung carcinoid tumors.
8. Gastrointestinal stromal tumors (GISTs): These are cancers that arise from specialized cells in the digestive system called interstitial cells of Cajal. Examples of GISTs include stomach cancer and small intestine cancer.
9. Hypothalamic hamartomas: These are rare benign tumors that occur in the brain and can cause seizures, cognitive impairment, and other symptoms.
10. Lymphangioleiomyomatosis (LAM): This is a rare lung disease that occurs almost exclusively in women of childbearing age. It is characterized by cysts and growths in the lungs and can lead to respiratory problems, chest pain, and other symptoms.

These are just a few examples of the many different types of rare diseases that exist. There are thousands more, each with its own unique set of symptoms and causes.

Nerve sheath neoplasms are usually slow-growing and may not cause any symptoms in the early stages. However, as they grow, they can exert pressure on the surrounding nerve tissue and cause a variety of symptoms, including:

1. Pain or numbness in the affected area
2. Weakness or paralysis of the muscles served by the affected nerve
3. Tingling or burning sensations in the skin or extremities
4. Seizures, in rare cases

The exact cause of nerve sheath neoplasms is not known, but they are thought to be associated with genetic mutations that affect the development and growth of nerve cells. Some cases may also be caused by inherited conditions, such as Neurofibromatosis type 1 (NF1) or schwannomatosis.

There are several types of nerve sheath neoplasms, including:

1. Neurofibromas: These are the most common type of nerve sheath tumor and are usually benign. They can occur in any part of the body and may grow slowly over time.
2. Schwannomas: These are also benign tumors that arise from the covering of nerves (the schwann cells). They are usually slow-growing and can occur in any part of the body.
3. Malignant peripheral nerve sheath tumors (MPNSTs): These are rare and aggressive tumors that can arise from the coverings of nerves. They can grow rapidly and can be difficult to treat.

Diagnosis of nerve sheath neoplasms typically involves a combination of imaging studies, such as MRI or CT scans, and a biopsy to confirm the presence of a tumor. Treatment options vary depending on the type, size, and location of the tumor, as well as the patient's overall health. Surgery is often the first line of treatment for nerve sheath neoplasms, and may be followed by radiation therapy or chemotherapy in some cases.

... and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms". ... Normal endometrial stroma Endometrial stromal sarcoma (ESS) are CD10+ (Smooth muscle tumors are usually CD10−, but can be CD10+ ... CD10+ differentiates mucinous cystic neoplasms (CD10+/CK20+) from intraductal papillary mucinous neoplasm of branch duct type ( ... Murali R, Delprado W (2005). "CD10 immunohistochemical staining in urothelial neoplasms". Am. J. Clin. Pathol. 124 (3): 371-9. ...
Huang HY, Ladanyi M, Soslow RA (2004). "Molecular detection of JAZF1-JJAZ1 gene fusion in endometrial stromal neoplasms with ... Oliva E, de Leval L, Soslow RA, Herens C (2007). "High frequency of JAZF1-JJAZ1 gene fusion in endometrial stromal tumors with ... analysis of the JAZF1-JJAZ1 gene fusion by RT-PCR and fluorescence in situ hybridization in endometrial stromal neoplasms". Am ... 2001). "Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors". Proc. Natl. Acad. Sci. U.S.A. 98 (11): ...
"Molecular detection of JAZF1-JJAZ1 gene fusion in endometrial stromal neoplasms with classic and variant histology: evidence ... analysis of the JAZF1-JJAZ1 gene fusion by RT-PCR and fluorescence in situ hybridization in endometrial stromal neoplasms". The ... This zinc finger gene has been identified at the breakpoints of a recurrent chromosomal translocation reported in endometrial ... "Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors". Proceedings of the National Academy of Sciences of ...
Breast carcinomas Vaginal, cervical and/or endometrial neoplasms Papillary neoplasms of several organs: papillary transitional ... It can be present in: Thyroid neoplasms: It is a characteristic feature of papillary thyroid carcinoma, but has also been seen ... in other types of thyroid neoplasms, as well as in non-neoplastic thyroid lesions. Ovarian tumors including Brenner tumors, ...
... malignant neoplasm Fibroids - benign neoplasms Adenomyosis - ectopic growth of endometrial tissue within the myometrium ... In cases of a lining 3 mm or less and clear endometrial fluid, endometrial biopsy was not regarded to be necessary, but ... ultrasonography should undergo endometrial biopsy if the endometrial lining is thicker than 3 mm or if the endometrial fluid is ... endometrial tuberculosis) resulting in endometrial scarring followed by adhesion formation that partially or completely ...
... endometrial, ovarian, salivary prostate, lung, pancreas, and colon neoplasms. PELP1 signaling contributes to hormonal therapy ... AR, PELP1 and Src form constitutive complexes in prostate neoplasms model cells that exhibit androgen independence. Cytoplasmic ... and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors". The Journal of ...
If the cause of the hematometra is unclear, a biopsy of endometrial tissue can be taken to test for the presence of a neoplasm ... Additionally, hematometra may develop as a complication of uterine or cervical surgery such as endometrial ablation, where scar ... Other causes are acquired, such as cervical stenosis, intrauterine adhesions, endometrial cancer, and cervical cancer. ... tissue in the endometrium can "wall off" sections of endometrial glands and stroma causing blood to accumulate in the uterine ...
... fallopian tube neoplasms MeSH C04.588.945.418.948 - uterine neoplasms MeSH C04.588.945.418.948.585 - endometrial neoplasms MeSH ... endometrial stromal MeSH C04.588.945.418.948.850 - uterine cervical neoplasms MeSH C04.588.945.418.955 - vaginal neoplasms MeSH ... skull base neoplasms MeSH C04.588.149.828 - spinal neoplasms MeSH C04.588.180.260 - breast neoplasms, male MeSH C04.588.180.390 ... bile duct neoplasms MeSH C04.588.274.120.250.250 - common bile duct neoplasms MeSH C04.588.274.120.401 - gallbladder neoplasms ...
Types include: Cancer of the female genital organs: (Cervical cancer, Endometrial cancer, Ovarian cancer, Uterine cancer, ... A urogenital neoplasm is a tumor of the urogenital system. ... Neoplasm stubs, Disease stubs, Genitourinary system stubs). ...
Progression of EIN to carcinoma, effectively a conversion from a benign neoplasm to a malignant neoplasm, is accomplished ... Mutter GL (March 2000). "Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial ... the long term endometrial cancer risk is 45 times greater for a woman with EIN compared to one with only a benign endometrial ... "Prediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosis". Mod. Pathol. 18 (3): 324-30 ...
... except isthmus Endometrial cancer 183 Malignant neoplasm of ovary and other uterine adnexa 184 Malignant neoplasm of other and ... 140 Malignant neoplasm of lip 141 Malignant neoplasm of tongue 142 Malignant neoplasm of major salivary glands 143 Malignant ... benign neoplasm of uterus 220 Benign neoplasm of ovary 221 Benign neoplasm of other female genital organs 222 Benign neoplasm ... neoplasm of oropharynx 147 Malignant neoplasm of nasopharynx 148 Malignant neoplasm of hypopharynx 149 Malignant neoplasm of ...
... s are a class of ovarian neoplasms that may be benign or malignant. Neoplasms in this group are ... Glands bearing a strong resemblance to endometrial-type glands Benign tumors have mature-appearing glands in a fibrous stroma ... Research suggests that in the first line treatment of Endometrial Ovarian Cancer (EOC), Pegylated Liposomal Doxorubicin paired ... One rare but noteworthy condition associated with mucinous ovarian neoplasms is pseudomyxoma peritonei. As primary ovarian ...
In normal endometrial tissue, there is no H19 expression; however, in endometrial cancer, H19 is expressed. The expression ... In contrast to most other cancers, adrenocortical neoplasms appear to have decreased expression of H19. To determine a possible ... endometrial cancer, breast cancer, acute T cell leukemia/lymphoma, Wilms' tumor, testicular germ cell cancer, esophageal cancer ... adrenocortical neoplasms, choriocarcinomas, hepatocellular carcinomas, bladder cancers, ovarian serous epithelial cancers, head ...
... and Uterine Corpus Endometrial Carcinoma. MORT is silenced in cervical cancer and therefore may serve as an independent ... lymphoid neoplasm diffuse large B-cell lymphoma, pancreatic adenocarcinoma, rectum adenocarcinoma, skin cutaneous melanoma, ...
There is an association with endometriosis and concurrent primary endometrial carcinoma (endometrial cancer). On gross ... They are part of the surface epithelial tumor group of ovarian neoplasms (10-20% of which are the endometrioid type). Benign ... Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN gene mutation profiles. PTEN mutations are more ... Endometrioid tumors are a class of tumor characterized by a resemblance to endometrium/ endometrial carcinoma, and over a third ...
Comparison of Neoplasms in Six Sources of Rats Diamond JM (January 2006). Collapse: How Societies Choose to Fail or Succeed. ... mammary gland tumors and endometrial carcinomas in females, and C-cell adenomas/adenocarcinomas of the thyroid gland and tumors ... The Lewis rat suffers from several spontaneous pathologies: first, they can suffer from high incidences of neoplasms, with the ... A 1972 study compared neoplasms in Sprague Dawley rats from six different commercial suppliers and found highly significant ...
... s or theca cell tumors are benign ovarian neoplasms composed only of theca cells. Histogenetically they are classified ... have endometrial carcinoma. Grossly, the tumour is solid and yellow. Grossly and microscopically, it consists of the ovarian ...
References for findings: - Ayana Suzuki, C.T., Andrey Bychkov, M.D., Ph.D. "Hürthle cell neoplasm". Pathology Outlines.{{cite ... The management of AGC is colposcopy with or without an endometrial biopsy. The Bethesda System for Reporting Thyroid ... Cytopathology suspicious for Hürthle cell neoplasm (Bethesda category IV, rather than Hürthle cell hyperplasia), Pap stain. ...
... aka Hurthle-Cell Neoplasms). Expression of PAX8 is increased in neoplastic renal tissues, Wilms tumors, ovarian cancer and ... and endometrial carcinomas. Expression of PAX8 is also induced during the development of cervical cancer. Tumors expressing the ...
Endometrial ablation greatly reduces or eliminates monthly bleeding in ninety percent of patients with DUB. It is not effective ... "Peritoneal Dissemination Complicating Morcellation of Uterine Mesenchymal Neoplasms". PLOS ONE. 7 (11): e50058. Bibcode: ... Menorrhagia (heavy or abnormal menstrual bleeding) may also be treated with the less invasive endometrial ablation which is an ... Surprisingly, a similar and only slightly weaker effect has been observed for endometrial ablation which is often considered as ...
One possibility is that FBXW7 substrate stabilization is detrimental in these neoplasms. For example, the FBXW7 substrate C/EBP ... "hCDC4 gene mutations in endometrial cancer". Cancer Res. 62 (16): 4535-9. PMID 12183400. Li J, Pauley AM, Myers RL, Shuang R, ... endometrial carcinoma (16%), colorectal carcinoma (16%), bladder cancer (10%), gastric carcinoma (6%), lung squamous cell ... amplification and hCDC4 mutations in endometrial carcinoma". J. Pathol. 201 (4): 589-95. doi:10.1002/path.1474. PMID 14648662. ...
... uterine neoplasms MeSH C13.371.852.762.200 - endometrial neoplasms MeSH C13.371.852.762.200.500 - endometrial stromal tumors ... uterine neoplasms MeSH C13.371.820.800.418.875.200 - endometrial neoplasms MeSH C13.371.820.800.418.875.200.124 - carcinoma, ... vaginal neoplasms MeSH C13.371.820.800.418.968 - vulvar neoplasms MeSH C13.371.820.800.820 - urologic neoplasms MeSH C13.371. ... uterine cervical neoplasms MeSH C13.371.852.150.150 - uterine cervicitis MeSH C13.371.852.228 - endometrial hyperplasia MeSH ...
Endometrial/Ovarian cancer A transvaginal ultrasound with or without endometrial biopsy is recommended annually for ovarian and ... and sebaceous neoplasms. Increased risk of prostate cancer and breast cancer has also been associated with Lynch syndrome, ... making endometrial cancer the most common sentinel cancer in Lynch syndrome. The most common symptom of endometrial cancer is ... Among women with HNPCC who have both colon and endometrial cancer, about half present first with endometrial cancer, ...
... there was no difference in the overall survival of women with unsuspected uterine malignancy with or without endometrial cancer ... "Peritoneal Dissemination Complicating Morcellation of Uterine Mesenchymal Neoplasms". PLOS ONE. 7 (11): e50058. Bibcode: ...
In advanced-stage endometrial cancer, adjuvant therapy is typically radiation, chemotherapy, or a combination of the two. While ... Depending on what form of treatment is used, adjuvant therapy can have side effects, like all therapy for neoplasms. ... Since most early-stage endometrial cancer cases are diagnosed early and are typically very curable with surgery, adjuvant ... Galaal, K; Al Moundhri, M (15 May 2014). "Adjuvant chemotherapy for advanced endometrial cancer". Cochrane Database of ...
v t e (Articles with short description, Short description is different from Wikidata, Benign neoplasms, Noninflammatory ... The microscopic differential diagnosis includes endometrial carcinoma and endocervical adenocarcinoma. Intermed. mag. Very high ...
More extensive testing might include an MRI and endometrial sampling. Endometrial sampling is recommended in those over the age ... neoplasm, drugs, or it may be otherwise unknown.[citation needed] Diagnosis of AUB starts with a medical history and physical ... endometrial problems, healthcare induced, and not yet classified. More than one category of causes may apply in an individual ... and surgery such as endometrial ablation or hysterectomy. Over the course of a year, roughly 20% of reproductive-aged women ...
The total endometrial transformation dose of MGA is 50 mg per cycle. MGA has antigonadotropic effects in humans at sufficient ... Frick J, Marberger H, Swoboda HP (May 1971). "[Hormone therapy of prostatic neoplasms]". Urologe (in German). 10 (3): 117-9. ... It is also used to treat breast cancer and endometrial cancer, and has been used in birth control. MGA is generally formulated ... MGA was reported to be effective in the treatment of endometrial hyperplasia in the mid-1960s. It first started to be studied ...
Endometrial cells in women with endometriosis demonstrate increased expression of splice variants of CD44, and increased ... On the contrary, in some neoplasms CD44 upregulation is associated with a favorable outcome. This is true of prostate cancer, ... Griffith JS, Liu YG, Tekmal RR, Binkley PA, Holden AE, Schenken RS (Apr 2010). "Menstrual endometrial cells from women with ... and CD44-soluble proteins markedly reduces the malignant activities of various neoplasms, stressing the therapeutic potential ...
Endometrial cancer and lymphomas can also metastasize to the ovary. Ovarian borderline tumors, sometimes called low malignant ... They can develop further into a variety of other neoplasms, including choriocarcinoma, yolk sac tumor, and teratoma. They occur ... Because these tumors produce estrogen, they can cause or occur at the same time as endometrial cancer or breast cancer. Other ... A strong family history of endometrial cancer, colon cancer, or other gastrointestinal cancers may indicate the presence of a ...
They form a subset of neoplasms. A neoplasm or tumor is a group of cells that have undergone unregulated growth and will often ... and endometrial cancer. Even in these cases, however, the use of glycolysis as an energy source rarely exceeds 60%. A few ... endometrial or cervical cancer). Although localized pain may occur in advanced cancer, the initial tumor is usually painless. ...
... and prevention of endometrial hyperplasia and endometrial cancer In each of these areas, there is considerable debate as to the ... androgen-secreting neoplasms, and other pituitary or adrenal disorders, should be investigated. History-taking, specifically ... Endometrial hyperplasia and endometrial cancer (cancer of the uterine lining) are possible, due to overaccumulation of uterine ... Barry JA, Azizia MM, Hardiman PJ (1 September 2014). "Risk of endometrial, ovarian and breast cancer in women with polycystic ...
These neoplasms were initially regarded as eosinophilias, hypereosinophilias, Myeloid leukemias, myeloproliferative neoplasms, ... of endometrial cancers (half amplifications, half other types of mutations); ~6% of prostate cancers (half amplifications, half ... Unlike many other myeloid neoplasms with eosinophil such as those caused by Platelet-derived growth factor receptor A or ...
This can eventually progress to endometrial cancer, and the risk of endometrial cancer similarly increases with duration of ... "Pharmacology and Clinical Utility of Hormones in Hormone Related Neoplasms". In Alan C. Sartorelli, David G. Johns (eds.). ... The risk of endometrial hyperplasia is greatly increased by 6 months of treatment (OR = 5.4) and further increased after 36 ... As a result, they are able to completely block the increase in risk of endometrial hyperplasia caused by estrogen therapy in ...
... infective Endocarditis Endocrinopathy Endometrial stromal sarcoma Endometriosis Endomyocardial fibroelastosis Endomyocardial ... coloboma talipes Esophageal atresia Esophageal disorder Esophageal duodenal atresia abnormalities of hands Esophageal neoplasm ...
The factors limiting the growth of malignant neoplasm include the basal membrane and various components of the surrounding ... Collective cell migration has been observed in the development and progression of breast and endometrial cancer, prostate ... The results of numerous experimental and clinical studies of malignant neoplasms have indicated that invasive growth and ... to collective migration is an important step towards increasing the invasive and metastatic potential of malignant neoplasms. ...
... is any one of a group of malignant neoplasms that have a characteristic appearance under the microscope, i.e. consisting of ... the more common fetal and embryonal types do not Merkel cell carcinoma Mesenchymal chondrosarcoma Endometrial stromal ...
List of cutaneous neoplasms associated with systemic syndromes Mester J, Eng C (January 2015). "Cowden syndrome: recognizing ... Female and Male Genitourinary Females have an elevated risk of developing endometrial cancers, which is highest for those under ... endometrial, thyroid, colorectal, renal, and skin cancer. See below for a complete list of recommendations from the NCCN: ... neoplasms, and cysts, Syndromes affecting the breast, Syndromes affecting the gastrointestinal tract). ...
A neoplasm is a tissue whose cells have lost normal differentiation. They can be either benign growths or malignant growths. ... The Amsterdam Criteria is too restrictive and was later expanded to include cancers of endometrial, ovarian, gastric, ... Paris classification of colorectal neoplasms. In colonoscopy, colorectal polyps can be classified by NICE (Narrow-band imaging ...
MRI can also identify other uterine (e.g. adenomyosis, endometrial polyps, endometrial cancer) and extrauterine (e.g. benign ... Benign neoplasms, Wikipedia medicine articles ready to translate, Uterine tumour). ... Endometrial ablation can be used if the fibroids are only within the uterus and not intramural and relatively small. High ... Bulun SE, Yang S, Fang Z, Gurates B, Tamura M, Zhou J, Sebastian S (2001). "Role of aromatase in endometrial disease". The ...
It arises in the setting of endometrial atrophy and is classified as a type II endometrial cancer. Chen MY, Jung SM, Ng KK, ... They are common neoplasms with a strong tendency to occur bilaterally, and they account for approximately a quarter of all ... A serous tumour is a neoplasm that typically has papillary to solid formations of tumor cells with crowded nuclei, and which ... Uterine serous carcinoma is an uncommon form of endometrial cancer that typically arises in postmenopausal women. It is ...
... islet cell Rectal cancer Small intestine cancer Bladder cancer Cervical cancer Endometrial cancer Extragonadal germ cell tumor ... Marginal zone B-cell lymphoma Mast cell leukemia Mediastinal large B cell lymphoma Multiple myeloma/plasma cell neoplasm ...
Studies on progestogenic endometrial changes with oral OHPC in women are mixed however, with one finding weak effects with 100 ... Dao, Thomas L. (1975). "Pharmacology and Clinical Utility of Hormones in Hormone Related Neoplasms". In Alan C. Sartorelli; ... In addition, OHPC is used in the treatment of endometrial cancer and has been found to be significantly effective in extending ... Following a single intramuscular injection of 1,000 mg OHPC in five women with endometrial cancer, peak levels of OHPC were ...
There is an estimated 18-21% risk of ovarian cancer, 9% risk of endometrial cancer, and 10% risk of cervical cancer, ... Melanocytic nevi and neoplasms, Oral mucosal pathology). ...
People with BHD were once thought to be at higher risk for colorectal polyps and neoplasms, but this has been disproven. The ... they also are prone to endometrial and salivary gland clear-cell hyperplasia as well as rhabdomyolysis. Homozygotes do not ... neoplasms, and cysts, Autosomal dominant disorders, Syndromes with tumors, Syndromes affecting the lung, Rare syndromes). ...
... benign or malignant neoplasms Large bowel obstruction caused by colorectal cancer, inflammatory bowel disease, volvulus, fecal ... endometrial cancer Left lower quadrant Bowel: diverticulitis, sigmoid colon volvulus, bowel obstruction, gas accumulation, ...
"Endometrial Neoplasms" by people in this website by year, and whether "Endometrial Neoplasms" was a major or minor topic of ... "Endometrial Neoplasms" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH (Medical ... Below are the most recent publications written about "Endometrial Neoplasms" by people in Profiles. ... Below are MeSH descriptors whose meaning is more general than "Endometrial Neoplasms". ...
Endometrial Neoplasms. Uterine Neoplasms. Genital Neoplasms, Female. Urogenital Neoplasms. Neoplasms by Site. Neoplasms. ... Immunotherapy in endometrial cancer Endometrial cancer is the only gynaecologic malignancy with a rising incidence and ... Dendritic Cells for Immunotherapy of Metastatic Endometrial Cancer Patients (DECENDO). The safety and scientific validity of ... Coosemans A, Moerman P, Verbist G, Maes W, Neven P, Vergote I, Van Gool SW, Amant F. Wilms tumor gene 1 (WT1) in endometrial ...
Computed tomography in malignant endometrial neoplasms. J Comput Assist Tomogr. 1983 Aug. 7(4):677-81. [QxMD MEDLINE Link]. ... may show a thick endometrial stripe as secondary to diffuse endometrial thickening, focal endometrial thickening, polyp or ... Images of endometrial carcinoma are provided below.). A 76-year-old woman with poorly differentiated endometrial adenocarcinoma ... CT findings in endometrial cancer include the following:. * Relatively hypoattenuated mass in the region of the endometrial ...
Endometrial hyperplasia, as currently diagnosed, includes the changes caused by an abnormal hormonal state and those caused ... Endometrial Hyperplasia / diagnosis* * Endometrial Hyperplasia / pathology * Endometrial Neoplasms / diagnosis* * Endometrial ... "endometrial intraepithelial neoplasia" (EIN), respectively. Benign endometrial hyperplasia involves the entire endometrial ... Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia Int J Gynecol Pathol. 2007 Apr;26(2):103-14. ...
The most common type, endometrial cancer, happens most often in women over 55. Know the signs and symptoms. ... ClinicalTrials.gov: Endometrial Neoplasms (National Institutes of Health) * ClinicalTrials.gov: Uterine Neoplasms (National ... Endometrial Cancer Screening (National Cancer Institute) Also in Spanish * Endometrial Cancer Stages (American Cancer Society) ... Endometrial Cancer Prevention (National Cancer Institute) Also in Spanish * Endometrial Cancer Risk Factors (American Cancer ...
Endometrial Neoplasms. 1. 2017. 1336. 0.080. Why? Liver Transplantation. 1. 2017. 2019. 0.080. Why? ...
Genital Neoplasms, Female, Brachytherapy, Uterine Cervical Neoplasms, Endometrial Neoplasms, Radiotherapy, Gynecology Image- ... Genital Neoplasms, Female/surgery, Laparoscopy, Ovarian Neoplasms, Carcinoma, Hysterectomy, Vaginal, Electrosurgery, Fertility ... Genital Neoplasms, Female, Medical Oncology, Gynecology, Radiotherapy International Video Workshop on Radical Surgery in ... Brachytherapy, Genital Neoplasms, Female, Gynecology, Radiotherapy, Drug Therapy Image-guided radiotherapy & chemotherapy in ...
Endometrial cancer off-line staging using two-dimensional transvaginal ultrasound and three-dimensional volume contrast imaging ... Dive into the research topics of Endometrial cancer off-line staging using two-dimensional transvaginal ultrasound and three- ...
d Endometrial adenocarcinoma. Reprinted with permission from Pillai et al. [3].. Close modal ... Epithelial neoplasms, Carcinoma, EpCAM, Pediatric neoplasms, Small-round-blue-cell tumors, Small-cell carcinoma ... Nonhematopoietic Neoplasms in Serous Effusions. Epithelial neoplasms are not commonly thought to be conducive to flow ... FC is not used routinely in the diagnosis or follow-up of nonhematopoietic neoplasms. However, most nonhematopoietic neoplasms ...
In this study, we investigated the anticancer effect of dienogest on endometrial neoplasms using mouse model of endometrial ... Endometrial neoplasms were found in one of the eight (12.5%) mice from each group treated with either dienogest or MPA. In ... Development of a mouse model for testing therapeutic agents: the anticancer effect of dienogest on endometrial neoplasms.. ... Each progestin treatment showed anticancer activity against endometrial neoplasms that developed in the mice compared to those ...
Endometrial Cancer. Endometrial Cancers. Endometrial Carcinoma. Endometrial Carcinomas. Endometrial Neoplasm. Endometrium ... Carcinoma, Endometrial Carcinomas, Endometrial Endometrial Cancer Endometrial Cancers Endometrial Carcinomas Endometrium Cancer ... Neoplasm, Endometrial. Neoplasms, Endometrial. Tree number(s):. C04.588.945.418.948.585. C12.050.351.500.852.762.200. C12.050. ... Endometrial Neoplasms Entry term(s). Endometrial Neoplasm Neoplasm, Endometrial Neoplasms, Endometrial Endometrial Carcinoma - ...
Dive into the research topics of A retrospective study for investigating the outcomes of endometrial cancer treated with ... A retrospective study for investigating the outcomes of endometrial cancer treated with radiotherapy. ...
OBJECTIVE: Endometrial cancer is the most common gynecologic neoplasm. To date, international guidelines recommend sentinel ... Hiperplasia Endometrial/complicaciones , Hiperplasia Endometrial/patología , Hiperplasia Endometrial/cirugía , Neoplasias ... OBJECTIVE: Atypical endometrial hyperplasia (AH) is the neoplastic precursor more often associated with endometrial cancer (EC ... METHODS: A multicenter retrospective cohort of endometrial cancer patients with apparently early-stage endometrial cancer ...
Endometrial Neoplasms 1 0 Adenocarcinoma 1 0 Pulmonary Disease, Chronic Obstructive 1 0 ... Urinary Bladder Neoplasms 1 0 Note: The number of publications displayed in this table will differ from the number displayed in ...
Endometrial cancer rate [Time Frame: 1 month after admission] Endometrial hyperplasia rate [Time Frame: 1 month after admission ... Endometrial Neoplasms Intervention(s) Diagnostic Test: Ultrasound Diagnostic Test: Hysteroscopy Primary Outcome(s) ... Endometrial Malignancy in Breast Cancer Patients With or Without AUB TamAUB. Scientific title: Ultrasonographic, Hysteroscopic ... In case of non-AUB group ultrasonographic suspicion of endometrial or myometrial abnormalities Exclusion Criteria: - severe ...
Endometrial Neoplasms 1 0 Eosinophilic Esophagitis 1 0 Adenocarcinoma 1 0 Sarcoma, Kaposi 1 0 ...
In patients aged 1 year should be evaluated for hyperplasia and neoplasm with an endometrial sample stromectol japan FSH plus ...
... or Endometrial Cancer. Jorgensen, K., Meernik, C., Wu, C. F., Murphy, C. C., Baker, V. L., Jarmon, P., Brady, P. C., Nitecki, R ... Endometrial Neoplasms 84% * Fertility 77% * Uterine Cervical Neoplasms 75% * Ovarian Neoplasms 75% ...
18F-FDG PET is Superior to WHO Grading as a Prognostic Tool in Neuroendocrine Neoplasms and Useful in Guiding PRRT: A ... Rare Presentation of Late Complications After Undiagnosed Perforated Appendicitis Mimicking Recurrent Endometrial Carcinoma on ... 64Cu-DOTATATE PET/CT and Prediction of Overall and Progression-Free Survival in Patients with Neuroendocrine Neoplasms. Carlsen ... 64Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 ...
Prevalence of Lynch syndrome among patients with newly diagnosed endometrial cancers. Egoavil, C., Alenda, C., Castillejo, A., ... Hereditary Nonpolyposis Colorectal Neoplasms 100% * Endometrial Neoplasms 78% * Mutation 64% * neoplasms 58% ...
Neoplasms 90% * Uterine Cervical Neoplasms 86% * Endometrial Neoplasms 64% * Fertility 58% * Uterus 57% ...
Endometrial Neoplasms Medicine & Life Sciences 61% * Polyps Medicine & Life Sciences 60% * Neoplasms Medicine & Life Sciences ... Endometrial polyps are non-neoplastic but harbor epithelial mutations in endometrial cancer drivers at low allelic frequencies ...
Potential of an age-stratified CA125 cut-off value to improve the prognostic classification of patients with endometrial cancer ... Paired boxed gene 1 expression: A single potential biomarker for differentiating endometrial lesions associated with favorable ... and Epithelial-Mesenchymal Transition in Endometrial Epithelial Cells. Ho, N. T., Lin, S. W., Lee, Y. R., Tzeng, C. R. & Kao, S ... outcomes in patients with endometrial carcinoma. Liu, L. C., Lai, H. C., Chou, Y. C., Huang, R. L., Yu, M. H., Lin, C. P., Tsai ...
RESULTS: Among 249 791 postmenopausal women with 7.3 years of follow-up on average (1.8 million person-years), endometrial ... the association between body size in early life and endometrial cancer risk in postmenopausal women can be largely explained by ... of endometrial cancer were estimated using Cox regression. ... in early life has been linked to increased endometrial cancer ... Adiposity, Body Mass Index, Body Size, Child, Endometrial Neoplasms, Female, Humans, Middle Aged, Postmenopause, Risk, United ...
Colorectal Neoplasms (Phase 3) Endometrial Neoplasms (Phase 2) Esophageal Neoplasms (Phase 2) ...
  • Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer. (uchicago.edu)
  • Adjuvant treatment in early-stage endometrial cancer: context-dependent impact of somatic CTNNB1 mutation on recurrence-free survival. (uchicago.edu)
  • Tumor board presentation of a woman with metastatic, hormone receptor-positive, mismatch repair-deficient endometrial cancer. (uchicago.edu)
  • Effects of Slide Storage on Detection of Molecular Markers by IHC and FISH in Endometrial Cancer Tissues From a Clinical Trial: An NRG Oncology/GOG Pilot Study. (uchicago.edu)
  • Endometrial cancer is the most common female genital cancer, with the most common type being adenocarcinoma. (medscape.com)
  • Genetic predisposition appears to play a role, since risk factors also include a family history of endometrial or breast cancer and a personal history of ovarian or breast cancer. (medscape.com)
  • Approximately 75% of women with endometrial cancer are postmenopausal. (medscape.com)
  • For the 25% of endometrial cancers in patients who are perimenopausal or premenopausal, the symptoms suggestive of cancer may be subtler. (medscape.com)
  • Endometrial biopsy, usually using an aspiration-type curet or other device, is generally accepted as the first-step office procedure for the diagnosis of endometrial cancer and should be coupled with endocervical curettage. (medscape.com)
  • The use of an internal standard for cytology assessment, combined with the distinctive topography of a clonal process, enables the diagnosis of EIN lesions with a long-term cancer risk 45-fold greater than that of their benign endometrial hyperplasia counterparts. (nih.gov)
  • This type is also called endometrial cancer. (medlineplus.gov)
  • What Is Endometrial Cancer? (medlineplus.gov)
  • Can Endometrial Cancer Be Found Early? (medlineplus.gov)
  • What's New in Endometrial Cancer Research? (medlineplus.gov)
  • INTRODUCTION: Given the growing interest in sentinel node mapping (SLN) biopsy in Endometrial Cancer (EC) patients, many efforts have been made to maximize the SLN bilateral detection rate. (bvsalud.org)
  • Postmenopausal endometrial cancer risk and body size in early life and middle age: prospective cohort study. (ox.ac.uk)
  • BACKGROUND: Greater adiposity in early life has been linked to increased endometrial cancer risk in later life, but the extent to which this association is mediated through adiposity in later life is unclear. (ox.ac.uk)
  • METHODS: Among postmenopausal women who had never used menopausal hormone therapies and reported not having had a hysterectomy, adjusted relative risks (RRs) of endometrial cancer were estimated using Cox regression. (ox.ac.uk)
  • RESULTS: Among 249 791 postmenopausal women with 7.3 years of follow-up on average (1.8 million person-years), endometrial cancer risk (n=1410 cases) was strongly associated with current body mass index (BMI) at baseline (RR=1.87 per 5 kg m(-2) increase in BMI, 95% confidence interval (CI): 1.77-1.96). (ox.ac.uk)
  • CONCLUSION: Among women who have never used hormone therapy for menopause, the association between body size in early life and endometrial cancer risk in postmenopausal women can be largely explained by women's current BMI. (ox.ac.uk)
  • 12 months) for a gynecological cancer (ovarian, endometrial, cervical, and vulvar) and their primary caregivers. (tilburguniversity.edu)
  • without atypia individual endometrial cancer may be increased, but, as with simple hyperplasia without atypia, the internal structure of cells remains normal. (netlify.app)
  • For example, for women in the postmenopausal age, taking medications for hormone replacement therapy, hysterectomy may be the preferred method of treatment, as they have in the complex atypical hyperplasia increased risk of endometrial cancer. (netlify.app)
  • The fact that endometrial cancer grows and spreads slowly, and its features are almost always appear very early - usually a non-menstrual bleeding (they are a major symptom hyperplasia). (netlify.app)
  • If a woman regularly undergo a medical examination, and is closely monitoring the health, noting any change in his status, complex atypical hyperplasia and endometrial cancer will certainly be identified long before they become life-threatening. (netlify.app)
  • Conclusion: Le cancer de l'endomètre étant un cancer souvent d'emblée de mauvais pronostic, il est d'intérêt de mettre en place une stratégie de prévention et de management adapté.Mots clés: cancer, endomètre, étude clinicopathologique, suivi, Gabon Abstract:Introduction:The general objective of our work was to provide an epidemiological and clinicopathological description of endometrial cancer in Gabon. (bvsalud.org)
  • Introduction: The general objective of our work was to provide an epidemiological and clinicopathological description of endometrial cancer in Gabon. (bvsalud.org)
  • Conclusion: As endometrial cancer is often a cancer with a poor prognosis , it is interest to put in place an appropriate prevention and management strategy. (bvsalud.org)
  • Fruits, vegetables and endometrial cancer risk in women in the European forces in synthesizing evidence on new methods for the risk of cancer: a multisite case-control study in Prospective Investigation into Cancer and Nutrition cervical cancer prevention. (who.int)
  • For some cancers, clear conclusions could be reached: use of combined oral contraceptives protects against epithelial ovarian cancer, reduces the risk of endometrial cancer, and does not influence the risk of either malignant melanoma of the skin or pituitary tumours. (who.int)
  • A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study. (uchicago.edu)
  • Images of endometrial carcinoma are provided below. (medscape.com)
  • Endometrial "hyperplasia," as currently diagnosed, includes the changes caused by an abnormal hormonal state and those caused by a separate category of monoclonal premalignant disease. (nih.gov)
  • The appearance of the disease in these 2 functional categories is discontinuous, permitting more specific diagnosis of the condition using the terms "benign endometrial hyperplasia" and "endometrial intraepithelial neoplasia" (EIN), respectively. (nih.gov)
  • Benign endometrial hyperplasia involves the entire endometrial compartment and, with protracted estrogen exposure, shows the progressive development of cysts, remodeled glands, vascular thrombi, and stromal microinfarcts. (nih.gov)
  • The results of recent research suggest that the diagnosis of the type of endometrial hyperplasia is necessary, first of all, to identify the following: whether simple or complex hyperplasia, as well as whether there are abnormal cells in the endometrium (in this case speak of atypia). (netlify.app)
  • This species is also called adenomatous hyperplasia endometrial hyperplasia. (netlify.app)
  • Since atypia is also divided into simple and complex, the following types of endometrial hyperplasia is simple atypical hyperplasia. (netlify.app)
  • Complex atypical hyperplasia endometrial cancers becomes approximately 25-30% of cases. (netlify.app)
  • Sagittal transvaginal ultrasound image of the uterus shows a central mass replacing the endometrial stripe, with hyperechoic and hypoechoic regions. (medscape.com)
  • Endometriosis is defined as the presence of endometrial glandular tissue outside of the uterus. (medscape.com)
  • The cluster of malignant cells depicted here, had originated in the endometrial, or innermost lining of the uterus. (cdc.gov)
  • Many epithelial neoplasms can be analyzed by flow cytometry (FC), particularly from serous cavity effusion samples, using EpCAM, a cell adhesion molecule expressed on most normal epithelial cells and expressed at a higher level in most epithelial neoplasms. (karger.com)
  • Here we discuss the utility of FC in the diagnosis of epithelial neoplasms and small-round-blue-cell tumors in various samples. (karger.com)
  • Epithelial neoplasms are not commonly thought to be conducive to flow cytometric analysis, given their cohesiveness compared to hematopoietic neoplasms. (karger.com)
  • However, we and others have shown that many common epithelial neoplasms can be easily analyzed by FC [ 3,4,5,6 ]. (karger.com)
  • It is expressed at a higher level in most epithelial neoplasms [ 9 ]. (karger.com)
  • Hence, detection of epithelial cells is significant in a patient with a history or suspicion of an epithelial neoplasm. (karger.com)
  • Mixed Malignant Mullerian Tumors (MMMT) is biphasic neoplasms with endometrial epithelial and stromal components which are both malignant. (hysteroscopy.info)
  • Most endometrial cancers are detected at an early stage , with the tumor confined to the uterine corpus in 75% of patients. (medscape.com)
  • An endometrial curettage must be carried out to rule out concomitant uterine cancers in patients with granulosa cell tumors. (medscape.com)
  • These neoplasms can be benign or malignant. (uchicago.edu)
  • Malignant pleural effusion from various neoplasms constitutes the commonest thoracic malignancy in our tertiary hospital. (who.int)
  • The theory that metaplasia causes endometriosis is supported by the fact that endometrial cells and peritoneal cells derive from the same celomic wall epithelium. (medscape.com)
  • ESR1 hotspot mutations in endometrial stromal sarcoma with high-grade transformation and endocrine treatment. (uchicago.edu)
  • Dilatation and curettage confirmed the fluid to be old blood and established the diagnosis of endometrial malignancy. (medscape.com)
  • For many years, hysteroscopy was only used for early diagnosis of endometrial adenocarcinoma, considering hysteroscopic surgery an absolute contraindication. (hysteroscopy.info)
  • Endometrial Carcinomas With Subclonal Loss of Mismatch Repair Proteins: A Clinicopathologic and Genomic Study. (uchicago.edu)
  • Panels of flow cytometric markers are useful for the assessment of pediatric nonhematopoietic neoplasms, including neuroblastomas, primitive neuroectodermal tumors, Wilms' tumor, rhabdomyosarcomas, germ cell tumors, and hemangiopericytomas, as well as small-round-blue-cell tumors in adults, including small-cell carcinomas. (karger.com)
  • A 76-year-old woman with poorly differentiated endometrial adenocarcinoma. (medscape.com)
  • An 83-year-old woman with moderately differentiated endometrioid endometrial adenocarcinoma. (medscape.com)
  • While both TAS and TVS allow visualization of the endometrium, exquisitely finer endometrial details are possible to depict transvaginally rather than transabdominally. (medscape.com)
  • Neoplasms of pure ovarian stroma: in morphologically ambiguous cases, an immunopanel of inhibin alpha, calretinin, and FOXL2, plus mutational analysis for FOXL2 (402C-G), is useful to confirm adult granulosa cell tumors (AGCTs). (medscape.com)
  • Surgical pathology revealed approximately 4.0 cm of pedunculated endometrial tumor associated with only superficial myometrial invasion (limited to inner one third). (medscape.com)
  • Endometrial Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (uchicago.edu)
  • One theory is that endometrial tissue is spread by retrograde menstruation or by vascular and/or lymphatic spread. (medscape.com)
  • The resolution of hormonal and premalignant subsets of traditional "endometrial hyperplasias" is possible using redefined diagnostic criteria, enabling patient therapy to be appropriately matched with the underlying disease mechanisms. (nih.gov)
  • Flow cytometry (FC) is well established as a useful diagnostic modality for the assessment of hematopoietic neoplasms [ 1 ]. (karger.com)
  • [ 7 ] This theory also is supported by development of endometriosis in women who lack normal endometrial tissue, such as those with Turner syndrome or uterine agenesis . (medscape.com)
  • What Is Endometrial Cancer? (medlineplus.gov)
  • Can Endometrial Cancer Be Found Early? (medlineplus.gov)
  • What's New in Endometrial Cancer Research? (medlineplus.gov)
  • Endometrial cancer is the most common female genital cancer, with the most common type being adenocarcinoma. (medscape.com)
  • Genetic predisposition appears to play a role, since risk factors also include a family history of endometrial or breast cancer and a personal history of ovarian or breast cancer. (medscape.com)
  • Approximately 75% of women with endometrial cancer are postmenopausal. (medscape.com)
  • Endometrial biopsy, usually using an aspiration-type curet or other device, is generally accepted as the first-step office procedure for the diagnosis of endometrial cancer and should be coupled with endocervical curettage. (medscape.com)
  • Genetic screening in young women diagnosed with endometrial cancer. (nih.gov)
  • Endometrial cancer and Lynch syndrome: clinical and pathologic considerations. (nih.gov)
  • Synthetically lethal nanoparticles for treatment of endometrial cancer. (nih.gov)
  • Uterine serous carcinoma, one of the most aggressive types of endometrial cancer, is characterized by poor outcomes and mutations in the tumour suppressor p53. (nih.gov)
  • Our objective was to engender synthetic lethality to paclitaxel (PTX), the frontline treatment for endometrial cancer, in tumours with mutant p53 and enhance the therapeutic efficacy using polymeric nanoparticles (NPs). (nih.gov)
  • In a xenograft model of endometrial cancer, this combinatorial therapy resulted in a marked inhibition of tumour progression and extended survival. (nih.gov)
  • 8. Screening and the prevention of gynecologic cancer: endometrial cancer. (nih.gov)
  • Conclusion: Le cancer de l'endomètre étant un cancer souvent d'emblée de mauvais pronostic, il est d'intérêt de mettre en place une stratégie de prévention et de management adapté.Mots clés: cancer, endomètre, étude clinicopathologique, suivi, Gabon Abstract:Introduction:The general objective of our work was to provide an epidemiological and clinicopathological description of endometrial cancer in Gabon. (bvsalud.org)
  • Introduction: The general objective of our work was to provide an epidemiological and clinicopathological description of endometrial cancer in Gabon. (bvsalud.org)
  • Conclusion: As endometrial cancer is often a cancer with a poor prognosis , it is interest to put in place an appropriate prevention and management strategy. (bvsalud.org)
  • Or should I use the code for endometrial cancer, even though she no longer has a uterus? (medscape.com)
  • Fruits, vegetables and endometrial cancer risk in women in the European forces in synthesizing evidence on new methods for the risk of cancer: a multisite case-control study in Prospective Investigation into Cancer and Nutrition cervical cancer prevention. (who.int)
  • Dilatation and curettage confirmed the fluid to be old blood and established the diagnosis of endometrial malignancy. (medscape.com)
  • Adequate diagnostic measures, including endometrial sampling when indicated, should be undertaken to rule out malignancy in all cases of undiagnosed persistent or recurring abnormal vaginal bleeding. (nih.gov)
  • Sagittal transvaginal ultrasound image of the uterus shows a central mass replacing the endometrial stripe, with hyperechoic and hypoechoic regions. (medscape.com)
  • There is no evidence that the use of "natural" estrogens results in a different endometrial risk profile than "synthetic" estrogens at equivalent estrogen doses. (nih.gov)
  • Pathologic examination revealed infiltrating low-grade endometrial sarcoma invading the myometrium and left adnexa, with intravenous extension into the pelvic veins and the IVC to the right side of the heart. (medscape.com)
  • CT image shows a relatively hypoattenuated mass in the region of the endometrial cavity. (medscape.com)